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Humankind has reached, in tow by the hand of a scientific
breakthrough called CRISPR, the Rubicon of precise genetic
manipulation first envisioned over fifty years ago. Despite CRISPR's
renown in science and its power to transform the world, it remains
virtually unaddressed in legal scholarship. In the absence of on-point
law, the scientific community has attempted to reach some consensus to
preempt antagonistic regulation and prescribe subjective standards of
use under the guise of a priori scientific empiricism. Significant and
complex legal issues concerning this technology are emerging, and the
void in legal scholarship is no longer tolerable.
This Article shrinks the scholarly gap, and it is the first to
introduce CRISPR to legal literature. By providing a resource for
jurists, scholars, and practitioners, it challenges conventional notions
concerning the false dichotomy frequently associated with mutually
exclusive normative roles for science and law. The Article makes two
independent contributions. First, it lays a robust and comprehensive
epistemic foundation of genome editing suitable for legal audiences.
This element is descriptive, but essential because a detailed and
coherent understanding of the nuts and bolts of the science is requisite
for a discussion of law and policy. Second, it advocates for a
jurisprudence of scientific empiricism, namely, a normative legal
framework that consolidates empiricism and technological-e.g.,
genome editing-applications into a uniform doctrinal structure
unencumbered by common substantive impediments to constructive
debate. These impediments consist of impractical and often
J.D., LL.M., Ph.D. Candidate, Structural and Molecular Biochemistry. I am
indebted to Michael Byrne, Terri Beiner, and Sean Murphy for their generous comments and
thoughtful suggestions.
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sensationalist claims about issues raised by technological advances
and are collectively characterized as "deceptive simplicity." The
proposed paradigm, which lays a blueprint for the legal community to
combat the deleterious effects of scientific illiteracy, flows from the
Supreme Court's recent decision in Association for Molecular
Pathology v. Myriad Genetics and is broadly adaptable to addressing
questions of science in law.
Applying this framework, the Article reconsiders Buck v. Bell
and argues that, contrary to long-held views, Buck is not a direct
product of false science, but of unbridled deceptive simplicity. Lastly,
the Article sets the stage for a series of forthcoming works that will
analyze genome editing from regulatory, constitutional, international,
egalitarian, ethical, and policy standpoints, which highlight pivotal
synergistic roles for law, science, and public policy in the development
of this remarkable nascent biotechnology.
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I. INTRODUCTION
The most significant technological breakthrough of this
generation, namely, a genome editing tool called "CRISPR," has
inconspicuously arrived. Only on rare occasions does a technology
with such far-reaching implications lightly knock to announce its
arrival while holding the power to forever change the world and
humankind.
The world has heard that sporadic light knock before. Nearly
eight decades ago, scientific inquiry conceptualized nuclear fission' as
a theoretical explanation for the recondite empirical evidence that
239U, an isotope of uranium produced by the neutronic irradiation of
238U, could have its nucleus split into highly radioactive fragments.2
That theory was ultimately supported by experimental observations
showing the enormous release of ionization energy resulting from
nuclear fragmentation,3 thereby confirming a decades-old relationship
between mass and energy-E = mc2 -first formulated by Albert
Einstein.4 With remarkable speed, the newfangled knowledge covertly
1. Lise Meitner & O.R. Frisch, Disintegration of Uranium by Neutrons: A New Type of
Nuclear Reaction, 143 NATURE 239, 239 (1939).
2. Von 0. Hahn & F. Strassmann, Uber den Nachweis und das Verhalten der bei der
Bestrahlung des Urans Mittels Neutronen Entstehenden Erdalkalimetalle [Concerning the
Existence of Alkaline Earth Metals Resulting from Neutron Irradiation of Uranium], 27 DIE
NATURWISSENSCHAFTEN 11 (1939), translated in Hans G. Graetzer, Discovery of Nuclear Fission,
32 AM. J. PHYSICS 9, 10 (1964).
3. O.R. Frisch, Physical Evidence for the Division of Heavy Nuclei Under Neutron
Bombardment, 143 NATURE 276, 276 (1939).
4. A. Einstein, Ist die Trdgheit Eines Korpers von Seinem Energieinhalt abhdngig?
[Does the Inertia of a Body Depend upon its Energy-Content?], 18 ANNALEN DER PHYSIK 639
(1905), translated in THE COLLECTED PAPERS OF ALBERT EINSTEIN, VOL. 2, THE SWISS YEARS:
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served as the basis for the Manhattan Project, the research program
that ultimately developed the atomic bomb through nuclear fission.5
The scientific breakthrough modus operandi is, to a certain
extent, wholly universal. The genesis of modern computing had its
principles neatly packaged in a seminal paper authored by the
mathematician Alan Turing.6  The revolutionary notion that a
machine could imitate computations performed by humans spawned
the first "Turing-complete," programmable, general-purpose,
Electronic Numerical Integrator and Computer (ENIAC). 7
Unpredictably, the technology evolved into personal computers and
smartphones, and enabled the ensuing development of the Internet.8
Other fundamental discoveries over the past few centuries-in
mathematics, physics, chemistry, and biology-have facilitated our
ability to harness the power of natural phenomena in space travel,
wireless communications, medicine, and a myriad other applications.
The technological breakthrough of this generation, unlike
many of its predecessors, holds the power to alter humankind from
5. For a historical account of the origins and development of the US atomic bomb
program of World War II, see generally F.G. GOSLING, THE MANHATTAN PROJECT: MAKING THE
ATOMIC BOMB (U.S. Dep't of Energy ed. 1999).
6. A.M. Turing, On Computable Numbers, with an Application to the
Entscheidungsproblem, 42 PROC. LONDON MATHEMATICAL SOC'y 230, 230 (1937).
7. Electronic Numerical Integrator and Computer, U.S. Patent No. 3,120,606 (filed
June 26, 1947) (issued Feb. 4, 1964). To this day, debate exists concerning whether the first
modern computer was the Atanasoff-Berry Computer (ABC) or the ENIAC. See generally ALICE
ROWE BURKS, WHO INVENTED THE COMPUTER?: THE LEGAL BATTLE THAT CHANGED COMPUTING
HISTORY 247-68 (2003). Honeywell Inc. v. Sperry Rand Corp., No. 4-67 Civ. 138, 1973 WL 903, at
*7, *30-38, *90 (D. Minn. Oct. 19, 1973), invalidated the ENIAC patent on grounds
that the ABC constituted prior art, which rendered the patent invalid and unenforceable.
However, the ABC was neither programmable nor Turing-complete. Atanasoff-Berry Computer,
COMPUTER HIST. MUSEUM, http://www.computerhistory.org/revolution/birth-of-the-computer/4/99
[https://perma.cc/MPU6-S6PX] (last visited Feb. 23, 2017). Indeed, the ABC may be considered
the first electronic computer, while the ENIAC was the first general-purpose, programmable,
electronic computer. BURKS, supra, at 247-49, 330-31. It is somewhat settled that ENIAC was
the first Turing-complete, large-scale, electronic, programmable digital computer. See Michael R.
Williams, A Preview of Things to Come: Some Remarks on the First Generation of Computers, in
THE FIRST COMPUTERS: HISTORY AND ARCHITECTURES 3 (Raxil Rojas & Ulf Hashagen eds., 2000).
Thus, the debate focuses on whether ENIAC's programmable and Turing-complete features
qualify it as the direct precursor to modern computers. Ultimately, some dismiss the importance
of whether. the ABC, ENTAC, or other machines of the time constituted the "first" computer. Id.
Others argue that the invention of the modern computer has ambiguous origins and involves
contributions from scientists in at least three different countries. See Ratil Rojas, Who Invented
the Computer? The Debate from the Viewpoint of Computer Architecture, in MATHEMATICS OF
COMPUTATION 1943-1993: A HALF-CENTURY OF COMPUTATIONAL MATHEMATICS, 48 PROC.
SYMPOSIA APPLIED MATHEMATICS 361, 364-65 (Walter Gautschi ed., 1993).
8. See BARRY M. LEINER ET AL., BRIEF HISTORY OF THE INTERNET 1 (2012),
http://www.internetsociety.org/sites/default/files/BriefHistoryof-theInternet.pdf
[https://perma.cc/ZL6B-37EP] (chronicling the origins and evolution of the Internet).
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within. A quantum leap in genome editing9 capabilities has led us to
the Rubicon of precise, endogenous, genetic manipulation-one
originally envisioned decades ago, yet methodologically beyond reach
for prior generations of scientists. The protagonist of this genome
editing revolution is an atomic, programmable, macromolecular
machine comprising a pair of precision scalpels that shear DNA
molecules and has been colloquially baptized as "CRISPR," an
acronym for the system of Clustered, Regularly Interspaced, Short
Palindromic Repeats (CRISPR) and CRISPR-associated (Cas)
proteins.10
In the last four years, CRISPR systems-and CRISPR-Cas9 in
particular-have been adapted in laboratories across the globe at an
exponential rate. Astoundingly, more than 2,500 scientific
publications" feature theory, empirical observations, and descriptions
of applications for this budding biotechnology. Stratospheric
expectations for CRISPR systems have already attracted more than $1
billion in venture capital1 2 in a brief period of time. One of a few
CRISPR-based companies became the first to file the requisite
paperwork for an initial public offering with the Securities and
9. See definition infra Part II; see also infra notes 53-55 and accompanying text.
10. See discussion infra Section III.D.
11. A search on the PubMed scientific database using the "CRISPR" acronym filtered by
title and abstract returned 2,565 hits as of February 10, 2016. PubMed.gov Search Results for
CRISPR, PUBMED.GOV, http://www.ncbi.nlm.nih.gov/pubmed/?term=CRISPR[Title%2FAbstract]
[https://perma.ccl7PC2-BNN8] (last visited Feb. 10, 2016) (search for CRISPR filtered by title
and abstract by using the language "CRISPR[Title/Abstract]"). Note that the search does not
include papers that refer to CRISPR in the body of the paper, which may return more hits.
12. See, e.g., John Carroll, Bayer Bets $335M on CRISPR Therapeutics and the
Future of Gene Editing, FIERCEBIOTECH (Dec. 21, 2015),
http://www.fiercebiotech.com/story/bayer-bets- 335-crispr-therapeutics-and-future-gene-
editing/2015-12-21 [https://perma.cclLU94-5MUF]; Caroline Chen, Gene-Editing Drugmaker
Backed by Google, Gates Files for IPO, BLOOMBERG Bus. (Jan. 4, 2016),
http://www.bloomberg.com/news/articles/2016-01-05/gene-editing-drugmaker-backed-by-google-
gates-files-for-ipo [https://perma.ce/S47Q-8EK8]; Matthew Herper, Bill Gates and 13 Other
Investors Pour $120 Million into Revolutionary
Gene-Editing Startup, FORBES (Aug. 10, 2015), http://www.forbes.com/sites/matthewherper
/2015/08/10/bill-gates-and- 13-other-investors-pour- 120-million-into-revolutionary-gene-editing-
startup/#12f70a01664c [https://perma.cclW7HL-7C5A]; Alex Lash, CRISPR Cash: Intellia the
Latest Gene-Editing Firm to Nab Big Money, XCONOMY (Sept. 1, 2015),
http://www.xconomy.com/boston/2015/09/01/crispr-cash-intellia-the-latest-gene-editing-firm-to
-nab-big-money/ [https://perma.cc/8CZ9-FBK5]; Vertex and CRISPR Therapeutics Establish
Collaboration to Use CRISPR-Cas9 Gene Editing Technology to Discover and Develop New
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Exchange Commission (SEC) recently,13 and rumors abound that
other firms will follow suit in the near future.14
Despite its renown1 5 in select scientific niches, CRISPR
continues to be an arcane secret in the legal realm. Whereas scientific
scholarship has produced thousands of publications on CRISPR,16
legal scholarship concerning this transformative biotechnology is
virtually nonexistent.17 The gap is striking, notably on account of an
ongoing, high-stakes, intellectual property battle over patent rights to
CRISPR systems with multi-billion-dollar ramifications.1 8
The neglect of CRISPR in legal scholarship poses grave
uncertainty regarding how the law will treat this emerging technology
going forward. Legal scholars have either largely ignored this field or
kept a distance from it, presumably due, in part, to the challenges that
complex scientific principles often pose to non-scientists in the legal
13. Editas Medicine, Inc., Form S-1 Registration Statement Under the Securities Act of
1933, U.S. SEC. & EXCHANGE COMMISSION (Jan. 4, 2016), http://www.sec.gov
/Archives/edgar/data/1650664/000104746916009534/a2226902zs-1.htm [https://perma.cc/4F4E-
TNRU].
14. See, e.g., Chen, supra note 12. Between the time this Article was accepted for
publication and its printing, other companies have filed for initial public offerings with the SEC.
For instance, CRISPR Therapeutics AG filed for an initial public offering with the SEC on
September 9, 2016. CRISPR Therapeutics AG, Form S-1 Registration Statement Under the
Securities Act of 1933, U.S. SEC. & EXCHANGE COMMISSION (Sept. 9, 2016),
http://www.nasdaq.com/markets/ipos/filing.ashx?filingid=11077159 [https://perma.ccKM9L-
9YEH].
15. CRISPR earned the 2015 "Breakthrough of the Year" accolade awarded by the
prominent Science journal. Marcia McNutt, Breakthrough to Genome Editing, 350 SCIENCE 1445,
1456 (2015).
16. See supra note 11 and accompanying text.
17. An unfiltered search on the Westlaw database using the "CRISPR" acronym at the
time this Article was completed in late 2015 returned zero hits for all primary-statutory and
case law-sources, and only one hit for all legal scholarship journals. Westlaw Search for
CRISPR, WESTLAW (search for all documents containing "CRISPR") (last visited Feb. 1, 2016).
The sole mention of CRISPR in all of legal scholarship was relegated to one sentence without
explanation of what CRISPR is or even what it means. See Girard Kelly, Note, Choosing the
Genetics of Our Children: Options for Framing Public Policy, 30 SANTA CLARA HIGH TECH. L.J.
303, 312 (2014).
18. A patent interference proceeding is underway, which challenges priority and validity
of the first CRISPR patent. See Engineering and Optimization of Systems, Methods and
Compositions for Sequence Manipulation with Functional Domains, U.S. Patent No. 8,993,233
(filed Dec. 12, 2013) (issued Mar. 31, 2015). In early 2016, the U.S. Patent and Trademark Office
agreed to allow the interference proceedings to determine whether the Broad Institute of MIT
and Harvard-on one side-or the University of California, Berkeley, the University of Vienna,
and Emmanuelle Charpentier--on the opposite side-were first to invent CRISPR under US
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and legislative arenas.1 9  A recent concurring opinion by the late
Justice Antonin Scalia famously illustrated the degree of scientific
antipathy among some members of the legal community.
20 Exercising
great candor,21 Scalia conceded his lack of knowledge of relevant
scientific details in a case before him.2 2 At the same time, he
disturbingly remarked he did not even believe in scientific facts that
have been well established for decades.
23
19. Consider, for example, the questions and commentary by Justices of the Supreme
Court during oral argument in a recent case involving complex concepts in genetics and
molecular biology. See generally Transcript of Oral Argument, Ass'n for Molecular Pathology v.
Myriad Genetics, Inc., 133 S. Ct. 2107 (2013) (No. 12-398), http://www.supremecourt.gov
loral-arguments/argumenttranscripts/12-398-amc7.pdf [https://perma.ccl8STG-PXJF].
"I thought that maybe the cDNA was kind of an economy class gene, was-it wasn't.... That
may be incorrect for the record, but that was my present understanding." Id. at 20:6 (Kennedy,
J.).
I just didn't understand, because I thought the ... chromosome has the BRCA gene in
the middle of it and it's attached to two ends. But also in the body, perhaps because
cells die, there is isolated DNA. . . . I probably misread it.
There's a better chance that I've misread it.
Id. at 38:2 (Breyer, J.) (BRCA appears without emphasis in the original transcript, though
proper scientific nomenclature requires the gene to be italicized).
My understanding is that here, ... what's involved, is snipping. You've got the thing
there and you snip-snip off the top and you snip off the bottom and there you've got
it. . . . I still don't understand what-in what sense it's different than just snipping
along-along the line.
Id. at 41:8, 42:22 (Roberts, C.J.).
To get back to your baseball bat example, which at least I-I can understand better
than perhaps some of this biochemistry, I suppose that in ... all of that time possibly
someplace a branch has fallen off a tree and it's fallen into the ocean and it's been
manipulated by the waves, and then something's been washed up on the shore, and
what do you know, it's a baseball bat.
Id. at 48:4 (Alito, J.).
"[I]f I've read it correctly, that when you have an R-the messenger RNA does not have
the same base pairs. There's a U or something instead of an A or whatever it is." Id. at 18:5
(Breyer, J.).
20. See Ass'n for Molecular Pathology v. Myriad Genetics, Inc., 133 S. Ct. 2107, 2120
(2013) (Scalia, J., concurring in part and concurring in the judgment) ("I join the judgment of the
Court . . . except Part I-A and some portions of the rest of the opinion going into fine details of
molecular biology. I am unable to affirm those details on my own knowledge or even my own
belief.").
21. To some extent, Scalia's admission is commendable from the perspective that a
person in a position of great power should not be afraid to admit knowledge gaps. After all, no
human holds absolute knowledge in any area. On the other hand, it is worrisome that a powerful
person may be called to decide pivotal questions with broad societal implications when that
person makes no effort whatsoever to close self-perceived knowledge gaps. Expressing disbelief
in science is not sufficient. Those with power to delineate the contours of what constitutes the
rule of law ought to educate themselves about matters before them.
22. Myriad, 133 S. Ct. at 2120.
23. See id.
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That kind of scientific aversion has corrosive effects. It
ultimately hinders the sort of interdisciplinary dialogue and insight
required to fully understand and address significant problems in an
increasingly interconnected world.2 4  In the near future, law- and
policy-makers will be confronted with many questions related to
CRISPR, and the legal community must proactively take steps.to
familiarize itself with this new technology. Given the rapid expansion
of CRISPR-based applications, the void in legal scholarship concerning
the technology is becoming increasingly problematic.
As a testament to this growing problem, Judge David
Neuberger, President of the UK Supreme Court, recently published a
commentary in Nature calling attention to the scientific community
and arguing that scientific primers would be "hugely beneficial" for
the legal community.25 Such primers, he contended, would save
money and time, help assess the reliability of expert witnesses, and
increase the proportion of cases that are settled without trial.2 6
Specifically, he singled out genetic engineering as an area in which a
primer would be useful to jurists given that legal controversies in the
field are likely to recur.2 7
In the absence of on-point law, some in the scientific
community are campaigning, in arguably self-serving ways,28 for a
24. Paul Enriquez, Deconstructing Transnationalism: Conceptualizing Metanationalism
as a Putative Model of Evolving Jurisprudence, 43 VAND. J. TRANSNAT'L L. 1265, 1269, 1336
(2010).




28. See Edward Lanphier et al., Don't Edit the Human Germ Line, 519 NATURE 410, 410
(2015) (advocating for a complete ban of germline genome editing). Notably, this commentary co-
authored by Edward Lanphier, President and Chief Executive Officer of Sangamo BioSciences,
highlights a meaningful need to elaborate on issues concerning competing financial interests.
Sangamo BioSciences currently controls a vast intellectual property portfolio comprising twenty
issued U.S. patents encompassing the foundational technology of design, selection, and
application of an older generation of genome editing tools consisting of Zinc Finger proteins,
nucleases, and transcription factors. See Sangamo BioSciences, Inc., Form 10-K Annual Report
Under the Securities Act of 1933, U.S. SEC. & EXCHANGE COMMISSION (Dec. 31, 2014),
https://www.sec.gov/Archives/edgar/data/1001233/000156459015000950/sgmo-1Ok_20141231.htm
[https://perma.cc/N68E-4X64]. As of February 4, 2015, Sangamo has compiled "133 families of
internally generated U.S. patent filings, including 120 U.S. and 437 foreign issued patents." Id.
A few things are worth pointing out.
First, CRISPR-based biotechnologies may pose an economic threat to Sangamo's monopoly
over genome editing using older Zinc Finger-based technologies. Although Sangamo has recently
hopped on the CRISPR wagon, see, e.g., Screening Assays for Therapeutics for Parkinson's
Disease, U.S. Patent Application No. 14/647,732 (filed Dec. 2, 2013), it lacks the commanding
foundational intellectual property it enjoys in the Zinc Finger field. Second, many of Sangamo's
gene editing biotechnologies, some of which are currently in clinical trials, see infra notes 179-
610 [Vol. XIX:3:603
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consensus to preempt antagonistic regulation and prescribe subjective
standards of use under the misguided auspices of a priori scientific
empiricism. This must give us pause. Einstein memorably remarked,
"[T]he man of science is a poor philosopher."
29 Most scientists-by
training-are unfamiliar with intricate legal principles, constitutional
doctrine, regulatory processes, and policy making; likewise, most
lawyers are oblivious to scientific theory, physico-chemical laws, and
cellular and macromolecular processes. Given these vastly different
realms of knowledge, it is understandable that many scientists and
lawyers often pursue insularism by academic discipline. Surely, there
is comfort in academic seclusion, but isolation is often dangerous to
learning and the pursuit of knowledge. "People do not learn very
much when they are surrounded only by the likes of themselves."
30
Interdisciplinary colloquy, therefore, is the most sensible approach to
bridge the current chasm between science and law surrounding this
momentous biotechnology.
Broadly speaking, this Article seeks to shrink the scholarly gap.
vis-A-vis genome editing and CRISPR-based technologies in legal
literature. It is the first of a series of forthcoming articleS31 that,
collectively, propose a normative structural legal framework; namely,
they conceptualize a jurisprudence of scientific empiricism that is
broadly adaptable to addressing questions of science in law. The
scientific empiricism referred to in this Article specifically concerns
the natural sciences-e.g., physics, chemistry, biology-and not the
81, are based on somatic cell, rather than germ cell, therapeutics. Correcting genomes in the
germline is arguably more effective than that in somatic cells, given that germ cells are
totipotent and give rise to all cell types. Accordingly, CRISPR-Cas9 germline editing could in
theory, if proven safe, obviate resorting to a number of Sangamo's therapeutic tools, which would
dilapidate more than a decade of capital investments in research and development. Third,
Lanphier and colleagues' efforts to distinguish somatic and germline editing along with claims
that germline therapeutic benefits are tenuous, and philosophically and ethically unjustifiable,
see Lanphier et al., supra, at 411, inordinately approach the logical fallacy of a distinction
without a difference, particularly given the commentary's moral-arbiter tone. The authors avoid
acknowledging that, as with any incipient biotechnology including Sangamo's own Zinc Finger
Nucleases at one time, safety and ethical concerns are always part of the calculus behind a cost-
benefit analysis for clinical applications of a technology in its early developmental stages. For a
more detailed discussion of Zinc Finger Nucleases and other older genome editing technologies
based on protein-DNA interactions, see discussion infra Section III.C.
29. Albert Einstein, Physics and Reality, 221 J. FRANKLIN INST. 349, 349 (Jean Piccard
trans., 1936). Whether his assessment is correct is, of course, beyond the scope of this Article.
30. Regents of the Univ. of Cal. v. Bakke, 438 U.S. 265, 312 n.48 (1978) (citing William
G. Bowen, Admissions and the Relevance of Race, PRINCETON ALUMNI WKLY., Sept. 26, 1977, at
9).
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social sciences-e.g., sociology, psychology, economics, political
science, etc. This distinction is mainly due to discrete research
methodologies and analytical tools endogenous to each discipline.32
The paradigm proposed here originates from the Supreme Court's
recent decision in Association for Molecular Pathology v. Myriad
Genetics, which this Article will refer to as Myriad.33
This Article introduces CRISPR and the next generation of
genome editing tools to legal scholarship. By providing a resource for
jurists, scholars, and practitioners alike, it challenges conventional
views regarding the false dichotomy frequently associated with
mutually exclusive normative roles for science and law-the
proximate cause driving laissez-faire attitudeS34 of deference to elude
questions of "law in science and science in law."35
32. In particular, this point revolves around the fact that, whereas the natural sciences
rely extensively on quantitative methods, the social sciences depend, to a great extent, on
qualitative research. The proposed framework in this Article is exclusively concerned with
scientific empirical data that is reproducible and quantifiable. Hence, for example, a
jurisprudence of scientific empiricism would seek to answer whether genome editing may
lawfully be used to correct a genetic mutation associated with a monogenic disease as a
consequence of a clinical trial, given the existence of empirical data demonstrating that such
genetic corrections are feasible and reproducible (or not) under controlled experiments. The
approach, however, would not apply to deciding the legal status by studying the decision making
processes and attitudes toward genome editing of the patients undergoing treatment under the
clinical trial. The primary empirical data acquired from social scientists in the former scenario
would largely depend on interviews and other qualitative research that may be considered
ontologically subjective.
It bears to note that, although the notion of a jurisprudence of scientific empiricism has not
previously been proposed as articulated in this Article, in the past, scholars have discussed-
amid great controversy-using empirical evidence from the social sciences to instruct legal
analysis. See, e.g., ANGELO N. ANCHETA, SCIENTIFIC EVIDENCE AND EQUAL PROTECTION OF THE
LAW (2006); Joshua B. Fischman, Reuniting 'Is'and 'Ought' in Empirical Legal Scholarship, 162
U. PA. L. REV. 117 (2013); Tracey L. Meares, Three Objections to the Use of Empiricism in
Criminal Law and Procedure--and Three Answers, 2002 U. ILL. L. REV. 851 (2002); Craig Allen
Nard, Empirical Legal Scholarship: Reestablishing a Dialogue Between the Academy and
Profession, 30 WAKE FOREST L. REV. 347 (1995); Steven R. Schlesinger & Janet Lesse, Justice
Harry Blackmun and Empirical Jurisprudence, 29 AM. U. L. REV. 405 (1980); J. Alexander
Tanford, The Limits of a Scientific Jurisprudence: The Supreme Court and Psychology, 66 IND.
L.J. 137 (1990); Timothy Zick, Constitutional Empiricism: Quasi-Neutral Principles and
Constitutional Truths, 82 N.C. L. REV. 115 (2003).
33. Ass'n for Molecular Pathology v. Myriad Genetics, Inc., 133 S. Ct. 2107 (2013).
34. See, e.g., Craig v. Boren, 429 U.S. 190, 204 (1976) ("There is no reason to belabor this
line of analysis. It is unrealistic to expect either members of the judiciary or state officials to be
well versed in the rigors of experimental or statistical technique."); ROBIN FELDMAN, THE ROLE
OF SCIENCE IN LAW 37-48 (2009) (discussing lawyers' proclivities to defer to scientific expertise).
35. This Article adopts this phrase from the title of an article penned by Oliver W.
Holmes, Jr. over a century ago. See Oliver Wendell Holmes, Law in Science and Science in Law,
12 HARV. L. REV. 443, 444 (1899). Ironically, the same Holmes authored the infamous Buck v.
Bell decision upholding the constitutionality of sexual sterilization for the mentally disabled
relying on dubious science. See discussion infra Section V.C.
612
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Although legal scholars need not become "amateur scientists,"36
this Article insists that law- and policy-makers must become engaged
and proactively strive to grasp the core elements of significant
technologies like CRISPR, which hold the power to transform the
world. The Article's overarching goals are to (1) ignite a measured
and scholarly conversation about the current and prospective uses of
select biotechnologies, stripped of illusory conjectures, and (2) provide
the legal community with a primer on genome editing to facilitate an
interdisciplinary exchange of ideas. There is much the legal
community can contribute to this field.
In furtherance of these goals, the Article makes two
independent but synergistic contributions. First, it provides a robust
and comprehensive epistemic foundation of the history and current
state of the scientific literature in the field of genome editing. It is
descriptive and technical, but is intended to be suitable for both legal
and scientific audiences. This work is precisely the type of primer for
which Judge David Neuberger recently advocated.37  Notably, it
faithfully tracks and explains primary scientific sources, something
generally absent from legal scholarship construing scientific themes.
This prologue is essential because, without a detailed explanation and
coherent understanding of the nuts and bolts of genome editing, the
audience may extrapolate unfounded notions of the immediate, short-
term, and long-term prospects and limitations of the technology.
38
Simply put, a solid foundation of key genome editing scientific
principles offers the structural scaffolding-an insurance policy, so to
speak-for a fruitful dialogue grounded in reason rather than baseless
conjecture.
The second contribution propounds positive claims for
prospective applications of genome editing that are firmly grounded in
empirical evidence.39 One substantial predicament about powerful
technologies is that they are often prone to manipulation by
speculative agents who-knowingly or not-spread misinformation
and oversell what is technologically feasible. By anchoring
prospective technological applications in a jurisprudence of scientific
empiricism, this Article advocates for a normative approach that
consolidates genome editing applications into a uniform doctrinal
36. Daubert v. Merrell Dow Pharm., Inc., 509 U.S. 579, 601 (1993) (Rehnquist, C.J.,
concurring in part and dissenting in part).
37. See Neuberger, supra note 25, at 9.
38. See discussion infra Parts IV and V.
39. A revolution is well underway in genome editing science with the potential to
fundamentally reshape the way we approach agriculture, synthetic biology, ecosystems,
bioterrorism, gene therapy, and biomedicine through law and policy. See discussion infra Part
TV.
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structure unencumbered by common substantive impediments to
constructive debate. These impediments consist of impractical and
often sensationalist claims about issues raised by technological
advances and are collectively characterized as "deceptive simplicity."40
This approach aims to cultivate and expand Myriad's roots of scientific
empiricism and is broadly applicable to other fields of law in which
scientific inquiry may play important or dispositive roles.
The synergism between these two contributions underscores
the importance of interdisciplinary efforts to prevent, mitigate, and
resolve future "global problems"41 raised by technological progress. In
essence, a jurisprudence of scientific empiricism is based on the notion
that "[c]ritical thinking . . . cannot possibly be restricted to the
examination of the concepts of [one's] own specific field." 4 2
This Article is divided into four sections. Part II begins by
proposing a genome editing definition,43 a necessity for any applicable
regulatory or statutory scheme.44 It introduces the reader to the
manipulation of genetic material, explains how this concept of
biotechnology is well rooted in popular and scientific history, and
describes the discovery of two critical elements that facilitated genome
editing.
Part III rummages through the genome editing toolbox and
examines the development of modern, cost-effective, powerful,
programmable tools that are democratizing researchers' access to
genome editing technologies.
Part IV examines current applications of genome editing in a
number of fields ranging from stem cell research and agriculture to
40. Although this term has not been used in the context proposed in this Article, it has
appeared in legal scholarship, at least as early as 1937. See The Availability of a Principal's
Defense to His Uncompensated Surety, 46 YALE L.J. 833, 839 (1937); see also, e.g., Brief for
Respondent, Tan v. Phelan, 333 U.S. 6 (1948) (No. 370), 1947 WL 44413, at *12; Georg
Schwarzenberger, The Inductive Approach to International Law, 60 HARv. L. REV. 539, 569
(1947); Frederick M. Rowe, Note, Price Discrimination, Competition, and Confusion: Another
Look at Robinson-Patman, 60 YALE L.J. 929, 961 n.210 (1951); Note, State Law and Uniformity
in Federal Taxation, 55 HARV. L. REV. 255, 255 (1941).
41. Enriquez, supra note 24, at 1269, 1336. CRISPR-based technologies are poised to
raise ethical and social problems with global implications. See, e.g., UN Panel Warns Against
'Designer Babies' and Eugenics in 'Editing' of Human DNA, U.N. NEWS CTR. (Oct. 5, 2015),
http://www.un.org/apps/news/story.asp?NewslD=52172 [https://perma.cc/7YHS-9KQ4].
42. Einstein, supra note 29, at 349.
43. See also infra notes 53-55 and accompanying text.
44. The search for meaning in ambiguous statutory text lacking robust definitions has,
in recent years, lead to increased use of dictionaries in judicial opinions. See, e.g., James J.
Brudney & Lawrence Baum, Oasis or Mirage: The Supreme Court's Thirst for Dictionaries in the
Rehnquist and Roberts Eras, 55 WM. & MARY L. REV. 483 (2013) (pointing out that as many as
one-third of statutory decisions in modern Supreme Court jurisprudence consult dictionaries in
often highly subjective modes).
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biofuels production and human pathophysiology. It meticulously
acquaints the reader with prospective genome editing uses in each
field, relying exclusively on primary scientific sources. Importantly,
the Article deliberately contemplates genome editing from diverse
viewpoints and recognizes that every technology endowed with awe-
inspiring powers should be handled responsibly and with respect.
4 5
This Part argues that, taken together, genome editing biotechnologies
are not mere tools for basic research, but rather epitomize prolific
mines for future significant medical and scientific breakthroughs. The
goal is to engage the legal community in discussions about the
technology's potential for good and bad, including what should or
should not be done to legally promote or hinder it.46
Finally, Part V concentrates on deceptive simplicity and
implements the normative framework articulated in this preamble to
delineate adequate contours for a discussion that avoids the squabbles
frequently set forth by manufactured fears; the kerfuffle concerning
"designer babies"47 is one example relevant to genome editing. To that
end, it reconsiders Buck v. Bell
4
8 and the indelible scar it left on
45. Consider the advent of the atomic bomb. Some argue that the technology changed
the world for the better as it brought an end to the bloodiest conflict the world has ever
witnessed. MICHAEL KORT, THE COLUMBIA GUIDE TO HIROSHIMA AND THE BOMB 8, 46-49 (2007);
Winston Churchill, Leader of the Opposition, Where Do We Stand?, (Aug. 16, 1945), in 11 VITAL
SPEECHES DAY 738 (1945), http://www.ibiblio.org/pha/policy/1945/1
9 4 5-08-16c.html
[https://perma.cc/7RS7-C76R]. Others decry the bomb as an instrument that led to utter
destruction in two cities, nearly a half-million deaths, and political instability for decades after
War World II. GOSLING, supra note 5, at 51, 54, (stating that the bombs dropped on Japan
eventually killed an estimated 340,000); KORT, supra, at 76-78, 81 (describing political
instability); Martin J. Sherwin, The Atomic Bomb and the Origins of the Cold War: U.S. Atomic-
Energy Policy and Diplomacy, 1941-45, 78 AM. HIST. REV. 945, 945 (1973). Computers and the
Internet have changed-in both positive and negative ways-how humans communicate, access
information, shop, and even perceive reality. See generally, e.g., Kaveri Subrahmanyam et al.,
The Impact of Home Computer Use on Children's Activities and Development, 10 CHILD. &
COMPUTER TECH. 123 (2000). Genome editing is no different in this sense. Although this Article
highlights many potential benefits, it by no means argues that the biotechnology should be
viewed as a panacea for all world problems.
46. To some extent, the scientific community has begun engaging in this debate. See,
e.g., Scientists Debate Ethics of Human Gene Editing at International Summit, GUARDIAN (Dec.
1, 2015), https://www.theguardian.comiscience/2015/dec/01/human-gene-editing-international-
summit [https://perma.cclFY62-EJCLI. However, the legal community has not assumed a
leadership role to direct a pervasive discussion of legal issues framed by genome editing
technologies.
47. See, e.g., Joan Mahoney, Genome Mapping and Designer Babies, 79 UMKC L. REV.
309, 313 (2010) (citing not a single primary scientific source for the proposition that new
technology may presumably allow parents to decide eye color and sexual orientation of designed
babies); discussion infra Section V.A.
48. Buck v. Bell, 274 U.S. 200 (1927).
VAND. J. ENT. & TECH. L.
American jurisprudence from a novel perspective-namely, to
illustrate the dangers of unchecked deceptive simplicity.
Much has been written about Buck in legal scholarship and
this Article will not belabor what has already been said about the
case. The conventional view is that Buck's holding is illegitimate
because it rests on false, or pseudo, science49 and incorrect moral and
ethical principles.50 This Article rejects that view and applies a
jurisprudence of scientific empiricism to instead contend that Buck is
a direct product, not of false science, but of rampant deceptive
simplicity that permeated every aspect of elite circles at the time it
was decided.51
The distinction between false science and deceptive simplicity
is crucial. Whereas false, or pseudo, science refers to a system of
theories and rules configured to give the appearance of being
grounded in scientific methodology, deceptive simplicity strips logic
beyond a bare minimum using vague intuition born out of second-
hand, reductive explanations that diminish a scientific concept to a
deceptively simple catchphrase. To support this proposition, the
Article studies Buck's substantively porous decision, which cited not a
single scientific source for the Court's lending of credence to the notion
that "heredity plays an important part in the transmission of insanity,
imbecility, etc."52
Lastly, this Part sets the stage for a series of upcoming articles
that aim to analyze the prospective benefits and risks associated with
the use of genome editing biotechnologies from statutory, regulatory,
constitutional, international, ethical, egalitarian, scientific, and policy
standpoints. In so doing, it encourages scholarly debate and
highlights the pivotal synergistic roles that law, science, and public
policy will play on the development of this truly exceptional and
transformative emerging biotechnology.
49. Pseudoscience is defined as "a system of theories, assumptions, and methods
erroneously regarded as scientific." Pseudoscience, MERRIAM-WEBSTER ONLINE DICTIONARY,
http://www.merriam-webster.com/dictionary/pseudoscience [https://perma.cc8FKP-4GVS] (last
visited Feb. 23, 2017); see also discussion infra Section V.C.
50. See, e.g., Stephen Jay Gould, Carrie Buck's Daughter, 2 CONST. COMMENT. 331, 339
(1985); Victoria Nourse, Buck v. Bell: A Constitutional Tragedy from a Lost World, 39 PEPP. L.
REV. 101, 107 (2013) (arguing Buck is not part of constitutional law curricula partly because it is
seen as a case about a false science).
51. See discussion infra notes 558-70 and accompanying text.
52. Buck, 274 U.S. at 206.
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II. GENOME EDITING-A SYNOPSIS
Genome editing,53 as referred to in this Article, encompasses
scientific technological advances that enable rational genetic
engineering54-at a local (gene) or global (genome) level-to facilitate
precise insertion, removal, or substitution of fragments of
Deoxyribonucleic acid (DNA) molecules, comprising one or more
nucleotides-Adenine (A), Thymine (T), Cystosine (C), Guanine (G),
and possibly others which may be synthetically derived
55-into the
cell(s) of an organism's genome. This process of manipulation of
53. Different colloquial permutations of the term 'genome editing' exist including, but
not limited to, 'gene editing,' 'genetic editing,' 'genetic engineering,' 'gene engineering,' 'gene
targeting,' 'gene splicing,' and 'genome surgery.' Although the line between these terms is often
blurred beyond discernible recognition, this Article proposes that genome engineering may be
best interpreted as the rational design of genomes, while genome editing may describe the
process of bringing the design to fruition. However, for purposes of this discussion, they are all
used interchangeably to denote genome editing as an umbrella term with the definition provided.
Notwithstanding, other definitions abound. For instance, Merriam-Webster Dictionary defines
genetic engineering as "the group of applied techniques of genetics and biotechnology used to cut
up and join together genetic material and especially DNA from one or more species of organism
and to introduce the result into an organism in order to change one or more of its
characteristics." Genetic Engineering, MERRIAM-WEBSTER ONLINE DICTIONARY,
http://www.merriam-webster.com/dictionary/genetic%20engineering [https://perma.cc/E3VG-
KDMU] (last visited Feb. 23, 2017). Genome editing involves the precise modification of the
nucleotide sequence of the genome. See, e.g., Matthew H. Porteus, Towards a New Era in
Medicine: Therapeutic Genome Editing, 16 GENOME BIOLOGY 1 (2015); accord Ignazio Maggio &
Manuel A.F.V. Gonvalves, Genome Editing at the Crossroads of Delivery, Specificity, and
Fidelity, 33 TRENDS BIOTECHNOLOGY 280, 280 (2015); Nature Am., Inc., Method of the Year 2011,
9 NATURE METHODS 1, 1 (2012). The propounded definition in this Article is presented as a more
robust and inclusive definition than that found in the current scientific literature.
54. The term genetic engineering was coined in the 1940s as the "purposive
manipulation of genetic material." BRIAN STABLEFORD, SCIENCE FACT AND SCIENCE FICTION: AN
ENCYCLOPEDIA 207 (Routledge 2006). At the time, the term was meant to describe the molecular
surgical cutting and stitching of chromosomes to remove or rearrange sets of genes. Id. Genetic
engineering, eugenics, and selective breeding were main themes in Robert A. Heinlein's novel
Beyond This Horizon, which originally appeared as a two-part serial in the spring of 1942.
Beyond This Horizon, WIKIPEDIA, https://en.wikipedia.org/wikilBeyondThisHorizon
[https://perma.cclN9B8-GCF9] (last updated Dec. 18, 2016). The term was also independently
imported into science fiction by Jack Williamson in Dragon's Island (1951). STABLEFORD, supra,
at 207.
55. Synthetic, non-natural nucleotides to expand the natural four-letter (A, C, T, G)
genetic alphabet or "code" have been reported in the scientific literature. See, e.g., Millie M.
Georgiadis et al., Structural Basis for a Six Nucleotide Genetic Alphabet, 137 J. AM. CHEMICAL
SOC'Y 6947 (2015); Denis A. Malyshev et al., A Semi-Synthetic Organism with an Expanded
Genetic Alphabet, 509 NATURE 385 (2014); Itaru Okamoto et al., High Fidelity, Efficiency and
Functionalization of Ds-Px Unnatural Base Pairs in PCR Amplification for a Genetic Alphabet
Expansion System, 5 ACS SYNTHETIC BIOLOGY 1220 (2016); Joseph A. Piccirilli et al., Enzymatic
Incorporation of a New Base Pair into DNA and RNA Extends the Genetic Alphabet, 343 NATURE
33 (1990); Liqin Zhang et al., Evolution of Functional Six-Nucleotide DNA, 137 J. AM. CHEMICAL
SOC'Y 6734 (2015).
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endogenous nucleotide sequences constitutes the bedrock of modern
biotechnology and molecular biology. It can be accomplished through
a variety of methods using DNA-cutting nucleases (proteins that act
as molecular scalpels), viral-based systems, chemistry-based DNA
scission systems, and, most recently, Ribonucleic acid (RNA)-guided
DNA nucleases.56
Despite the recent fervor surrounding genome editing in the
last three years,57 the concept itself is not new. Following the
discovery of genes by Gregor Mendel in 1866,58 DNA in 1869 by
Friedrich Miescher,59 and the subsequent work of Nobel Laureate
Thomas Morgan, who demonstrated that genes are carried on
chromosomes and constitute the molecular basis of heredity,60 the
notion of manipulating genetic material took root in the popular
culture.61 A peculiar finding concerning reduced efficiency of viral
infection in bacterial hosts-i.e., bacterial defensive mechanisms to
viral infection-in the 1950S62 led to the hypothesis of the existence of
"restriction and modification" systems, which functioned as effective
56. For a detailed discussion of these methods, see infra Sections III.A-D.
57. See, e.g., Meeri Kim, Scientists Are Growing Anxious About Genome-Editing Tools,
WASH. POST (May 18, 2015), https://www.washingtonpost.com/national/health-science/scientists-
are-growing-anxious-about-genome-editing-tools/2015/05/18/Oa4db63c-ef4e -1 1e4-8abc-
d6aa3bad79dd-story.html [https://perma.cc/LKH8-6EB9]; Vivek Wadhwa, Why There's an
Urgent Need for a Moratorium on Gene Editing, WASH. POST (Sept. 8, 2015),
https://www.washingtonpost.com/news/innovations/wp/2015/09/08/why-theres-an-urgent-need-
for-a-moratorium-on-gene-editing/ [https://perma.cclL83M-4FM9].
58. Peter Little, The Book of Genes, 402 NATURE 467, 467-68 (1999). Although Mendel
did not coin the term "gene," he described the presence of discrete inherited units that give
rise to observable physical characteristics-now called genes. See generally Gregor
Mendel, Versuche iiber Plflanzenhybriden [Experiments in Plant Hybridization] (1866),
http://www.esp.org/foundations/genetics/classical/gm-65.pdf [https://perma.cc/ZX84-RT2K].
Mendel's seminal 1866 paper was largely overlooked for over thirty-five years, long after his
death in 1884, until three scientists rediscovered his work and independently verified some of his
original findings. Thomas H. Morgan, The Relation of Genetics to Physiology and Medicine, in
NOBEL LECTURES, PHYSIOLOGY OR MEDICINE 1922-1941, at 313-15 (Elsevier Publishing Co.
1965), http://www.nobelprize.org/nobel-prizes/medicine/laureates/1933/morgan-lecture.pdf
[https://perma.cc/5TNV-YRU6] (original lecture by Thomas H. Morgan delivered in 1934).
59. See generally Ralph Dahm, Discovering DNA- Friedrich Miescher and the Early
Years of Nucleic Acid Research, 122 HUM. GENETICS 565 (2008).
60. Edward B. Lewis, Thomas Hunt Morgan and His Legacy, NOBELPRIZE.ORG,
http://www.nobelprize.org/nobel-prizes/medicine/laureates/1933/morgan-article.html
[https://perma.cclL8AZ-RSNU].
61. Numerous works in scientific romance and science fiction began to incorporate
themes of biological engineering and genetic manipulation in creative ways during the 1910s,
1920s, and every decade thereafter. For a detailed list of such popular works in the 20th
Century, see STABLEFORD, supra note 54, at 207-09.
62. S.E. Luria, Host-Induced Modifications of Viruses, 18 COLD SPRING HARBOR
SYMPOSIA ON QUANTITATIVE BIOLOGY 237, 237 (1953).
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barriers to DNA uptake.63  And in 1970, the first "restriction
enzyme"64 was characterized,65 thus offering proof-of-concept that a
protein can trigger sequence-specific enzymatic cleavage of DNA
molecules.
The restriction enzyme quantum leap underscored the
requirement of DNA double-stranded breakS66 (DSBs) as the critical
first step in genome editing. However, as time passed, it became
apparent that these breaks in DNA were highly deleterious
67 because
they promoted genome instability,68 interfered with the pivotal
processes of replication and transcription,69 led to chromosomal
rearrangements-inversions and translocations-associated with
cancers and other diseases,70 and often induced apoptosis (cell
death).71 Due to the hazardous nature of DSBs to DNA stability,
63. Werner Arber, Host-Controlled Modification of Bacteriophage, 19 ANN. REV.
MICROBIOLOGY 365, 370-72 (1965).
64. Restriction enzymes, also known as restriction endonucleases, are proteins capable
of cutting DNA at or near specific nucleotide sequences. See Richard J. Roberts & Kenneth
Murray, Restriction Endonucleases, 4 CRITICAL REVS. BIOCHEMISTRY 123, 123 (1976).
65. Thomas J. Kelly & Hamilton 0. Smith, A Restriction Enzyme from Hemophilus
Influenzae: II. Base Sequence of the Recognition Site, 51 J. MOLECULAR BIOLOGY 393, 393 (1970).
To date, more than 3,800 restriction enzymes have been biochemically or genetically
characterized. Richard J. Roberts, Tamas Vincze, Janos Posfai & Dana Macelis,
REBASE-Enzymes and Genes for DNA Restriction and Modification, 35 NUCLEIC ACIDS RES.
D269, D269 (2007).
66. Structurally, DNA comprises two single-stranded molecules that come together via
hydrogen bonds to form the famous DNA double helix. See James D. Watson & Francis H.C.
Crick, A Structure for Deoxyribose Nucleic Acid, 171 NATURE 737, 737 (1953). Accordingly,
introducing a double-stranded, rather than a single-stranded, break is necessary to complete full
scission of DNA.
67. E.g., Thomas Bonura et al., Enzymatic Induction of DNA Double-Strand Breaks in
Gamma-Irradiated Escherichia Coli K-12, 72 PROC. NAT'L ACAD. SCi. U.S. 4265 (1975); David 0.
Ferguson & Frederick W. Alt, DNA Double Strand Break Repair and Chromosomal
Translocation: Lessons from Animal Models, 20 ONCOGENE 5572 (2001); Paul Howard-Flanders
& Lee Theriot, Mutants of Escherichia coli K-12 Defective in DNA Repair and in Genetic
Recombination, 53 GENETICS 1137 (1966).
68. Cynthia J. Sakofsky et al., Break-Induced Replication and Genome Stability, 2
BIOMOLECULES 483, 483 (2012).
69. Andriy Khobta & Bernd Epe, Interactions Between DNA Damage, Repair, and
Transcription, 736 MUTATION RES. 5, 5 (2012).
70. E.g., Giovanni Bosco & James E. Haber, Chromosome Break-Induced DNA
Replication Leads to Nonreciprocal Translocations and Telomere Capture, 150 GENETICS 1037
(1998); Janet D. Rowley, A New Consistent Chromosomal Abnormality in Chronic Myelogenous
Leukaemia Identified by Quinacrine Fluorescence and Giemsa Staining, 243 NATURE 290 (1973);
L. Zech et al., Characteristic Chromosomal Abnormalities in Biopsies and Lymphoid-Cell Lines
from Patients with Burkitt and Non-Burkitt Lymphomas, 17 INT'L J. CANCER 47 (1976);
Chengming Zhu et al., Unrepaired DNA Breaks in p53-Deficient Cells Lead to Oncogenic Gene
Amplification Subsequent to Translocations, 109 CELL 811 (2002).
71. Anthony J. Davis & David J. Chen, DNA Double Strand Break Repair Via Non-
Homologous End-Joining, 2 TRANSLATIONAL CANCER RES. 130, 130 (2013).
VAND. J. ENT. & TECH. L.
complex mechanisms associated with deployment of specialized
macromolecules that trigger repair of an injured DNA site have
evolved within cells.
To date, at least three DSB repair pathways have been
characterized7 2:
(1) Nonhomologous End Joining (NHEJ), 73 (2) Microhomology-
Mediated End Joining (MMEJ), 74 and (3) Homology-Directed Repair
(HDR).75 NHEJ is an error-prone DSB repair mechanism that can
efficiently introduce small, random nucleotide mutations-insertions
and deletions-capable of disrupting gene expression.7 6 MMEJ is also
an error-prone pathway, but uses microhomologous sequences-short
homology sequences of a few nucleotides flanking the initial DSB
site-to anneal and ligate broken DNA ends.7 7 MMEJ DSB repair
often leads to deletion mutations that play a role in cancers involving
chromosomal translocation and telomere fusions.7 8 Unlike NHEJ and
MMEJ, HDR is significantly more precise, but requires the presence of
an undamaged, homologous, donor template for repair.79 This is the
case in Homologous Recombination (HR), the most common form of
HDR, where the requirement of longer sequence homology between
the donor and acceptor DNA ensures highly accurate rates of DSB
72. Other DNA repair mechanisms-Direct Reversal, Base Excision Repair, Nucleotide
Excision Repair, and Mismatch Repair-have been identified and act exclusively on single-
stranded DNA breaks (SSB), rather than DSB. See generally GEOFFREY M. COOPER, THE CELL: A
MOLECULAR APPROACH (2d ed. 2000), http://www.ncbi.nlm.nih.gov/books/NBK9900/
[https://perma.cc/JJJ2-M9RE]. In addition, a recent report describes what appears to be a novel
chromatin structure-specific mechanism of DNA repair involving nucleosomal DNA SSB. See
Nikolay A. Pestov et al., Structure of Transcribed Chromatin Is a Sensor of DNA Damage, 1 SCl.
ADVANCES e1500021 (2015). Although three pathways for DSB repair are known to date, there
may be others awaiting characterization.
73. J. Kent Moore & James E. Harber, Cell Cycle and Genetic Requirements of Two
Pathways of Nonhomologous End-Joining Repair of Double-Strand Breaks in Saccharomyces
Cerevisiae, 16 MOLECULAR & CELLULAR BIOLOGY 2164, 2164 (1996); Thomas E. Wilson et al.,
Yeast DNA Ligase IVMediates Non-Homologous DNA End Joining, 388 NATURE 495, 495 (1997).
74. Mitch McVey & Sang Eun Lee, MMEJ Repair of Double-Strand Breaks (Director's
Cut): Deleted Sequences and Alternative Endings, 24 TRENDS GENETICS 529, 529-30 (2008).
MMEJ is also known as "Alternative End Joining" or "Alternative NHEJ." S. Sharma et al.,
Homology and Enzymatic Requirements of Microhomology-Dependent Alternative End Joining, 6
CELL DEATH & DISEASE e1697, e1697 (2015).
75. HARVEY LODISH ET AL., MOLECULAR CELL BIOLOGY § 12.5 (4th ed. 2000).
76. For an overview of the mechanism of NHEJ repair, see Davis & Chen, supra note 71,
at 131-37.
77. McVey & Lee, supra note 74, at 529.
78. Id. at 535-36, 552 tbl.3; Catherine T. Yan et al., IgH Class Switching and
Translocations Use a Robust Non-Classical End-Joining Pathway, 449 NATURE 478, 481 (2007).
79. Xuan Li & Wolf-Dietrich Heyer, Homologous Recombination in DNA Repair and
DNA Damage Tolerance, 18 CELL RES. 99, 99 (2008).
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repair. Together, these mechanisms of DNA repair constitute the
second critical element required to facilitate genome editing.
A. The Rise of Recombinant DNA
The discovery of restriction enzymes capable of inducing DNA
double-stranded breaks prone for repair marked the genesis of modern
molecular medicine and biotechnology and gave rise to the era of
recombinant DNA technology. As the list of restriction enzymes grew,
the rational manipulation of genes and DNA sequences to study
function yielded important research with pharmaceutical applications
such as the large-scale production of insulin,80 other hormones,
81 and
vaccines.82 The fundamental knowledge derived from the research
fueled innovation in genetic engineering,83 gave rise to new
intellectual property,84  and spawned a multi-billion-dollar
biotechnology industry. At the same time, scientific fears of the
repercussions of gene editing technologies began to percolate through
popular discourse.85
The concept of genome editing is well rooted in history.
Scientists have long recognized the value of developing methods to
80. Lydia Villa-Komaroff et al., A Bacterial Clone Synthesizing Proinsulin, 75 PROC.
NAT'L ACAD. ScI. U.S. 3727, 3727 (1978).
81. E.g., David V. Goeddel et al., Direct Expression in Escherichia coli of a DNA
Sequence Coding for Human Growth Hormone, 281 NATURE 544 (1979); Keiichi Itakura et al.,
Expression in Escherichia coli of a Chemically Synthesized Gene for the Hormone Somatostatin,
198 SCIENCE 1056 (1977).
82. E.g., Cladd E. Stevens et al., Hepatitis B Vaccine: Immune Responses in
Haemodialysis Patients, 316 LANCET 1211 (1980).
83. See, e.g., Stanley N. Cohen et al., Construction of Biologically Functional Bacterial
Plasmids in Vitro, 70 PROC. NAT'L ACAD. SCI. U.S. 3240 (1973); David A. Jackson, Robert H.
Symons & Paul Berg, Biochemical Method for Inserting New Genetic Information into DNA of
Simian Virus 40: Circular SV40 DNA Molecules Containing Lambda Phage Genes and the
Galactose Operon of Escherichia Coli, 69 PROC. NAT'L ACAD. SCI. U.S. 2904 (1972); Peter E.
Lobban & Armin D. Kaiser, Enzymatic End-to-End Joining of DNA Molecules, 78 J. MOLECULAR
BIOLOGY 453 (1973); Janet E. Mertz & Ronald W. Davis, Cleavage of DNA by RI Restriction
Endonuclease Generates Cohesive Ends, 69 PROC. NAT'L ACAD. SCI. U.S. 3370 (1972); Daniel
Nathans & Hamilton 0. Smith, Restriction Endonucleases in the Analysis and Restructuring of
DNA Molecules, 44 ANN. REV. BIOCHEMISTRY 273 (1975).
84. E.g., Process for Producing Biologically Functional Molecular Chimeras, U.S. Patent
No. 4,237,224 (filed Jan. 4, 1979).
85. The famous Asilomar Conference on Recombinant DNA took place in 1975 to discuss
the potential safety hazards of emerging recombinant DNA biotechnologies. See generally Paul
Berg, Meetings That Changed the World: Asilomar 1975: DNA Modification Secured,
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induce DNA breaks and modify nucleotide sequences.86 However,
recent additions to the technological toolbox of genome editing have
overruled long-held views of what is technologically feasible.
Remarkable, cost-effective, easy-to-use, programmable tools developed
in the last few years finally allow researchers to precisely engineer
genomes in ways originally envisioned decades ago, yet
methodologically beyond reach to prior generations of scientists.8 7
The next Section surveys the transformative technologies of
modern day genome editing that have revolutionized, and are
revolutionizing, molecular biotechnology and biomedicine. Together,
these biotechnologies offer potential promising applications for
agriculture, synthetic biology, gene therapy, and eradication of
diseases.
III. THE GENOME EDITING TOOLBOX
Armed with the bipartite insights of restriction enzyme-
mediated DSBs and DNA repair, scientists began to explore genome
engineering apace. As of this writing, the genome editing toolbox
consists of systems that fit four categories: chemistry-based synthetic
DNA scission, viral-based editing, nucleases that rely on protein-DNA
interactions for targeting, and a revolutionary RNA-guided DNA
nuclease system.
A. Chemistry-Based Synthetic DNA Scission
Early methods of chemical-mediated DNA scission involved the
use of oligonucleotides88-short DNA or RNA molecules-coupled to
chemical reagents.89  These complexes successfully induced site-
specific cleavage of DNA90 and activated DNA repair91 in yeast and
86. Stewart Scherer & Ronald W. Davis, Replacement of Chromosome Segments with
Altered DNA Sequences Constructed in Vitro, 76 PROC. NAT'L AcAD. Sci. U.S. 4951 (1979); see
also supra notes 65, 80-84 and accompanying text.
87. See discussion infra Part III.
88. See Oligonucleotide, MERRIAM-WEBSTER ONLINE DICTIONARY, http://www.merriam-
webster.com/dictionary/oligonucleotide [https://perma.cc/DP46-8MXP] (last visited Feb. 25, 2017)
(defining oligonucleotide as "a short nucleic-acid chain usually consisting of up to approximately
20 nucleotides.").
89. Barbara C.F. Chu & Leslie E. Orgel, Nonenzymatic Sequence-Specific Cleavage of
Single-Stranded DNA, 82 PROC. NAT'L ACAD. SCl. U.S. 963, 963 (1985).
90. Scott A. Strobel & Peter B. Dervan, Site-Specific Cleavage of a Yeast Chromosome by
Oligonucleotide-Directed Triple-Helix Formation, 249 SCIENCE 73, 73 (1990); Scott A. Strobel et
al., Site-Specific Cleavage of Human Chromosome 4 Mediated by Triple-Helix Formation, 254
SCIENCE 1639, 1639 (1991).
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mammalian cells without the use of nucleases. Alternative DSB
approaches also emerged involving Peptide Nucleic Acids (PNA)92 that
associate with nucleaseS93 and synthetic polyamides that bind DNA's
minor groove.94 Reports that the element Cerium95 Ce(IV) species is
highly stable and capable of cutting DNA via hydrolysiS96 paved the
way for more sophisticated artificial DNA-cutting methods involving
complexation of Ce(IV) with the chelating reagent
Ethylenediaminetetraacetic acid (EDTA). 97 In recent years, a research
team conceived a novel chemistry-based artificial restriction DNA
cutter strategy featuring pseudo-complementary PNA and the metal
complex Ce(IV)EDTA for targeting and cleavage.
98 Although these
synthetic scission platforms-with or without the use of nucleases-
have not been widely adopted, they demonstrate the value of
chemistry-based cutting tools for genome editing.
B. Viral-Based Editing
A nuclease-free, viral-based system consisting of vectors using
adeno-associated viruses99 (AAV) has proven able to introduce specific
91. A. Fawad Faruqi et al., Recombination Induced by Triple-Helix-Targeted DNA
Damage in Mammalian Cells, 16 MOLECULAR CELL BIOLOGY 6820, 6820 (1996).
92. PNA is an artificial molecule that resembles DNA or RNA, but has a protein-like,
rather than a sugar phosphate, backbone. Peter E. Nielsen et al., Sequence-Selective Recognition
of DNA by Strand Displacement with a Thymine-Substituted Polyamide, 254 SCIENCE 1497, 1498
fig.1 (1991).
93. Vadim Demidov et al., Sequence Selective Double Strand DNA Cleavage by Peptide
Nucleic Acid (PNA) Targeting Using Nuclease S1, 21 NUCLEIC ACIDS RES. 2103, 2103 (1993).
94. Joel M. Gottesfeld et al., Regulation of Gene Expression by Small Molecules, 387
NATURE 202, 202 (1997).
95. Cerium is the fifty-eighth element on the Periodic Table. It is an iron-gray,
malleable, lustrous metal that is susceptible to rapid oxidation at room temperature. C.R.
HAMMOND, THE ELEMENTS 4-7 (n.d.), http://www-
dO.fnal.gov/hardware/cal/lvps-info/engineering/elements.pdf [https://perma.cc/986X-Z2L4].
96. Makoto Komiyama et al., Catalytically Active Species for CeCIs-Induced DNA
Hydrolysis, 115 J. BIOCHEMISTRY 809, 809 (1994).
97. Wen Chen & Makoto Komiyama, Site-Selective DNA Hydrolysis by CelV-EDTA with
the Use of One Oligonucleotide Additive Bearing Two Monophosphates, 6 CHEMBIOCHEM 1825,
1825 (2005); Jia-Ming Yan et al., (Ethylenediaminetetraacetic A id)cerium(IV) [CeIV(EDTA)]
Complexes with Dual Hydrophobic Binding Sites as Highly Efficient Catalysts for the Hydrolysis
of Phosphodiesters, 85 HELVETICA CHIMICA ACTA 1496, 1496 (2002).
98. Makoto Komiyama et al., Artificial Restriction DNA Cutter for Site-Selective Scission
of Double-Stranded DNA with Tunable Scission Site and Specificity, 3 NATURE PROTOCOLS 655,
655 (2008).
99. AAV is a nonpathogenic, nonenveloped virus featuring a 4.7 kilobase long linear
single-stranded DNA genome. David V. Schaffer et al., Molecular Engineering of Viral Gene
Delivery Vehicles, 10 ANN. REV. BIOMEDICAL ENGINEERING 169, 171 (2008).
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genetic modifications at high frequencies.100 With this approach,
engineered recombinant AAV vectors can replace some or all of the
viral genes with packaged foreign DNA sequences of interest for
efficient cellular delivery.101 Subsequent cargo release into the
nucleus mediates HR at selected loci, which demonstrates promising
therapeutic gene targeting applications.102 Because they have proven
to be safe and effective, commercialization of AAV vectors103 and
testing in clinical trials are underway.104 Despite a modest
commercial performance, likely due to the platform's labor-intensive
manufacturing and costs, preliminary results from clinical testing
show significant improvement of patients with an incurable, inherited
retinal disease.o10
C. Nuclease Genome Editing Based on Protein-DNA Interactions
1. Meganucleases
Meganucleases, also known as Homing Endonucleases,106 are
naturally occurring DSB nucleases that target relatively long DNA
100. David W. Russell & Roli K. Hirata, Human Gene Targeting by Viral Vectors, 18
NATURE GENETICS 325, 325 (1998). The term "high frequencies" used by the authors is
ambiguous without an explanation. A closer look at the study reveals that high frequencies
relate to gene-targeting events in cell populations and stem directly from a comparative analysis
of gene-targeting frequencies between AAV-transduction (10-3) and other methods (10-5 to 10-8).
Id. at 328.
101. Manuel A.F.V. Gongalves, Adeno-Associated Virus: From Defective Virus to Effective
Vector, 2 VIROLOGY J. 43, 49-50 (2005), http://virologyj.biomedcentral.com/articles/10.1186/1743-
422X-2-43 [https://perma.cc/3J83-P674].
102. Russell & Hirata, supra note 100, at 328-29.
103. For instance, Horizon Discovery Group plc, a biotechnology company based in
Cambridge, UK, markets a proprietary version of nuclease-free, recombinant AAV genome
editing. See rAAV, HORIZON, https://www.horizondiscovery.com/about-us/our-science/raav
[https://perma.ccY3TZ-3APR] (last visited Feb. 25, 2017).
104. See, e.g., SPARK THERAPEUTICS, A PHASE 1 SAFETY STUDY IN SUBJECTS WITH LEBER
CONGENITAL AMAUROSIS (LCA) USING ADENO-ASSOCIATED VIRAL VECTOR TO DELIVER THE GENE
FOR HUMAN RPE65 INTO THE RETINAL PIGMENT EPITHELIUM (RPE) [AAV2-HRPE65v2-101]
(2007), https://clinicaltrials.gov/ct2/show/study/NCT00516477 [https://perma.cc/C8KS-W6TN].
105. See, e.g., Artur V. Cideciyan et al., Human RPE65 Gene Therapy for Leber
Congenital Amaurosis: Persistence of Early Visual Improvements and Safety at 1 Year, 20 HuM.
GENE THERAPY 999 (2009); Albert M. Maguire et al., Age-Dependent Effects of RPE65 Gene
Therapy for Leber's Congenital Amaurosis: A Phase 1 Dose-Escalation Trial, 374 LANCET 1597
(2009); Albert M. Maguire et al., Safety and Efficacy of Gene Transfer for Leber Congenital
Amaurosis, 358 NEW ENG. J. MED. 2240 (2008).
106. The term "homing" refers to a gene conversion process, whereby a mobile sequence is
copied and inserted into a new cognate site lacking the sequence. Maria J. Marcaida et al.,
Homing Endonucleases: From Basics to Therapeutic Applications, 67 CELLULAR & MOLECULAR
LIFE SCI. 727, 727 (2010).
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sequences ranging from twelve to forty base pairs.
1 07 Meganucleases
have been instrumental in the study of DSB repair.108 They were
initially identified as potential site-specific DNA nucleases for genome
editing from the use of self-splicingl0
9 introns1 10 and became the first
type of nucleases with demonstrable ability to modify the mammalian
genome with precision.' Long recognition sequences intrinsic to
meganucleases confer high target specificity, but often render them
futile because lengthy target sequences in particular arrangements
occur rarely in a whole genome.112 The problem, therefore, is that a
researcher might have a very specific nuclease at her disposal for a
DNA sequence she has no interest in targeting. Complex protein
engineering strategies to alter DNA preference of the meganuclease
can ameliorate this predicament.11
3  However, due to inherent
intricacies of protein engineering, and the fact that meganuclease
DNA binding and cleavage functions are interlaced in a single
domain,114 this platform for genome editing has found it challenging to
progress into translational medicine.
107. Id.
108. Tamas Lukacsovich et al., Repair of a Specific Double-Strand Break Generated
Within a Mammalian Chromosome by Yeast Endonuclease I-Scel, 22 NUCLEIC ACIDS RES. 5649,
5650 (1994).
109. Steven Zimmerly et al., A Group II Intron RNA Is a Catalytic Component of a DNA
Endonuclease Involved in Intron Mobility, 83 CELL 529, 529 (1995). See generally Bruce A.
Sullenger & Thomas R. Cech, Ribozyme-Mediated Repair of Defective mRNA by Targeted Trans-
Splicing, 371 NATURE 619 (1994).
110. An intron is a noncoding piece of RNA transcript, or the DNA encoding it, that is
removed before translation into a protein. See Intron, SCITABLE,
http://www.nature.comiscitable/definition/intron-introns-
6 7 [https://perma.cclRZH2-DBNA] (last
visited Feb. 25, 2017).
111. See, e.g., Philippe Rouet et al., Expression of a Site-Specific Endonuclease Stimulates
Homologous Recombination in Mammalian Cells, 91 PROC. NAT'L ACAD. SCI. U.S. 6064 (1994); R.
Geoffrey Sargent et al., Repair of Site-Specific Double-Strand Breaks in a Mammalian
Chromosome by Homologous and Illegitimate Recombination, 17 MOLECULAR & CELLULAR
BIOLOGY 267 (1997); Jian Yang et al., Efficient Integration of an Intron RNA into Double-
Stranded DNA by Reverse Splicing, 381 NATURE 332 (1996).
112. Marcaida et al., supra note 106, at 727.
113. See Jordan Jarjour et al., High-Resolution Profiling of Homing Endonuclease
Binding and Catalytic Specificity Using Yeast Surface Display, 37 NUCLEIC ACIDS RES. 6871,
6878 (2009) (investigating DNA binding and catalysis for protein engineering); Pilar Redondo et
al., Molecular Basis of Xeroderma Pigmentosum Group C DNA Recognition by Engineered
Meganucleases, 456 NATURE 107, 107 (2008) (engineering a meganuclease derivative to target a
particular gene).
114. Julianne Smith et al., A Combinatorial Approach to Create Artificial Homing
Endonucleases Cleaving Chosen Sequences, 32 NUCLEIC ACIDS RES. e149, 2, 6-7 (2006).
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2. Zinc Finger Nucleases
A study of transcription in the African clawed frog first
revealed that zinc-binding domains, potentially looped into finger-like
arrangements, were required for transcription factor-mediated gene
regulation.115 These modules rely on interactions between Cysteine
and Histidine residues with a zinc ion ligand,116 which together form
three-dimensional structures where one zinc finger recognizes three
contiguous nucleotides of DNA.117 Scientists quickly realized that the
modular DNA recognition of each zinc finger motif could be exploited
by coupling it to the nuclease domain of Fokl-a restriction
endonuclease known at the time-to engineer artificial fusion
proteins'18 called Zinc Finger Nucleases (ZFNs)." 9
Combining a non-specific nuclease like FokI to zinc fingers
capable of recognizing specific sequences of DNA provided a solution
to the barriers posed by meganucleases.120 Thus, ZFNs became the
first method to demonstrate the practicability of genome editing in
human cells 121 and animals in vivo.12 2 A decade later, ZFNs entered
clinical trials amid high expectations.123 However, as critical as ZFNs
have been to promote the progress of genome editing technologies,
their widespread use has been limited by the high technical expertise
needed to engineer them-due primarily to context-dependent
115. J. Miller et al., Repetitive Zinc-Binding Domains in the Protein Transcription Factor
IIIA from Xenopus Qocytes, 4 EMBO J. 1609, 1612 (1985).
116. Id.
117. Nikola P. Pavietich & Carl 0. Pabo, Zinc Finger-DNA Recognition: Crystal Structure
of a Zif268-DNA Complex at 2.1 A, 252 SCIENCE 809, 813 (1991).
118. Yang-Gyun Kim et al., Hybrid Restriction Enzymes: Zinc Finger Fusions to Fok I
Cleavage Domain, 93 PROC. NAT'LACAD. SCI. U.S. 1156, 1156 (1996).
119. Although the name 'zinc finger nuclease' has become standard in biotechnology, in
the past, the terms 'chimeric restriction enzyme' and 'chimeric nuclease' have also been used. See
Jeff Smith et al., Requirements for Double-Strand Cleavage by Chimeric Restriction Enzymes
with Zinc Finger DNA-Recognition Domains, 28 NUCLEIC ACIDS RES. 3361, 3361 (2000).
120. See supra Section III.C.1.
121. See, e.g., Matthew H. Porteus & David Baltimore, Chimeric Nucleases Stimulate
Gene Targeting in Human Cells, 300 SCIENCE 763 (2003); Matthew H. Porteus, Mammalian
Gene Targeting with Designed Zinc Finger Nucleases, 13 MOLECULAR THERAPY 438 (2006);
Fyodor D. Urnov et al., Highly Efficient Endogenous Human Gene Correction Using Designed
Zinc-Finger Nucleases, 435 NATURE 646 (2005).
122. See, e.g., Marina Bibikova et al., Enhancing Gene Targeting with Designed Zinc
Finger Nucleases, 300 SCIENCE 764 (2003); Marina Bibikova et al., Targeted Chromosomal
Cleavage and Mutagenesis in Drosophila Using Zinc-Finger Nucleases, 161 GENETICS 1169
(2002).
123. See generally Autologous T-Cells Genetically Modified at the CCR5 Gene by Zinc
Finger Nucleases SB- 728 for HIV (Zinc-Finger), CLINICALTRIALS.GOV,
https://clinicaltrials.gov/ct2/show/study/NCT00842634 [https://perma.cc/RB7E-VGE3] (last
visited Feb. 13, 2017).
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specificity-and extensive screening processes to validate them.
124
Adoption has lagged even despite frequent reporting of strategies
designed to simplify and update engineering challenges associated
with ZFNs.125
3. TALENs
For a number of years, ZFNs and meganucleases dominated
the genome editing landscape despite their technical shortcomings.
Then, in 2007, two research teams independently discovered that a
particular bacterial strain, pathogenic to certain crop plants, secretes
effector (transcription activator-like effector-TALE) proteins capable
of specific DNA binding by mimicking transcription factors.
126 The
mechanism and code responsible for DNA recognition was promptly
deciphered.127 And borrowing from its ZFN predecessor, versions of
TALE proteins fused to the FokI nuclease domain led to the creation
of TALE nucleases (TALENs). 128
TALENs and ZFNs share similar architectural features, most
prominently the fusion of the FokI nuclease domain to the DNA
recognition domain.129 However, TALENs exhibit greater simplicity of
design because a single TALE recognizes one nucleotide, in contrast to
124. Scot A. Wolfe et al., DNA Recognition by Cys2His2 Zinc Finger Proteins, 29 ANN.
REV. BIOPHYSICS & BIOMOLECULAR STRUCTURE 183, 199-201, 203-05 (2000); see also infra note
126 (reporting various ways to address challenges inherently associated with ZFNs.).
125. See, e.g., Ankit Gupta et al., An Optimized Two-Finger Archive for ZFN-Mediated
Gene Targeting, 9 NATURE METHODS 588 (2012); Seokjoong Kim et al., Preassembled Zinc-Finger
Arrays for Rapid Construction of ZFNs, 8 NATURE METHODS 7 (2011); Morgan L. Maeder et al.,
Rapid "Open-Source" Engineering of Customized Zinc-Finger Nucleases for Highly Efficient Gene
Modification, 31 MOLECULAR CELL 294 (2008); David A. Wright et al., Standardized Reagents
and Protocols for Engineering Zinc Finger Nucleases by Modular Assembly, 1 NATURE
PROTOCOLS 1637 (2006).
126. Sabine Kay et al., A Bacterial Effector Acts as a Plant Transcription Factor and
Induces a Cell Size Regulator, 318 SCIENCE 648, 650 (2007); Patrick Romer et al., Plant Pathogen
Recognition Mediated by Promoter Activation of the Pepper Bs3 Resistance Gene, 318 SCIENCE
645, 646 (2007).
127. Jens Boch et al., Breaking the Code of DNA Binding Specificity of TAL-Type III
Effectors, 326 SCIENCE 1509, 1509 (2009); Matthew J. Moscou & Adam J. Bogdanove, A Simple
Cipher Governs DNA Recognition by TAL Effectors, 326 SCIENCE 1501, 1501 (2009).
128. See, e.g., Michelle Christian et al., Targeting DNA Double-Strand Breaks with TAL
Effector Nucleases, 186 GENETICS 757 (2010); Ting Li et al., TAL Nucleases (TALNs): Hybrid
Proteins Composed of TAL Effectors and FokI DNA-Cleavage Domain, 39 NUCLEIC ACIDS RES.
359 (2011); Magdy M. Mahfouz et al., De Novo-Engineered Transcription Activator-Like Effector
(TALE) Hybrid Nuclease with Novel DNA Binding Specificity Creates Double-Strand Breaks, 108
PROC. NAT'L ACAD. Scl. U.S. 2623 (2011); Jeffrey C. Miller et al., A TALE Nuclease Architecture
for Efficient Genome Editing, 29 NATURE BIOTECHNOLOGY 143 (2011).
129. Id.
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zinc fingers, which recognize three nucleotides.130 Engineering of
TALE arrays is therefore less onerous than zinc finger arrays, and
TALENs lead to decreased toxicity thanks to higher specificity for
cognate DNA targets.131 Simplicity has contributed to a relatively
healthy expansion of TALENs in recent years, surpassing even
ZFNs.132 Indeed, TALENs have successfully been used to modify
cells,133 as well as plant1 34 and animal1 35 genomes. Nonetheless,
TALENs are not without limitations. The size and highly repetitive
nature of TALEN-coding sequences pose great challenges for delivery
using standard viral vectors.136 Construction of TALENs is also costly
and can require up to four times the materials needed for comparable
ZFN constructs.137
D. Programmable, RNA-guided, DNA Nuclease Genome Editing
The latest and most remarkable additions to the genome
editing toolbox are programmable, RNA-guided, DNA nucleases. Of
these, the best-known and characterized system is the Clustered,
Regularly Interspaced, Short Palindromic Repeat (CRISPR) and
CRISPR-associated (Cas) proteins.138 Unlike the nuclease genome
editing methods based on protein-DNA interactions discussed above,
RNA-guided, DNA nucleases circumvent the intricate and often
cumbersome requirement of protein engineering to target DNA
130. Boch et al., supra note 127, at 1509-10.
131. Marine Beurdeley et al., Compact Designer TALENs for Efficient Genome




133. See, e.g., Dirk Hockemeyer et al., Genetic Engineering of Human Pluripotent Cells
Using TALE Nucleases, 29 NATURE BIOTECHNOLOGY 731 (2011); Deepak Reyon et al., FLASH
Assembly of TALENs for High-Throughput Genome Editing, 30 NATURE BIOTECHNOLOGY 460
(2012).
134. See, e.g., Ting Li et al., High-Efficiency TALEN-Based Gene Editing Produces
Disease-Resistant Rice, 30 NATURE BIOTECHNOLOGY 390 (2012).
135. See, e.g., Victoria M. Bedell et al., In Vivo Genome Editing Using a High-Efficiency
TALEN System, 491 NATURE 114 (2012); Daniel F. Carlson et al., Efficient TALEN-Mediated
Gene Knockout in Livestock, 109 PROC. NAT'L ACAD. SCl. U.S. 17382 (2012); Laurent Tesson et al.,
Knockout Rats Generated by Embryo Microinjection of TALENs, 29 NATURE BIOTECHNOLOGY 695
(2011).
136. Jia Liu et al., Cell-Penetrating Peptide-Mediated Delivery of TALEN Proteins via
Bioconjugation for Genome Engineering, 9 PLOS ONE e85755, e85755-56 (2014).
137. Beurdeley et al., supra note 131, at 6.
138. Ruud Jansen et al., Identification of Genes That Are Associated with DNA Repeats in
Prokaryotes, 43 MOLECULAR MICROBIOLOGY 1565, 1565 (2002).
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sequences.139 Instead, RNA-guided, DNA nucleases harness nature's
principles of Watson-Crick base-pairing of nucleic acids to mediate
DNA recognition.140
The origins of CRISPR can be traced back nearly three decades
when a team of Japanese researchers published findings of a
mysterious repeat cluster of unknown function in the bacterium
Escherichia coli (E. coli).141 The accumulation of sequenced bacterial
genomes in public databases by the turn of the millennium revealed
that such particular clusters are pervasive in numerous bacterial and
archaeal strains.142
Soon after, scientists coined the term CRISPR and identified a
group of Casl43 genes encoding proteins involved in catalyzing
biochemical reactions using nucleic acids as substrates.1
44  These
findings sparked a great deal of interest in the scientific community
for CRISPR systems. Then in 2007, two decades after their discovery,
key experiments performed at Danisco presented the first empirical
evidence that CRISPR was, in fact, an adaptive immunity system used
by bacteria and archaea,145 a mnemonic-so to speak-designed to
provide immunological memory against viral infection.
As research into CRISPR systems has accelerated, so too has
our knowledge of the mechanistic details of this adaptive immunity
phenomenon. To date, five CRISPR types and sixteen subtypes have
been classified on the basis of phylogenetic analyses, with more likely
awaiting characterization.14 6 Among CRISPR systems, CRISPR-Cas9
has emerged as the foremost genome editing platform, partly due to
being the first RNA-guided, DNA nuclease discovered. However, other
139. See discussion supra Section III.C.
140. Watson-Crick base pairing refers to the principle through which DNA bases-
Adenine-Thymine and Guanine-Cytosine--pair up with each other via hydrogen bonds to allow
DNA to maintain its double-helical structure. See Watson & Crick, supra note 66, at 738.
141. Yoshizumi Ishino et al., Nucleotide Sequence of the lap Gene, Responsible for
Alkaline Phosphatase Isozyme Conversion in Escherichia coli, and Identification of the Gene
Product, 169 J. BACTERIOLOGY 5429, 5432 (1987).
142. Francisco J.M. Mojica et al., Biological Significance of a Family of Regularly Spaced
Repeats in the Genomes of Archaea, Bacteria and Mitochondria, 36 MOLECULAR MICROBIOLOGY
244, 244 (2000).
143. In standard genetic scientific nomenclature, gene names are generally italicized. In
contrast, gene products such as proteins are designated using the same gene name, but in non-
italicized font.
144. Jansen et al., supra note 138, at 1568-69. Helicase-unwinding of double-helical
nucleic acids-and nuclease activities are two such biochemical reactions.
145. Rodolphe Barrangou et al., CRISPR Provides Acquired Resistance Against Viruses in
Prokaryotes, 315 SCIENCE 1709, 1711 (2007).
146. Kira S. Makarova et al., An Updated Evolutionary Classification of CRISPR-Cas
Systems, 13 NATURE REVS. MICROBIOLOGY 722, 724 (2015).
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CRISPR systems,1 4 7 such as CRISPR-Cpfl,148 have very recently been
identified and are likely to offer valuable alternatives for DNA
targeting.
FIGURE 1149
X-Ray, three-dimensional structure of the CRISPR-Cas9 endonuclease (gray)
from Streptococcus pyogenes in complex with a sgRNA (blue) and double-
stranded DNA (red) primed for target DNA cleavage. Yellow spheres
represent the two active site residues indispensable for enzyme catalysis
(Aspartate 10, bottom; Histidine 840, top). The figure appears in color in the
online version of this Article. 50
147. See Sergey Shmakov et al., Discovery and Functional Characterization of Diverse
Class 2 CRISPR-Cas Systems, 60 MOLECULAR CELL 385, 386 (2015).
148. Bernd Zetsche et al., Cpfl Is a Single RNA-Guided Endonuclease of a Class 2
CRISPR-Cas System, 163 CELL 759, 760 (2015).
149. The model was built using the atomic coordinates deposited in the Protein Data
Bank, accession code 5F9R (2016), http://www.rcsb.org/pdb/explore/explore.do?structureld=5F9R
[https://perma.cc/F5TB-7T9P].
150. The online version can be accessed at the Journal's website, JETLaw.org, by clicking
on the "Journal Archives" tab, Volume 19, Issue 3. [https://perma.cc/6BKD-D5DQ].
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From a genome editing standpoint, CRISPR-Cas9 has garnered
worldwide attention largely because the Cas9 enzyme is part of the
CRISPR type II system, which requires only a single protein (Cas9) for
RNA-guided, DNA cleavage.151 DNA targeting and formation of DSBs
by the CRISPR-Cas9 complex require three essential components: (1)
a short CRISPR RNA (crRNA) that recognizes the target DNA; (2) a
short trans-activating crRNA (tracrRNA) that hybridizes with crRNA
and helps recruit the nuclease;152 and (3) Cas9, the enzyme that cuts
DNA.153 When assembled into a complex, this machinery seeks,
detects, and cuts the target DNA a few nucleotides away from a proto-
spacer adjacent motif (PAM) site.154
A defining moment for the future of genome editing came in
2012 when an article published in Science revealed that Cas9 is an
RNA-guided, DNA endonuclease and the two small RNAs it associates
with can be fused together into a synthetic, single-guide RNA (sgRNA)
that could be engineered to direct Cas9 to any target DNA sequence of
interest.155 This finding earned two scientists-a biochemist and a
microbiologist-$3 million each and the Breakthrough Prize.
156
Thus, the landscape of genome editing changed. Scientists are
no longer confined to the tedious process of protein design inherent in
other nuclease-based tools. Today, any researcher armed with an
active Cas9157 needs merely to design and order an inexpensive
151. Josiane E. Garneau et al., The CRISPRICas Bacterial Immune System Cleaves
Bacteriophage and Plasmid DNA, 468 NATURE 67, 70 (2010) (discussing cas9's involvement in
DNA cleavage while it was still labeled as cas5); Rimantas Sapranauskas et al., The
Streptococcus Thermophilus CRISPRICas System Provides Immunity in Escherichia Coli, 39
NUCLEIC ACIDS RES. 9275, 9279 (2011).
152. Notably, unlike CRISPR-Cas9, the CRISPR-Cpfl system does not require a
tracrRNA. Zetsche et al., supra note 148, at 760.
153. Martin Jinek et al., A Programmable Dual-RNA-Guided DNA Endonuclease in
Adaptive Bacterial Immunity, 337 SCIENCE 816, 816 (2012).
154. The PAM site is a very short nucleotide sequence in the target DNA critical for
initial DNA binding of the CRISPR-Cas9 complex, before Cas9 cuts the DNA. Samuel H.
Sternberg et al., DNA Interrogation by the CRISPR RNA-Guided Endonuclease Cas9, 507
NATURE 62, 63-64 (2014).
155. See generally Jinek, supra note 153.
156. Jennifer Doudna, a biochemist, and Emmanuelle Charpentier, a microbiologist,
received the Breakthrough Prize for "harnessing an ancient mechanism of bacterial immunity
into a powerful and general technology for editing genomes, with wide-ranging implications
across biology and medicine." See Recipients of the 2015 Breakthrough Prizes, BREAKTHROUGH
PRIZE, https:/fbreakthroughprize.org/News/
2 1 [https://perma.ccU7RY-79BK] (last visited Feb.
25, 2017). Their discovery may one day also earn them a Nobel Prize.
157. A multitude of Cas9 plasmids for a researcher's experiment of choice are widely
available from commercial sources for as little as $65.00. See, e.g., eSpCas9(1.1), ADDGENE,
https://www.addgene.org/71814/ [https://perma.ccl8AT6-TK38] (last visited. Feb. 25, 2017).
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sgRNA,158 wait for it to be delivered to the lab, and-voilA!-edit her
favorite genome for less than one hundred dollars. Even more
striking, to edit additional sites, the researcher may use the same
Cas9 with another made-to-order sgRNA. The inexpensive, accurate,
and easy-to-use essence of CRISPR-Cas9 has changed the rules of the
genome editing game; to such an extent, it has been hailed as a tool
for the democratization of genome editing.159
Widespread use of a biotechnology may not occur for years
after it is first introduced to the scientific community. However,
unlike its predecessor technologies, CRISPR-Cas9 has been adopted
by laboratories around the world with unprecedented speed.160 Within
months of the Science publication, reports of genome editing in human
cancer cells 161 and pluripotent stem cells1 62 surfaced. And soon after, a
flurry of publications followed detailing genome editing studies on
various organisms including mice,163 nematodes,164 fruit flies, 165
zebrafish,166 frogs,167 rabbits,168 pigs, 169 goats,170 cattle,171 rice,172
wheat,173 tobacco,174 thale cress,17 sorghum,176 and others. In just
158. At a cost of as little as $10. See Wadhwa, supra note 57.
159. Id.
160. Jacob Corn, The Explosion of CRISPR/Cas9, INNOVATIVE GENOMICS (July 18, 2015),
https://innovativegenomics.org/blog/crispr-cas9-explosion/ [https://perma.cc/ZS4P-5C8B].
161. See Prashant Mali et al., RNA-Guided Human Genome Engineering via Cas9, 339
SCIENCE 823 (2013).
162. E.g., id.; Martin Jinek et al., RNA-Programmed Genome Editing in Human Cells, 2
ELIFE e00471 (2013)
163. See generally Bin Shen et al., Generation of Gene-Modified Mice via Cas9/RNA-
Mediated Gene Targeting, 23 CELL RES. 720 (2013).
164. See generally Ari E. Friedland, Heritable Genome Editing in C. elegans via a
CRISPR-Cas9 System, 10 NATURE METHODS 741 (2013).
165. See generally Zhongsheng Yu et al., Highly Efficient Genome Modifications Mediated
by CRISPR/Cas9 in Drosophila, 195 GENETICS 289 (2013).
166. See generally Li-En Jao et al., Efficient Multiplex Biallelic Zebrafish Genome Editing
Using a CRISPR Nuclease System, 110 PROC. NAT'L ACAD. Scl. U.S. 13904 (2013).
167. See generally Takuya Nakayama et al., Simple and Efficient CRISPR/Cas9-
Mediated Targeted Mutagenesis in Xenopus tropicalis, 51 GENESIS 835 (2013).
168. See generally Dongshan Yang et al., Effective Gene Targeting in Rabbits Using RNA-
Guided Cas9 Nucleases, 6 J. MOLECULAR CELL BIOLOGY 97 (2014).
169. See generally Wenfang Tan et al., Efficient Nonmeiotic Allele Introgression in
Livestock Using Custom Endonucleases, 110 PROC. NAT'L ACAD. SCI. U.S. 16526 (2013).
170. Id.
171. Id.
172. See generally Wenzhi Jiang et al., Demonstration of CRISPR/Cas9/sgRNA-
Mediated Targeted Gene Modification in Arabidopsis, Tobacco, Sorghum and Rice, 41 NUCLEIC
ACIDS RES. e188 (2013).
173. See generally id.; Qiwei Shan et al., Targeted Genome Modification of Crop Plants
Using a CRISPR-Cas System, 31 NATURE BIOTECHNOLOGY 686 (2013).
174. See generally Jiang et al., supra note 172.
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over three years, more than 2,500 papers1
7 7 referring to this nascent
biotechnology have been published. CRISPR systems have had a
major impact on genome editing and will likely soon be applied for
translational applications in agriculture, synthetic biology,
biomedicine, and human therapeutics.
This Article next presents a comprehensive survey of the
current applications of genome editing technologies in general, but
with particular emphasis on CRISPR-derived advances. It further
propounds positive claims for prospective applications of genome
editing that are firmly grounded in empirical evidence.
IV. CURRENT AND PROSPECTIVE APPLICATIONS OF GENOME EDITING
A. Editing to Target Somatic Cells and Stem Cells
Genome editing technologies have already shown great promise
in the treatment of human diseases. Editing of somatic cells
178-that
is, differentiated cells, not including germline or undifferentiated stem
cells-for example, is revolutionizing therapeutic approaches to HTV
and AIDS.
A rationale for genome editing-based HIV treatment first
appeared after an article in Cell reported that some individuals'
resistance to HIV-1, the most commonly transmitted strain of HIV,
had a genetic basis.17 9 To enter its host cells, the HIV virus requires a
CD4 receptor and a chemokine coreceptor, predominantly the cell-
surface protein called C-C Chemokine Receptor Type 5 (CCR5).
180
Approximately 1% of Caucasians carry a 32-nucleotide deletion in the
CCR5 gene that renders the coreceptor unable to detect the HIV
virus.181 The effect of this mutation is that individuals who are
175. Id.
176. Id.
177. A search on the PubMed scientific database using the "CRISPR" acronym filtered by
title and abstract returned 2,565 hits. PubMed.gov Search Results for CRISPR, PUBMED.GOV,
http://www.ncbi.nlm.nih.gov/pubmed/?term=CRISPR[Title%
2 FAbstract] [https://perma.cc/7PC2-
BNN8] (last visited Feb. 10, 2016) (search for CRISPR filtered by title and abstract by using the
language "CRISPR[Title/Abstract]"). Note that the search does not include papers that refer to
CRISPR in the body of the paper, which may return more hits.
178. Somatic cells are all of the body's cells except the reproductive cells. Somatic Cells,
BIOLOGY ONLINE, http://www.biology-online.org/dictionary/Somatic-cells [https://perma.cc/A8ZT-
MRZ6] (last visited Feb. 13, 2017).
179. Rong Liu et al., Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of
Some Multiply-Exposed Individuals to HIV-1 Infection, 86 CELL 367, 370 (1996).
180. Gero Hiltter et al., Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell
Transplantation, 360 NEw ENG. J. MED. 692, 695 (2009).
181. Id.
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homozygous-those who inherit the deletion from both parents-are
virtually immune to HIV. 182
The potential for interrogating CCR5 was later clinically
validated when Timothy Brown,183 an HIV-infected patient, received a
bone marrow transplant from a donor who had the CCR5 deletion.184
The procedure led to restoration of normal CD4+ T-cell counts and
undetectable levels of HIV in Brown's body, even two years post-
transplantation.185  This remarkable study, and its long-lasting
effects, confirmed that conversion of a patient's genome-although not
through genome editing-could potentially lead to a cure for HIV and
AIDS.
Inspired by the critical role of CCR5 in HIV infection, scientists
at Sangamo, the California-based biopharmaceutical company, in
collaboration with academic researchers, tested whether genome
editing could be used to trim out a piece of the CCR5 gene in human
T-cells and a mouse model of HIV infection.186 Using ZFNs, they
demonstrated the feasibility of this approach as a strategy to confer
robust protection against HIV. 187
A recent phase I clinical trial featuring this principle sought to
remove CD4' T-cells from HIV patients, edit them with ZFNs
targeting the CCR5 locus, and transplant the edited cells back into the
patients.188 Remarkably, results show that infusion of autologously
modified CD4* T-cells in which the CCR5 receptor had been rendered
dysfunctional by ZFN targeting is safe,189 thereby paving the path for
a phase II trial 90 and potential cure in the near future. Furthermore,
scientists have now used the CRISPR platform not only to target T-
cells, but also to successfully disrupt expression of latently integrated
182. Id.
183. Timothy Brown remains HIV free to this day. Timothy Ray Brown, FRED HUTCH,
https://www.fredhutch.org/en/news/timothy-ray-brown.html [https://perma.cc/G42T-UKM7] (last
visited Feb. 25, 2017).
184. Hiltter et al., supra note 180, at 692.
185. Id.
186. Elena E. Perez et al., Establishment of HIV-1 Resistance in CD4+ T Cells by Genome
Editing Using Zinc-Finger Nucleases, 26 NATURE BIOTECHNOLOGY 808, 808 (2008).
187. Id.
188. Autologous T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger
Nucleases SB-728 for HIV (Zinc-Finger), CLINICALTRIALS.GOV, https://clinicaltrials.gov/ct2
/show/study/NCT00842634 [https://perma.cc/RB7E-VGE3] (last visited Feb. 13, 2017).
189. Pablo Tebas et al., Gene Editing of CCR5 in Autologous CD4 T Cells of Persons
Infected with HIV, 370 NEW ENG. J. MED. 901, 908 (2014).
190. Sangamo BioSciences Presents Phase 2 Clinical Data from Two SB-728-T HIV





HIV-1 provirus and excise it from the host genome. altogether in T-
cells,191 microglial cells,192 promonocytic cells, 193 and human-induced
pluripotent stem cells.194 These studies are a vivid testament to the
power of genome editing technologies to provide long-term, adaptive
immunity against viral infections by introducing a disease-resistant
allele-in the case of CCR5-or to completely deracinate a virus from
its host genome. The implications of this research go far beyond HIV
and could apply to other acquired diseases.
Progress has not been confined to one disease. Genome editing
has successfully corrected a mutation associated with hereditary
tyrosinemia type I (HTI), a fatal genetic disorder, in the liver cells of a
mouse model of the disease.195 Cystic Fibrosis (CF), a debilitating
disease in which viscous mucus accumulates in the pulmonary and
gastrointestinal tracts of patients-leading to a life expectancy of
approximately forty years196-appears to be vulnerable to genome
editing as well. CRISPR-Cas9 editing of the Cystic Fibrosis
Transmembrane Conductor Receptor (CFTCR or CFTR) protein in
cultured intestinal stem cells isolated from CF patients corrected a
one-amino-acid deletion mutation associated with the most common
form of the disease.197
Furthermore, a mutation in the Leucine-Rich Repeat Kinase 2
(LRRK2) gene associated with a hereditary form of Parkinson's
Disease was rectified in induced pluripotent stem cells derived from
patients afflicted with the disease, resulting in functional phenotypic
rescue of differentiated neurons.198 Correction of an IL2RGl
99 gene
mutation in hematopoietic stem cells (HSCs) derived from patients
suffering from X-linked Severe Combined Immunodeficiency
191. E.g., Hirotaka Ebina et al., Harnessing the CRISPR/Cas9 System to Disrupt Latent
HIV-1 Provirus, 3 Scl. REP. 2510 (2013).
192. E.g., Wenhui Hu et al., RNA-Directed Gene Editing Specifically Eradicates Latent
and Prevents New HIV-1 Infection, 111 PRoc. NAT'L ACAD. ScI. U.S. 11461, 11462 (2014).
193. Id.
194. E.g., Hsin-Kai Liao et al., Use of the CRISPR/Cas9 System as an Intracellular
Defense Against HIV-1 Infection in Human Cells, 6 NATURE COMM. 6413 (2015).
195. Hao Yin et al., Genome Editing with Cas9 in Adult Mice Corrects a Disease Mutation
and Phenotype, 32 NATURE BIOTECHNOLOGY 551, 551 (2014).
196. Gerald Schwank et al., Functional Repair of CFTR by CRISPR/Cas9 in Intestinal
Stem Cell Organoids of Cystic Fibrosis Patients, 13 CELL STEM CELL 653, 655 (2013).
197. Id. at 653.
198. Peter Reinhardt et al., Genetic Correction of a LRRK2 Mutation in Human iPSCs
Links Parkinsonian Neurodegeneration to ERK-Dependent Changes in Gene Expression, 12 CELL
STEM CELL 354, 354 (2013).
199. Interleukin 2 Receptor Subunit Gamma, also known as Cytokine Receptor Common
Subunit Gamma.
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Syndrome (SCID-X1) gave rise to functional lymphoid cells.2 00 Editing
of HSCs is of particular significance given that they differentiate into
all hematopoietic cell types and can be autologously transplanted.2 0 1
Thus, genome editing using HSCs could open treatment avenues for
many genetic blood disorders.
Efforts are underway to develop treatments for other types of
monogenic diseases. For instance, an allele-specific editing strategy to
combat Meesmann's Epithelial Corneal Dystrophy (MECD)
demonstrates that a faulty allele can be ablated without affecting the
healthy allele in a heterozygous disease.202 Promising applications of
genome editing could soon change therapeutic approaches in a
multitude of hereditary diseases including Huntington's disease,
where a single mutation repeat causes a devastating
neurodegenerative disorder;203 Achondroplasia, where one of two
mutations leads to dwarfism;204 Amyotrophic Lateral Sclerosis (ALS),
also known as Lou Gehrig's disease, in which point mutations trigger
death of neurons;20 5 Nicolaides-Baraitser syndrome (NBS), where
mutations in a chromatin-remodeling gene lead to severe intellectual
disability;2 0 6 or Tay-Sachs disease, where deleterious mutations
prompt deterioration of nerve cells that render a child dead by age
four.2 07
Finally, it bears noting that although monogenic diseases are
likely to be the focus of early genome editing therapies,208 in the long-
run, genome editing biotechnologies will likely tackle more complex,
200. Pietro Genovese et al., Targeted Genome Editing in Human Repopulating
Haematopoietic Stem Cells, 510 NATURE 235, 235 (2014).
201. See generally R. Aggarwal et al., Hematopoietic Stem Cells: Transcriptional
Regulation, ex Vivo Expansion and Clinical Application, 12 CURRENT MOLECULAR MED. 34
(2012).
202. D.G. Courtney et al., CRISPR/Cas9 DNA Cleavage at SNP-Derived PAM Enables
Both in Vitro and in Vivo KRT12 Mutation-Specific Targeting, 23 GENE THERAPY 108, 108
(2016).
203. Mahru C. An et al., Genetic Correction of Huntington's Disease Phenotypes in
Induced Pluripotent Stem Cells, 11 CELL STEM CELL 253, 253 (2012).
204. Douglas J. Wilkin et al., Mutations in Fibroblast Growth-Factor Receptor 3 in
Sporadic Cases of Achondroplasia Occur Exclusively on the Paternally Derived Chromosome, 63
AM. J. HuM. GENETICS 711, 715 (1998).
205. Thomas Gaj, Therapeutic Genome Editing for Amyotrophic Lateral Sclerosis,
GRANTOME, http://grantome.com/grant/NIH/F32-GM113446-01A1 [https://perma.cc/JS5M-9ZC6]
(last visited Feb. 25, 2017).
206. Jeroen K.J. Van Houdt et al., Heterozygous Missense Mutations in SMARCA2 Cause
Nicolaides-Baraitser Syndrome, 44 NATURE GENETICS 445, 448 (2012).
207. Rachel Myerowitz, Tay-Sachs Disease-Causing Mutations and Neutral
Polymorphisms in the Hex A Gene, 9 HUM. MUTATION 195, 196 (1997).
208. The probable focus on monogenic diseases is likely due to the perception that
targeting a single gene is inherently simpler than targeting multiple genes.
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non-monogenic diseases as well-think cancer
209 and even aging.
Indeed, recent evidence in HSCs shows CRISPR-Cas9 can target
noncoding regions-sections of chromosomal DNA without genes-of
the genome to interrogate the BCL11A
210 erythroid enhancer2 11
involved in regulation of hemoglobin disorders.
212  This proof-of-
concept suggests viable, alternative therapeutic strategies to treat
sickle-cell disease and thalassemias. Likewise, genome editing offers
an opportunity to tackle other complex pathologies like Alzheimer's
Disease,213 HIV, 2 1 4 cardiovascular disease,
215 and Acute Lymphoblastic
Leukemia2 16 by conferring protective mutations as treatment for
affected patients or as prophylactic measures for those unaffected.
These and other examples demonstrate both the feasibility and
inevitability of applying genome editing technologies to rid society of
congenital disorders-whether ecessive or dominantly inherited-and
acquired diseases.
209. See, e.g., B. Berdien et al., TALEN-Mediated Editing of Endogenous T-Cell Receptors
Facilitates Efficient Reprogramming of T Lymphocytes by Lentiviral Gene Transfer, 21 GENE
THERAPY 539 (2014); Elena Provasi et al., Editing T Cell Specificity Towards Leukemia by Zinc
Finger Nucleases and Lentiviral Gene Transfer, 18 NATURE MED. 807 (2012).
210. B-cell Lymphoma/Leukemia 11A is a gene that encodes a C2H 2 zinc finger protein
involved in normal lymphoid development. Yang-Jun Gao et al., Expression of the B-Cell
Lymphoma/Leukemia 11A Gene in Malignant Hematological Cell Lines Through Quantitative
Reverse Transcription Polymerase Chain Reaction, 8 CLINICAL ONCOLOGY & CANCER RES. 242,
242 (2011); Pentao Liu et al., Bcll1a Is Essential for Normal Lymphoid Development, 4 NATURE
IMMUNOLOGY 525, 525 (2003).
211. Enhancers generally refer to distal genetic elements involved in the regulation of
gene expression in an orientation-independent manner. Matthew C. Canver et al., BCL11A
Enhancer Dissection by Cas9-Mediated in Situ Saturating Mutagenesis, 527 NATURE 192, 192
(2015) (citing Julian Banerji et al., Expression of a /-globin Gene Is Enhanced by Remote SV40
DNA Sequences, 27 CELL 299 (1981)).
212. Id. at 196.
213. Thorlakur Jonsson et al., A Mutation in APP Protects Against Alzheimer's Disease
and Age-Related Cognitive Decline, 488 NATURE 96, 96 (2012).
214. See discussion supra notes 179-94 and accompanying text.
215. Jonathan Cohen et al., Low LDL Cholesterol in Individuals of African Descent
Resulting from Frequent Nonsense Mutations in PCSK9, 37 NATURE GENETICS 161, 162 (2005)
(identifying two PCSK9 mutations having a protective effect against hypercholesterolemia); The
TG and HDL Working Group of the Exome Sequencing Project, National Heart, Lung, and Blood
Institute, Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease, 371 NEW
ENG. J. MED. 22, 23 (2014) (identifying rare APOC3 mutations associated with a lower risk of
heart disease).
216. Shannon L. Maude et al., Chimeric Antigen Receptor T Cells for Sustained
Remissions in Leukemia, 371 NEW ENG. J. MED. 1507, 1512 (2014).
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B. Gene Drives
In what might seem like a concept straight out of a sci-fi script,
reshaping entire populations of wild organisms with relatively short
lifespans is now within technological reach thanks to a method
coupling genome editing technology with old-fashioned sexual
reproduction. This method, called a gene drive, encompasses the
alteration of traits in wild populationS217 via self-propagating,
synthetic, genetic constructs that can artificially disseminate-i.e.,
drive-a gene modification through an organism's progeny with
unprecedented speed.
The notion of gene drives dates back to the late 1960s, when a
theoretical comment published in Nature proposed the hypothetical
utility of chromosomal translocations as a way to control insect pest
populations.218 At the time, that possibility was merely hypothetical
because the technology to test the hypothesis-namely, the tools and
knowledge required for triggering translocations via enzyme
manipulation-simply did not exist.219 However, by' the turn of the
century, interest in gene drives resurfaced following insights that
meganucleaseS220 could be used as drivers.221 The premise of targeting
the fertility genes of vermin species provided a roadmap to carry out
population-wide genetic engineering.222  And by 2011, the first
validation of a meganuclease-based gene drive-aimed at controlling
the human malaria vector-established proof-of-principle for the
genetic manipulation of an entire population starting from only a few
laboratory individuals.223
It was not long before others realized that the same concept
could be used to engineer drives by integrating genes encoding the
more efficient Cas9 enzyme alongside specific sgRNAs. Less than two
years ago, US scientists used the CRISPR-Cas9 system to develop the
Mutagenic Chain Reaction (MCR).224 In contrast to classic laws of
217. James E. DiCarlo et al., Safeguarding CRISPR-Cas9 Gene Drives in Yeast, 33
NATURE BIOTECHNOLOGY 1250, 1250 (2015).
218. Christopher F. Curtis, Possible Use of Translocations to Fix Desirable Genes in Insect
Pest Populations, 218 NATURE 368, 368 (1968).
219. The requisite tools and knowledge to test these synthetic gene drives are now
available to the scientific community. See discussion supra Part III.
220. See supra notes 108-111.
221. Austin Burt, Site-Specific Selfish Genes as Tools for the Control and Genetic
Engineering of Natural Populations, 270 PROC. ROYAL Soc'Y B: BIOLOGICAL SCI. 921, 921 (2003).
222. Id.
223. Nikolai Windbichler et al., A Synthetic Homing Endonuclease-Based Gene Drive
System in the Human Malaria Mosquito, 473 NATURE 212, 212 (2011).
224. Valentino M. Gantz & Ethan Bier, The Mutagenic Chain Reaction: A Method for
Converting Heterozygous to Homozygous Mutations, 348 SCIENCE 442, 442 (2015).
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genetic inheritance, in which there is a 50% chance that a given
offspring will inherit a modified allele, MCR-mediated gene drive
introduced biased inheritance patterns to swiftly spread a select gene
through an entire population of laboratory fruit flies.
2 2 5 With an
average 97% success rate-as opposed to 50%-gene drives can
convert heterozygous mutations into homozygous mutations in as
little as two generations.226
In the last few months, researchers have used CRISPR-Cas9-
based gene drives to introduce genes that confer resistance to the
malaria parasite, Plasmodium falciparum, into a South Asian
mosquito species.2 27 An alternate approach to suppress a different
species of mosquito vector for human malaria succeeded by targeting
female mosquitoes that overwhelmingly-and helplessly-
relinquished fertility by gene drive.228 The former strategy seeks to
spare mosquitoes by making them malaria-resistant and incapable of
spreading the disease, whereas the latter aims to drastically reduce-
or even wipe out-mosquito populations from an ecosystem.
Ultimately, both share the goal of suppressing a disease that places
half the total world population at risk, particularly in low-income
countries.229
Yeast,230 fruit flies, 231 and mosquito specieS232-including the
potent vector for the chikungunya, yellow fever, and dengue
225. Id. at 443.
226. Id.
227. Valentino M. Gantz et al., Highly Efficient Cas9-Mediated Gene Drive for Population
Modification of the Malaria Vector Mosquito Anopheles stephensi, 112 PROC. NAT'L ACAD. Sol.
U.S. E6736, E6736 (2015).
228. Andrew Hammond et al., A CRISPR-Cas9 Gene Drive System Targeting Female
Reproduction in the Malaria Mosquito Vector Anopheles gambiae, 34 NATURE BIOTECHNOLOGY
78, 78 (2016).
229. The World Health Organization estimates that as of 2013, ninety-seven countries
had ongoing malaria transmission and approximately 3.4 billion people were at risk of
contracting malaria, 1.2 billion of whom were at a high risk. Factsheet on the World Malaria
Report 2013, WORLD HEALTH ORG. (Dec. 2013), http://www.who.int/malaria
/medialworld malariareport_2013/en/ [https://perma.cc/Z2XH-JLPN].
230. See DiCarlo et al., supra note 217, at 1250 (reporting gene drive systems in wild and
laboratory strains of the yeast Saccharomyces cerevisiae).
231. See Gantz et al., supra note 227, at E6737 (testing a gene drive in Drosophila
melanogaster).
232. See, e.g., id. at E6736 (experimenting with Anopheles Stephensi); Hammond et al.,
supra note 228, at 78 (targeting Anopheles gambiae); see also Andrea L. Smidler et al., Targeted
Mutagenesis in the Malaria Mosquito Using TALE Nucleases, 8 PLOS ONE e74511, e74511
(2013) (using transgenic expression of TALENs for genetic manipulation of mosquitoes instead of
CRISPR-Cas9).
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viruseS233-have thus far been the subjects of CRISPR-mediated gene
drive, or related, research. Though the technology remains enclosed
within laboratory walls for now, some researchers have begun to study
and model how releasing mosquitoes in the wild would spread certain
engineered traits.234 Others have used mathematical and quantitative
modeling to estimate the rate of fixation of a mutant allele and
caution the release of gene drives in the wild. 2 3 5
Already, Oxitec, a British firm, has developed transgenic Aedes
aegypti mosquitoes-through older technologies-and released them
in field trials in Brazil, Malaysia, the Cayman Islands, and Panama
with results showing up to a 90% reduction of insect populations.236
Trial successes led to Brazilian approval of the first genetically
modified insect for commercial use.2 3 7 However, in the United States,
Oxitec has faced intense criticism for releasing genetically modified
moths in small outdoor trials in New York,238 and Florida rejected a
proposal to permit Oxitec to release mosquitoes in the wild without
federal approval.239
Diametric public views concerning the apt use of genetically
modified insects highlight the pivotal role that public opinion will play
in the development of gene drive biotechnologies. Consider the recent
threat to global human health posed by the Zika virus in the past
year. Zika outbreaks have already been reported in more than fifty
233. Kathryn E. Kistler et al., Genome Engineering with CRISPR-Cas9 in the Mosquito
Aedes aegypti, 11 CELL REP. 51, 51 (2015).
234. See Hammond et al., supra note 228, at 80 (demonstrating that alleles inserted at
female-fertility loci can spread rapidly in mixed caged populations-of 600 mosquitoes per
cage-with high gene drive activity).
235. Robert L. Unckless et al., Modeling the Manipulation of Natural Populations by the
Mutagenic Chain Reaction, 201 GENETICS 425, 427-28 (2015).
236. See United States, OXITEC, http://www.oxitec.com/programmes/united-states/
[https://perma.cc/D2LH-7RF4] (last visited Feb. 9, 2017); see also Kerry Grens,
Mutant Mosquitoes Deployed to Stop Zika, Dengue, SCIENTIST (Jan. 19, 2016),
http://www.the-scientist.com/?articles.view/articleNo/45128/title/Mutant-Mosquitoes-Deployed
-to-Stop-Zika-Dengue/ [https://perma.cc/94DJ-AV9X].
237. Press Release, Oxitec, Oxitec's Solution for Controlling the Dengue Mosquito Is
Approved by CTNBio (Apr. 10, 2014), http://www.oxitec.com/press-release-high-tech-solution-for-
controlling-the-dengue-mosquito-is-approved-by-ctnbio/ [https://perma.cc/5MXV-XHQX].
238. Christina Sarich, Genetically Modified Moths Released in New York, NAT. SoC'Y
(June 19, 2015), http://naturalsociety.com/outrage-oxitecs-gm-moths-are-released-in-new-york/
[https://perma.cc/C4HB-SCA4].
239. William Axford, Keys Bug Board Says No to Contract for Genetically Modified




countries.240 The World Health Organization declared a public health
emergency of international concern as more than 4,000 microcephaly
cases and neurological disorders have been documented in areas
affected by the Zika virus.241  The first case of Zika-related
microcephaly in a new born baby in the United States surfaced in
January 2016,242 which prompted the Centers for Disease Control and
Prevention to issue warnings for pregnant women to avoid traveling to
countries with Zika outbreaks.243 Fears were further augmented
when studies revealed that, although mosquito bites are the main
source of transmission, the virus can be spread through sexual
intercourse and blood transfusions. 244
Throughout 2015 and 2016, Zika brought panic to many areas
of the world. Babies born with microcephaly and intracranial
calcification became a fixture in the news.
2 4 5 Public support for the
release of genetically modified insects as a method of population
control in areas affected by Zika may be low at this point in time,
particularly in the United States.
246 However, the prospect of an
epidemic at home coupled with laggard progress in research toward
development of a vaccine could awaken the public's appetite for
drastic measures to prevent the spread of the virus. Groups that
vehemently oppose genetic engineering under any circumstances
might soon find themselves fighting a losing battle in the court of
240. Sandee LaMotte, Zika Around the World: Where Do We Stand?, CNN,
http://www.cnn.com/2016/08/30/health/zika-around-the-world/ [https://perma.cc/2AGH-CVXJ]
(last updated Aug. 30, 2016, 7:54 AM).
241. Public Health Emergency of International Concern (PHEIC) Declared for Zika and
Clusters of Microcephaly and Neurological Disorders, EUROPEAN CTR. DISEASE PREVENTION &
CONTROL (Feb. 3, 2016), http://ecdc.europa.eu/enlactivities/sciadvice
/_1ayouts/forms/ReviewDispForm.aspx?List=a3216f4c-f040-4f51-9f77-a96046dbfd7
2 &ID=790
[https://perma.cc/2KAD-HBXL] cf. Dom Phillips & Lena H. Sun, Brazil May Have Fewer Zika-
Related Microcephaly Cases than Previously Reported, WASH. POST (Jan. 29, 2016),
https://www.washingtonpost.cominews/worldviews/wp/2016/01/29/brazil-may-have-fewer-zika
-related-microcephaly-cases-than-previously-reported/?utm term=. 130b760628a2
[https://perma.cc/22HZ-3GXG] (reporting that many of the documented microcephaly cases in
Brazil may not actually be microcephaly, nor related to the Zika virus).
242. Donald G. McNeil, Jr., Hawaii Baby with Brain Damage Is First U.S. Case Tied to
Zika Virus, N.Y. TIMES (Jan. 16, 2016), https://www.nytimes.com/2016/01/17/health/hawaii-
reports-baby-born-with-brain-damage-linked-to-zika-virus.html [https://perma.cc/2MD6-FXS3].
243. See, e.g., Donald G. McNeil, Jr., To Protect Against Zika Virus, Pregnant Women Are
Warned About Latin American Trips, N.Y. TIMES (Jan. 15, 2016),
https://www.nytimes.com/2016/01/16/health/zika-virus-cdc-pregnant-women-travel-warning.html
[https://perma.ccIK8DF-F63T].
244. See, e.g., Adrija Hajra et al., Zika Virus: A Global Threat to Humanity: A
Comprehensive Review and Current Developments, 8 N. AM. J. MED. SCI. 123 (2016).
245. See, e.g., McNeil, supra note 242.
246. See, e.g., Axford, supra note 239; Sarich, supra note 238.
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public opinion. Such an outlook is not hypothetical; other countries
confronting mosquito-related health crises have weighed the social
and economic costs and benefits of releasing bioengineered insects into
the environment and opted to avail themselves of biotechnology to
allay the spread of disease.247
It is only a matter of time-and a brief one, at that-before the
technological knack required for large-scale testing of a CRISPR gene
drive is refined. Indeed, field trials could likely be ready to launch
anytime now if a general consensus to support them formed and gave
the green light to proceed.248
The stark imminence of these developments has prompted a
debate about biosecurity and the benefits and harms of using gene
drives for biological control of certain species, including how to
safeguard gene drive testing in laboratory settings.249  In fact,
scientists wary of the potential consequences of unintended release of
species carrying gene drives into the environment have already
designed and tested split-drives-to separate the pieces of a gene
drive-and reversal-drives-to verwrite changes of the original gene
drive-as molecular confinement insurance strategies to guard
against inadvertent escape of mutant organisms.250
The wondrous capacity to circumvent Mendelian genetics
constraints to guarantee that a gene can fix itself in a population is
unprecedented. Regardless of the future regulatory decisions made to
promote, control, or curtail gene drives altogether, no one can deny the
power of the technology. For better or worse, the ability to hack
genomes in pests finally bestows upon the world a weapon with the
potential to help eradicate a long list of vector-borne
247. See, e.g., supra notes 236-37 and accompanying text.
248. Carl Zimmer, A Call to Fight Malaria One Mosquito at a Time by Altering DNA, N.Y.
TIMES (July 17, 2014), http://www.nytimes.com/2014/07/17/science/a-call-to-fight-malaria-one-
mosquito-at-a-time-by-altering-dna.html?_r=o [https://perma.cc/D27C-K2MS] (quoting George
Church, senior author of one of the papers targeting malaria mosquito vectors, as stating: "In a
year or two, we could be doing field trials if there was a general consensus this was a good
idea.").
249. See, e.g., Omar S. Akbari et al., Safeguarding Gene Drive Experiments in the
Laboratory, 349 SCIENCE 927 (2015); Keith G. Kozminski, Biosecurity in the Age of Big
Data: A Conversation with the FBI, 26 MOLECuLAR BIOLOGY CELL 3894 (2015);
Bruce L. Webber et al., Opinion: Is CRISPR-Based Gene Drive a Biocontrol Silver Bullet or
Global Conservation Threat?, 112 PROC. NAT'L AcAD. Sci. U.S. 10565 (2015); Katie Langin,
Genetic Engineering to the Rescue Against Invasive Species?, NAT'L GEOGRAPHIC (July 18,
2014), http://news.nationalgeographic.com/news/2014/07/140717-gene-drives-invasive
-species-insects-disease-science-environment/ [https://perma.cclK9WH-EBH6]; Gene Drive
Research in Non-Human Organisms: Recommendations for Responsible Conduct, NAT'L ACAD.
Sci., ENG'G, & MED., https://www8.nationalacademies.org/cp/projectview.aspx?key=49717
[https://perma.ccVAT3-WVPM] (last visited Feb. 26, 2017).
250. See DiCarlo et al., supra note 217, at 1252-53.
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diseases-malaria, dengue, yellow fever, Zika, epidemic typhus, Lyme
disease, Rocky Mountain spotted fever, etc.-as well as neglected
tropical diseaseS25 1 (NTDs) caused by parasitic organisms-e.g.,
schistosomiasis, caused by helminth parasites of the genus
Schistosoma, which has brought suffering to hundreds of millions of
people worldwide.252 Science has produced a method that offers a
meaningful opportunity to strike back at the mosquito, the deadliest
animal in the world.25 3
By the same token, science has produced a tool to reshape
entire ecosystems. On one hand, given the reported success of gene
drives to endow a species with anti-parasite resistance,
254 one can
imagine possible scenarios where an endangered species could be
generously armed with a gene drive to help it cope with changes in its
habitat, or become immunized against parasites and opportunistic
organisms driving it into extinction. On the other hand, CRISPR-
based gene drives could be used to deliver a coup de grAce to invasive
and noxious species like the Asian carp in the Great Lakes,
255
251. NTDs are a group of parasitic and bacterial diseases affecting more than one billion
people worldwide, predominantly in low-income countries. Neglected Tropical Diseases, CTRS.
DISEASE CONTROL & PREVENTION, http://www.cdc.gov/globalhealth/ntd/ [https://perma.cclTK9L-
9LZ3] (last updated June 7, 2016). NTDs cause substantial illness and death, impair physical
and cognitive development, and limit productivity in the workplace. Id. They are considered
neglected because they are largely nonexistent in developed nations, but persist only in the
poorest, most marginalized areas of low-income countries. Id. The list of common NTDs includes
Buruli ulcers, Chagas disease, Cysticercosis, Dengue fever, Echinococcosis, Fascioliasis, Leprosy,
Onchocerciasis, Rabies, Schistosomiasis, and others. See Diseases, CTRS. DISEASE CONTROL &
PREVENTION, http://www.cde.gov/globalhealth/ntd/diseases/index.html [https://perma.cclBE7T-
4HPN] (last updated Feb. 17, 2017), for a list and information about NTDs.
252. See Chapter 3: Infectious Diseases Related to Travel, CTRS. DISEASE CONTROL &
PREVENTION, https://wwwnc.cdc.gov/travel/yellowbook/2016/infectious-diseases-related-to-travel
/schistosomiasis [https://perma.cc/2MM8-5C73] (last updated July 10, 2015). In terms of impact,
schistosomiasis is second only to malaria as the most devastating parasitic disease. The Burden
of Schistosomiasis (Schisto, Bilharzia, Snail Fever), CTRS. DISEASE CONTROL & PREVENTION,
http://www.cdc.gov/globalhealth/ntd/diseases/schisto burden.html [https://perma.cc/9MP3-LR7K
(last updated June 6, 2011). In more than seventy-five countries spanning tropical and sub-
tropical areas, 800 million people are at risk of contracting schistosomiasis, and more than 200
million people are infected with schistosomes. Sutas Suttiprapa et al., Genetic Manipulation of
Schistosomes - Progress with Integration Competent Vectors, 139 PARASITOLOGY 641, 641 (2012).
253. Bill Gates, The Deadliest Animal in the World, GATES NOTES (Apr. 25, 2014),
https://www.gatesnotes.com[HealthlMost-Lethal-Animal-Mosquito-Week [https://perma.ccl7T6Z-
L8F3].
254. See Gantz et al., supra note 227 (using a gene drive to make the mosquito Anopheles
Stephensi resistant to the malaria parasite).
255. See Asian Carp Threat to the Great Lakes, NAT'L WILDLIFE FED'N,
https://www.nwf.orgfWildlife/Threats-to-Wildlife/Invasive-Species/Asian-Carp.aspx
[https://perma.cc/6YHH-AE2D] (last visited Feb. 26, 2017); see also Asian Carp Breed in Great
Lakes, Threaten Fishing, USA TODAY (Oct. 28, 2013), http://www.usatoday.com
/story/news/nation/2013/10/28/asian-carp-great-lakes/
32 89 3 87/ [https://perma.cc/R3MB-GPQJ].
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Argentine cactus moth in the Southern United States and Mexico,256
cane toads in Australia,257 tropical fire ants in the Galapagos
Islands,258 Giant African snails,259 zebra mussels,260 kudzu,261 soybean
cyst nematode-affecting soybean crops worldwide262-and a
miscellany of other aquatic2 63 and terrestrial264 invasive plant and
animal species.
C. Transgenic Animals for Translational and Basic Research
Animals have long played an integral role in scientific inquiry.
From Aristotle's experiments on living animalS265 to Pasteur's
groundbreaking studies on rabbits and dogs,266 scientists have always
sought animal models to explore biomedical research. Well over 100
million animals have been used for scientific research in Europe and
the United States alone since governmental agencies began tracking
256. Argentine Cactus Moth (Cactoblastis cactorum), DESERT MUSEUM,
http://www.desertmuseum.org/invaders/invaders-cactusmoth.php [https://perma.cc/lKXA5-9RPZ]
(last visited Feb. 26, 2017).
257. Australian Government Policy on Cane Toads, AUSTRALIAN GOV'T: DEP'T ENV'T &
ENERGY, https://www.environment.gov.au/biodiversity/invasive-species/publications/cane-toad-
policy#why [https://perma.cc/X8MQ-EKWN] (last visited Feb. 26, 2017).
258. Managing Invasive Ants, GALAPAGOS CONSERVANCY,
http://www.galapagos.org/conservation/conservation/project-areas/ecosystem-
restoration/managing-invasive-ants/ [https://perma.cc/GM2Z-2ABN] (last visited Feb. 26, 2017).
259. Darryl Fears, This Invasive Giant Snail Is Spreading in Florida-and Bringing
Nasty Parasites with It, WASH. POST (July 10, 2015), https://www.washingtonpost.com
/news/energy-environment/wp/2015/07/10/giant-land-snails-are-on-the-move-and-a-nasty-
parasite-is-riding-them-like-a-bus/ [https://perma.cclU286-35H2].
260. The Lionfish Invasion!: Can We Stop the Invasion?, NAT'L OCEANIC &
ATMOSPHERIC ADMIN., http://oceanservice.noaa.gov/education/stories/lionfish/lionO5_stop.html
[https://perma.cc/P5HB-VCJN] (last visited Feb. 26, 2017).
261. Kudzu, Control, Mo. DEP'T CONSERVATION, https://mdc.mo.gov/trees-plants/problem-
plant-controllinvasive-plants/kudzu-control [https://perma.cc/RGL2-NXEJ] (last visited Feb. 26,
2017).
262. Qing Yu, Soybean Cyst Nematode (Heterodera glycines Ichinohe), in SOYBEAN
PHYSIOLOGY AND BIOCHEMISTRY 461, 461 (Hany El-Shemy ed., 2011),
http://cdn.intechopen.com/pdfs-wm/22782.pdf [https:/perma.cc/8Q8G-JSES].
263. Aquatic Species, U.S. DEP'T OF AGRIC., NAT'L INVASIVE SPECIES INFO.
CTR., http://www.invasivespeciesinfo.gov/aquatics/main.shtml#aqan [https://perma.cc/P6SB-
Y3EQ] (last visited Feb. 26, 2017).
264. Animals, U.S. DEP'T AGRIC., NAT'L INVASIVE SPECIES INFO. CTR.,
http://www.invasivespeciesinfo.gov/animals/main.shtml [https://perma.c/54VY-A22R] (last
visited Feb. 26, 2017).
265. Rachel Hajar, Animal Testing and Medicine, 12 HEART VIEWS 42, 42 (2011).
266. Kendall A. Smith, Louis Pasteur, the Father of Immunology?, 3 FRONTIERS
IMMUNOLOGY, art. 68, 8 (2012).
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animal studies.267 A long list of model organismS268 has helped to
elucidate fundamental questions in science over many decades.
Without question, animal experimentation has provided insights into
anatomy, physiology, and medicine that have dramatically
transformed our ability to cope with and ameliorate human
suffering.269  It would be nearly impossible to establish safety
measures and criteria prior to launching new treatments without the
use of animal models of human disease.270
1. Mouse Pre-Clinical Models of Disease
In recent years, genome editing has routinely been utilized to
edit a multitude of animal genomes.271 Of these, the mouse has
become the foremost mammalian model organism for genetic and
biomedical pre-clinical research, thanks in part to physiological
similarities between mice and humans.272 Indeed, genome editing
studies in mice are instrumental for translational purposes and
demonstrate great promise in forging a path toward human clinical
applications. For instance, last month, three independent US teams
published proof-of-concept studies showing how CRISPR-based gene
editing can be used to improve skeletal muscle function in adult and
neonatal mice models of Duchenne muscular dystrophy (DMD), a fatal
genetic disease that causes muscle degeneration, loss of mobility, and
premature death.273  One of the three teams had previously
267. Daniel Butzke et al., The Advent of the Golden Era of Animal Alternatives, in
ANIMAL MODELS FOR THE STUDY OF HUMAN DISEASE 49-50 (P. Michael Conn ed., 2013). In 2014,
834,453 animals-excluding rats, mice, birds and other species not covered by the Animal
Welfare Act-were used in research and teaching in the United States. Animals Used in
Research, NAT'L ANTI-VIVISECTION SOC'Y, http://www.navs.org/the-issues/animals-in-
research/#.WJ5tO5KgQxU [https://perma.cc/9BSA-YVBJI (last visited Feb. 25, 2017).
268. See List of Model Organisms, WIKIPEDIA, https://en.wikipedia.org
/wiki/List of model-organisms [https://perma.cc/8T3Y-AXTA] (last updated Dec. 29, 2016).
269. For a works-in-collection featuring a thorough examination of the use of animal
models for human disease in a wide array of fields ranging from ophthalmology and cardiology to
genetics, behavior, cancer, and development, see ANIMAL MODELS FOR THE STUDY OF HUMAN
DISEASE (P. Michael Conn ed., 2013).
270. See, e.g., Lars Dalgaard, Comparison of Minipig, Dog, Monkey and Human Drug
Metabolism and Disposition, 74 J. PHARMACOLOGICAL & TOXICOLOGICAL METHODS 80 (2015).
271. See, e.g., supra notes 163-71; supra Sections IV.A & IV.B.
272. S.K. Chung et al., Mouse Models for Human Diseases, 3 H.K. MED. J. 201, 201
(1997); Background on Mouse as a Model Organism, NAT'L HUM. GENOME RES. INST. (Dec. 2002),
http://www.genome.gov/100058
3 4 [https://perma.cc/EJ85-MCV8] (last reviewed May 31, 2012).
273. Chengzu Long et al., Postnatal Genome Editing Partially Restores Dystrophin
Expression in a Mouse Model of Muscular Dystrophy, 351 SCIENCE 400, 400 (2016); Christopher
E. Nelson et al., In Vivo Genome Editing Improves Muscle Function in a Mouse Model of
Duchenne Muscular Dystrophy, 351 SCIENCE 403, 403 (2016); Mohammadsharif Tabebordbar et
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demonstrated the feasibility of preventing the disease by editing the
germline-an organism's sex cells (e.g., eggs and sperm) that
pass on genes from one generation to the next during sexual
reproduction274-of mice models of DMD. 2 7 5
Researchers have also corrected a mutation in the Crygc gene
responsible for cataracts by editing the germline of mice, leading to
the birth of fertile pups that went on to pass the corrected allele to
their progeny.276  A mouse model of mitochondrial disease
demonstrated that germline genome editing can prevent transmission
of faulty mitochondria-organelles that supply energy to cellS2 7 7-to
mice offspring.278 CRISPR-mediated genome editing in postmitotic
neurons of adult mice brain has been achieved in vivo.279
And a separate team showed that Cas9-mediated germline
multiplexing-the simultaneous disruption of multiple genes by gene
editing-can be accomplished by targeting genes into zygotes, thereby
producing animals with desired mutations in various genes.28 0
Despite the widespread use of mouse models of human disease,
there are stark limitations associated with pre-clinical trials in
rodents. First, the very characteristics that make mice useful
models-relatively short life cycle compared to other mammals,
physical size, short gestation periods, abundant progeny, etc.-may
render them inadequate for validating the relevance of clinical
findings.281 Second, metabolic and physiological differences between
mice and humans lead to differences in species-specific susceptibility
to disease and pharmacological responses.282 Third, mice models of
al., In Vivo Gene Editing in Dystrophic Mouse Muscle and Muscle Stem Cells, 351 SCIENCE 407,
407 (2016).
274. What Are the Ethical Issues Surrounding Gene Therapy?, U.S. NAT'L LIBR. MED.
(Feb. 7, 2017), https://ghr.nlm.nih.gov/primer/therapy/ethics [https://perma.cc/B5HY-R83D].
275. Chengzu Long et al., Prevention of Muscular Dystrophy in Mice by CRISPR/Cas9-
Mediated Editing of Germline DNA, 345 SCIENCE 1184, 1184 (2014).
276. Yuxuan Wu et al., Correction of a Genetic Disease in Mouse via Use of CRISPR-Cas9,
13 CELL STEM CELL 659, 659, 662 (2013).
277. Mitochondrial DNA, GENETICS HOME REFERENCE (Feb. 7, 2017),
http://ghr.nlm.nih.gov/mitochondrial-dna [https://perma.cc/A3DW-4TL4].
278. Pradeep Reddy et al., Selective Elimination of Mitochondrial Mutations in the
Germline by Genome Editing, 161 CELL 459, 459 (2015).
279. Lukasz Swiech et al., In Vivo Interrogation of Gene Function in the Mammalian
Brain Using CRISPR-Cas9, 33 NATURE BIOTECHNOLOGY 102, 102 (2015).
280. Haoyi Wang et al., One-Step Generation of Mice Carrying Mutations in Multiple
Genes by CRISPRICas-Mediated Genome Engineering, 153 CELL 910, 910 (2013). See generally
Wataru Fujii et al., Efficient Generation of Large-Scale Genome-Modified Mice Using gRNA and
CAS9 Endonuclease, 41 NUCLEIC ACIDS RES. e187 (2013).
281. Chung et al., supra note 272, at 201.
282. Id.; see also Dalgaard, supra note 270 (discussing comparative pharmacology and
toxicology in humans and other large mammals).
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disease often cannot recapitulate features associated with many
human pathologies. A quintessential illustration of this phenomenon
is the inability of mice to replicate the full panoply of
neuropathologies-most notably, overt neurodegeneration in the
human brain-that constitute the hallmark of many
neurodegenerative diseases such as Parkinson's Disease,283
Huntington's Disease,284 and Alzheimer's Disease.285 The same holds
true for Cystic Fibrosis,2 8 6 Lesch-Nyhan syndrome,28
7 and many other
conditions. The lack of accurate pathological reproducibility is
problematic and may be linked to the meager impact these mouse
models have had in clinical outcomes.288
2. Large Animal Pre-Clinical Models on the Rise
As a result of the natural constraints imposed by mice models
of human disease, large animal models have become an increasingly
attractive alternative for clinical investigation.289  Indeed, as
controversial as the research might be,290 dogs,29 1 cats,292 pigs,2 9 3
283. J.A. Potashkin et al., Limitations of Animal Models of Parkinson's Disease, 2011
PARKINSON's DISEASE art. ID 658083, at 5 (2011).
284. Xiao-Jiang Li & Shihua Li, Large Animal Models of Huntington's Disease, in
BEHAVIORAL NEUROBIOLOGY OF HUNTINGTON'S DISEASE & PARKINSON'S DISEASE 149 (2013).
285. Karen Duff & Faraha Suleman, Transgenic Mouse Models of Alzheimer's Disease:
How Useful Have They Been for Therapeutic Development?, 3 BRIEFINGS FUNCTIONAL GENOMICS
& PROTEOMICS 47, 49-50 (2004).
286. Isabel Carvalho-Oliveira, What Have We Learned from Mouse Models for Cystic
Fibrosis?, 7 EXPERT REV. MOLECULAR DIAGNOSTICS 407 (2007).
287. Chao-Liang Wu & David W. Melton, Production of a Model for Lesch-Nyhan
Syndrome in Hypoxanthine Phosphoribosyltransferase-Deficient Mice, 3 NATURE GENETICS 235
(1993).
288. DR. Howlett, APP Transgenic Mice and their Application to Drug Discovery, 26
HISTOLOGY & HISTOPATHOLOGY 1611 (2011).
289. See e.g., Ashish R. Pinnapureddy et al., Large Animal Models of Rare Genetic
Disorders: Sheep as Phenotypically Relevant Models of Human Genetic Disease, 10 ORPHANET J.
RARE DISEASES 107 (2015).
290. Compare Allyson J. Bennett, Animal Research: The Bigger Picture and Why We Need
Psychologists to Speak out, AM. PSYCHOL. ASS'N, (Apr. 2012),
http://www.apa.org/science/about/psa/2012/04/animal-research.aspx, with Animal Testing Is Bad
Science: Point/Counterpoint, PETA, http://www.peta.org/issues/animals-used-for-
experimentation/animal-testing-bad-science/ [https://perma.cc/2JLH-SAH3] (last visited Feb. 12,
2017).
291. Meg M. Sleeper et al., Gene Therapy in Large Animal Models of Human
Cardiovascular Genetic Disease, 50 INST. FOR LABORATORY ANIMAL RES. J. 199, 200-01 (2009).
292. Id.
293. Nana Fan & Liangxue Lai, Genetically Modified Pig Models for Human Diseases, 40
J. GENETICS & GENOMICS 67 (2013).
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sheep,294 rabbits,295 goats,296 horses,297 non-human primates,298 and
other large animals have contributed greatly to our understanding of
human pathologies. Advocates of research on large animals argue
that using higher mammalian species offers a more rigorous and
reliable system to validate the efficacy of pre-clinical trials in small
rodents.299 Accordingly, a tide of experiments on large animals is
surfing apace thanks to novel genome editing technologies that have
turned the unimaginable into a reality.3 00
In almost parallel studies, CRISPR systems have been
effectively used to create muscular versions of pigS301 and beagle
dogs,302 the canine breed most widely used in biomedical research, via
engineering MSTNa30 3 mutations. At least nine genes, some of which
are associated with lipid metabolism and cardiovascular conditions,
have been targeted and mutated in rabbits.304 Editing the vWF gene,
responsible for von Willebrand Disease (vWD)-a bleeding disorder
that prevents normal blood clotting305-- led to a striking phenotype in
mutant pigs; the animals exhibited prolonged bleeding that lasted
nearly fifteen times longer than that of non-mutant pigs. 3 0 6 Because
mice models cannot fully recapitulate the severe bleeding phenotype of
294. Pinnapureddy et al., supra note 289.
295. V. Duranthon et al., On the Emerging Role of Rabbit as Human Disease Model and
the Instrumental Role of Novel Transgenic Tools, 21 TRANSGENIC RES. 699 (2012).
296. E.J. Olivier ten Hallers et al., The Saanen Goat as an Animal Model for Post-
Laryngectomy Research: Practical Implications, 41 LABORATORY ANIMALS 270 (2007).
297. C.W. Mcflwraith et al., The Horse as a Model of Naturally Occurring Osteoarthritis,
1 BONE & JOINT RES. 297 (2012).
298. David T. Evans & Guido Silvestri, Non-Human Primate Models in AIDS Research, 8
CURRENT OPINIONS HIV & AIDS 255 (2013).
299. Li & Li, supra note 284, at 157.
300. Amy Harmon, Open Season Is Seen in Gene Editing of Animals, N.Y. TIMES, Nov. 27,
2015, at Al.
301. Kankan Wang et al., Efficient Generation of Myostatin Mutations in Pigs Using the
CRISPR/Cas9 System, 5 SC. REP. 16623 (2015).
302. Qingjian Zou et al., Generation of Gene-Target Dogs Using CRISPR/Cas9 System, 7
J. MOLECULAR CELL BIOLOGY 580 (2015).
303. Myostatin, also known as growth differentiation factor-8 (GDF-8), is a gene involved
in regulation of skeletal muscle growth that has been linked to muscle hypertrophy. See
Alexandra C. McPherron et al., Regulation of Skeletal Muscle Mass in Mice by a New TGF-beta
Superfamily Member, 387 NATURE 83 (1997).
304. Yang et al., supra note 168.
305. What Is Von Willebrand Disease?, NAT'L HEART, BLOOD, & LUNG INST.,
http://www.nhlbi.nih.gov/healthlhealth-topics/topics/vwd [https://perma.cc/4R7N-WC6G] (last
updated June 1, 2011).
306. Tang Hai et al., One-Step Generation of Knockout Pigs by Zygote Injection of
CRISPRICas System, 24 CELL RES. 372, 374 (2014).
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vWD, 307 the ability of CRISPR-edited pigs to mimic human vWD is a
major step toward developing a bona fide model to study the disease.
Similar phenotypic replication of pathologies that could not be
realized in mouse models has been accomplished in sheep,308 pigs,309
and other large animals,310 lending credence to the hypothesis that
large animal models constitute a more precise platform to study some
human diseases. Now that CRISPR technologies and their use are
starting to become routine, we should fully expect numerous reports in
the coming months and years establishing new large animal models
for clinical research.
On this point, perhaps the most salient examples of the
potential of genome editing for translational applications are the
recent publications vis-A-vis CRISPR-edited non-human primates. In
a world first, Chinese scientists have recently used genome editing
technologies to modify the embryos of cynomolguS3 11 and rhesuS
3 12
monkeys and implant them into surrogate mothers, who delivered
transgenic infant monkeys after full-term pregnancies. Proof that
non-human primates' genomes can, in fact, be modified at the
embryonic stage to produce progeny with desired modifications turns
the prospect of human germline modification from a forlorn aspiration
into a feasible goal. Indeed, the race to produce monkeys with
307. Id. at 372.
308. See, e.g., Eric W.F.W. Alton et al., The Safety Profile of a Cationic Lipid-Mediated
Cystic Fibrosis Gene Transfer Agent Following Repeated Monthly Aerosol Administration to
Sheep, 34 BIOMATERIALS 10267, 10276 (2013).
309. Compare, e.g., Bernhardt G. Zeiher et al., A Mouse Model for the AF508 Allele of
Cystic Fibrosis, 96 J. CLINICAL INVESTIGATION 2051, 2062 (1996) (introducing the most common
CF-associated mutation of CFTR into transgenic mice without accurately replicating the CF
pathology), with Lynda S. Ostedgaard et al., The AF508 Mutation Causes CFTR Misprocessing
and Cystic Fibrosis-Like Disease in Pigs, 3 SCl. TRANSLATIONAL MED. 74ra24 (2011) (engineering
pigs carrying the same mutation-AF508-as was done in the mouse, but observing a range of
human CF pathology), and Christopher S. Rogers et al., Disruption of the CFTR Gene Produces a
Model of Cystic Fibrosis in Newborn Pigs, 321 SCIENCE 1837 (2008) (disrupting the CFTR gene
in pigs led to development of human CF clinical manifestations). See also Huaqiang Yang et al.,
Species-Dependent Neuropathology in Transgenic SOD1 Pigs, 24 CELL RES. 464 (2014)
(engineering transgenic pigs that showed nuclear accumulation and ubiquitinated nuclear
aggregates in the brain, as seen in some human Amyotrophic lateral sclerosis (ALS) patient
brains, but not in ALS mouse models).
310. See, e.g., Xingshen Sun et al., Disease Phenotype of a Ferret CFTR-Knockout Model of
Cystic Fibrosis, 120 J. CLINICAL INVESTIGATION 3149 (2010).
311. Yuyu Niu et al., Generation of Gene-Modified Cynomolgus Monkey via Cas9/RNA-
Mediated Gene Targeting in One-Cell Embryos, 156 CELL 836 (2014).
312. Hailiang Liu et al., TALEN-Mediated Gene Mutagenesis in Rhesus and Cynomolgus
Monkeys, 14 CELL STEM CELL 323 (2014).
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targeted genome modifications for more accurately modeling human
diseases is now on.313
In the last year, the birth of monkeys with markedly depleted
dystrophin and muscle degeneration seen in early human DMD has
been reported.314  A one-step method demonstrated successful
embryonic editing and delivery of live monkeys carrying homozygous
mutations in the tumor suppressor p5 3 gene.3 15  Furthermore,
scientists recently published an article describing the creation of
transgenic monkeys that exhibit autism-like behaviors and,
remarkably, showed successful germline transmission of the modified
gene by bringing their progeny into this world.316 These findings
demonstrate that, unlike mouse models lacking higher perceptual and
cognitive function seen in primates,3 17 studies using non-human
primate genome editing are better equipped to provide models to
further our understanding-and ultimately lead to treatments-of the
cognitive, behavioral, anatomical, and emotional symptoms associated
with a long list of neurological-autism spectrum disorder;
behavioral-Attention Deficit Hyperactivity Disorder (ADHD), drug
abuse, and alcohol abuse; psychiatric-schizophrenia, obsessive
compulsive disorder, and depression; and neurodegenerative
disorders-Alzheimer's and Parkinson's Disease-that contribute to
human suffering worldwide.
3. Xenotransplantation-A Case Study
Genome editing technologies can now be used to create useful
animal models to interrogate the mechanisms of human diseases,
which may lead to future diagnoses and treatments, as discussed
above. However, other translational applications of animal genome
editing are even closer on the horizon, and a prime example is the field
of xenotransplantation.318
313. See, e.g., infra notes 314-16 and accompanying text.
314. Yongchang Chen et al., Functional Disruption of the Dystrophin Gene in Rhesus
Monkey Using CRISPR/Cas9, 24 HUM. MOLECULAR GENETICS 3764 (2015); Yongchang Chen et
al., Germline Acquisition of Cas97RNA-Mediated Gene Modifications in Monkeys, 25 CELL RES.
262 (2015).
315. Haifeng Wan et al., One-Step Generation of p53 Gene Biallelic Mutant Cynomolgus
Monkey via the CRISPR/Cas System, 25 CELL RES. 258 (2015).
316. Zhen Liu et al., Autism-Like Behaviours and Germline Transmission in Transgenic
Monkeys Overexpressing MeCP2, 530 NATURE 98 (2016).
317. Jon H. Kaas, The Evolution of Brains from Early Mammals to Humans, 4 WILEY
INTERDISC. REVS. 33 (2013).
318. Xenotransplantation refers to the process of transplanting living cells, tissues, or
organs from one species to another. See Xenotransplantation, WORLD HEALTH ORG. (May 2,
2005), http://www.who.int/transplantation/xeno/en/ [https://perma.ccIV65A-FZW5].
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Organ donation and transplantation is the best, and often sole,
form of treatment for end-stage organ failure worldwide.
3 19  In the
United States alone, a shortage of organs for transplantation claims
approximately twenty-two lives every day-over 8,000 annually.
320
Similarly, massive shortages of organ donors in China and India lead
to tens-of-thousandS321  and hundreds-of-thousands of deaths,322
respectively, with worldwide death tolls likely reaching the millions.
323
319. C. Rudge et al., International Practices of Organ Donation, 108 BRITISH J.
ANAESTHESIA i48 (2012).
320. Donation and Transplantation, U.S. DEP'T HEALTH & HUM. SERVS.,
http://www.organdonor.gov/about/data.html [https://perma.cc/R77B-YBP6] (updated Mar. 31,
2015).
321. Wang Yan, Still Waiting, NEWS CHINA, (July 2011),
http://old.newschinamag.com/magazine/still-waiting [https://perma.ccXM33-2PT8].
322. Approximately 500,000 people die annually in India due to a shortage of organs for
transplantation. Shruti Saxena, Organ Donation: Does India Lack Will?, INDILENS, (Aug. 7,
2014), http://indilens.com/57441-world-organ-donation-day-does-india-lack-will/
[https://perma.cc[LJM5-JPHV]. India has a rate of less than 0.2 donors per one million
population. Id.
323. It is difficult to determine exactly how many people on organ waiting lists die every
year globally due to the lack of reporting mechanisms in most of the developing world. According
to the International Registry in Organ Donation and Transplantation (IRODaT), only seventy-
one countries currently report national data of donation and transplantation activity for
database compilation on IRODaT. Final Numbers 2013, INT'L REGISTRY ORGAN DONATION &
TRANSPLANTATION 2 (Dec. 2014), http://www.irodat.org/img/database/pdf/IRODaT
%20Newsletter%202013%20.pdf [https://perma.cc/7Q2Y-C7A7]. The World Health Organization
(WHO) reported 117,700 solid organ transplants in 2013. Map: Global Observatory on Donation
and Transplantation, Global Transplantation Activities of Solid Organs, 2013, WORLD HEALTH
ORG., (2015), http://www.transplant-observatory.org/report-
2 013/ [https://perma.cc/4MTP-
BGCU]. In contrast, 29,532 individuals received organ transplants in 2014 in the United
States, where over 123,000 people are currently on waiting lists for lifesaving organ
transplants. U.S. DEP'T HEALTH & HUM. SERVS., supra note 320; Facts and Myths, AM.
TRANSPLANT FOUND., http://www.americantransplantfoundation.org/about-transplant/facts-and-
myths/ [https://perma.cc/4WS7-TP22] (last visited Feb. 12, 2017). It is important to point out that
organ transplant statistics do not include corneas, veins, heart valves, tendons, bones, skin, and
other tissues. Facts and Myths, supra. For example, 40,000 corneal transplants-the most
routinely transplanted tissue-are performed every year in the United States. Id.
An overwhelmingly conservative, low-end estimate of worldwide deaths attributable to organ
shortages could, at the very least, be purportedly derived by looking at US statistics. If roughly
6.5% of people on waiting lists die every year (8,000 deaths per annum from a select population
of 123,000), and approximately 24% of wait-listed individuals receive transplants (29,532
recipients of a 123,000 applicant pool), we can use the number of reported worldwide transplants
(117,700) and US-derived statistical rates to arrive at a baseline putative worldwide organ
transplant waitlist population-limited to less than half (seventy-one) of total countries-of
nearly a half-million individuals (-491,000), of which -32,000-or 6.5%-would die annually.
Yet, even this figure likely grossly underestimates the actual number given that there are nearly
200 countries in the world, and most of the non-reporting countries house low-income, poverty-
stricken populations with limited access to healthcare and education. Undoubtedly, in this
context, current statistics on organ transplantation-related data excludes individuals in low-
income regions of the world who are in dire need of access to lifesaving organ transplantation.
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To mitigate the shortage of organs, scientists began to
experiment, decades ago, with xenotransplantation to determine
whether animals could provide a supply of organs to humans.324
Animal kidney, heart, and liver organs were first in line, with
catastrophic results for patients as a result of severe infection,
immune reactions, and rejection of the organs.325 However, after
decades of research on xenotransplantation and the advent of genome
editing technology, researchers may now be on the verge of breaking
through the non-human organ donor glass ceiling.
Recent articles published encouraging results from
xenotransplantation of heartS326 and a life-supporting kidney graft32 7
Furthermore, many people in both reporting and non-reporting countries may harbor long-held
cultural apprehensions regarding transplantation, including distrust of the medical system and
religious or ethnic myths and misbeliefs about diseased organ donation and transplantation. See
e.g., L.P. Wong, Factors Limiting Deceased Organ Donation: Focus Groups' Perspective from
Culturally Diverse Community, 42 TRANSPLANTATION PROC. 1439 (2010). Such ethnic, religious,
and cultural limitations could even be responsible for under-reporting figures in developed
countries with tightly clustered and self-isolating immigrant populations.
One might arrive at a closer estimate using the above, or a similar, mathematical
formulation with rates derived from developing countries like China and India where death rates
are believed to be in the tens-of-thousands in China and as high as 500,000 in India. See Saxena,
supra note 322; see also Yan, supra note 321. Combining figures stemming from much-needed
independent statistical and mathematical modeling among developed and developing countries
may shed more light on the actual state of organ transplantation worldwide. Moreover, it bears
noting that individuals in need of organ transplantations in some parts of the world may not
have the resources or capabilities to get on a waitlist, even if one were available in their country
of origin, due to hurdles imposed by corrupt governments and international cartels engaged in
organ trafficking. See Bruce Watson, How Corrupt Governments Make a Killing on Human
Organs, DAILY FIN. (Jan. 7, 2011), http://www.dailyfinance.com/2011/01/07/human-organ-
trafficking-is-big-business-in-kosovo-china/ [https://perma.cc/ZS64-R9LC].
Lastly, a statistical caveat involves potentially incomplete figures found on current waitlists
across developed and developing nations. For instance, when the United States began tracking
organ transplantation data in 1991, there were roughly 16,000 transplants performed and a little
over 23,000 people on waitlists. The Gap Continues to Widen, U.S. DEP'T HEALTH & HUM. SERVS.,
https://www.organdonor.gov/statistics-stories/statistics/data.html [https://perma.cc/22B7-XCYJ]
(last visited Feb. 12, 2017). Since then, the number of transplants has less than doubled. Id. Yet,
remarkably, the number of patients waiting for transplants has increased by more than 530%
over the past two-and-a-half decades. Id. Although it is possible-though not plausible-one can
hardly imagine that such a disparate number of people today require transplants compared to
yesteryears. A more likely explanation for such soaring numbers includes, inter alia, patients
with more access to healthcare and well-trained physicians able to characterize a patient as a
candidate for organ transplantation.
324. David K.C. Cooper, A Brief History of Cross-Species Organ Transplantation, 25
BAYLOR U. MED. CTR. PROC. 49, 51-52 (2012).
325. Id.
326. Muhammad M. Mohiuddin et al., Genetically Engineered Pigs and Target-Specific
Immunomodulation Provide Significant Graft Survival and Hope for Clinical Cardiac
Xenotransplantation, 148 J. THORACIC & CARDIOVASCULAR SURGERY 1106 (2014).
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from genetically modified pigs to baboons. Last fall, a group of
researchers used CRISPR-Cas9 to simultaneously eradicate all
sixty-two copies of a porcine endogenous retrovirus (PERV)-a type of
pig virus that could be transmitted to humans-in a pig kidney cell
line and prevented in vitro viral infection and transmission to human
cells.32 8 The same group also reported a forthcoming publication
involving the editing of more than twenty genes in pig embryos,
including some known to trigger human immune responses or blood
clotting.329
These and other findings have spurred entrepreneurial interest
in using synthetic biology and genome editing methods to generate
ready-for-transplant, human-compatible pig organs.
330 Backed by an
infusion of venture capital, biotech companies aim to get pig lungs in
human clinical trials by 2020,331 and academic researchers funded by
the National Institutes of Health are working to carry out parallel
studies that may bring clinical trials of pig kidney, heart, and liver
transplantation in humans within the realm of possibility.
332 A
327. Hayato Iwase et al., Pig Kidney Graft Survival in a Baboon for 136 Days: Longest
Life-Supporting Organ Graft Survival to Date, 22 XENOTRANSPLANTATION 302 (2015).
328. Luhan Yang et al., Genome-Wide Inactivation of Porcine Endogenous Retroviruses
(PERVs), 350 SCIENCE 1101 (2015).
329. Sara Reardon, Gene-Editing Record Smashed in Pigs, NATURE (Oct. 6, 2015),
http://www.nature.com/news/gene-editing-record-smashed-in-pigs-1. 18525
[https://perma.cc/B379-BDKX].
330. See, e.g., Press Release, United Therapeutics, Synthetic Genomics Inc. Signs
Collaborative Research and Development Agreement with Lung Biotechnology Inc., a Subsidiary
of United Therapeutics Corporation, to Develop Humanized Pig Organs to Revolutionize
Transplantation Field (May 4, 2014), http://ir.unither.com/releasedetail.cfm?releaseid=845454
[https://perma.cc/C2G8-6G23] (announcing a $50 million equity investment to develop
humanized pig organs); Douglas W. House, United Therapeutics Subsidiary Expands R&D
Agreement to Develop Transplant-Ready Pig Organs, SEEKING ALPHA NEWS (Sept. 22, 2015),
http://seekingalpha.com/news/2792636-united-therapeutics-subsidiary-expands-r-and-d-
agreement-to-develop-transplant-ready-pig-organs [https://perma.cc/682T-UZGX] (expanding the
multi-year agreement with an additional $50 million investment); About Us, EGENESIS,
http://www.egenesisbio.com/about-us.html [https://perma.cc/KRR5-4XE5] (last visited Feb. 26,
2017).
331. See, e.g., Shelly Banjo, The Highest-Paid Woman in America Is Working on Robot
Clones and Pigs with Human DNA, QUARTZ (Mar. 16, 2015), http://qz.com/362933
[https://perma.cc/GJ95-CZX4] (reporting on America's highest-paid female and transgender
executive and her goal to produce transgenic pig organs to meet the demands for human organ
transplantation); Jason Koebler, Martine Rothblatt Wants to Grow Human Organs in Pigs at
This Farm, MOTHERBOARD (June 14, 2015), http://motherboard.vice.com/read/martine-rothblatt-
wants-to-grow-human-organs-in-pigs-at-this-farm [https://perma.cclHG8M-6TTY] (describing
United Therapeutics CEO's goal of building a farm where production of 100,000 lungs, hearts,
and other transplantable organs can grow inside transgenic pigs by 2020).
332. David K.C. & Richard N. Pierson, Genetically-Engineered Pig Organ
Transplantation into Non-Human Primates, GRANTOME, http://grantome.com/grant/NIHfUl9-
AI090959-06 [https://perma.cclHR63-RWANI (last visited Feb. 13, 2017).
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hopeful preview came last year when the Chinese Food and Drug
Administration approved the sale of the world's first bioengineered
cornea derived from pig's eyes.3 33 Within months, the first transplant
was performed in an older patient suffering from a serious corneal
ulcer with successful results.334  As genome editing technologies
mature, we should expect further developments in
xenotransplantation and other important fields of clinical relevance.
D. Agriculture
1. Crops and Biofuels
The United Nations projects the world population will rise from
today's 7.2 billion to 9.6 billion by the year 2050.335 This gargantuan
increase will pose significant challenges to the world's ability to foster
food security and meet nutritional needs using limited arable land and
water available for irrigation.336 *As a result, sustainability and the
contributions of rising agriculture-related pollution to climate change
will become global problems.337 Analyses for global crop demand
forecast an increase between 100% and 110% from current levels by
2050.338 Investment in biotechnologies aimed at increasing food yields
and producing pest-resistant genetically modified (GM) crops have
been proposed as a solution to the global food crisis.339
Fervid, and at times intemperate, controversy exists over the
use of GM crops-colloquially known as GMOS340-with supporters
333. Jing Yang, Seeing the World Through Pig's Eyes: Chinese Firm to Launch Artificial
Cornea, S. CHINA MORNING POST (July 29, 2015, 7:12 PM), http://www.semp.com/business/china-
business/article/1844830/seeing-world-through-pigs-eyes-chinese-firm-launch
[https://perma.ce/3LFB-G54J].
334. Doctors Conduct 'Animal-Human' Cornea Transplant, CHINA.ORG.CN (Dec. 22, 2015),
http://www.china.org.cn/china/2015-12/22/content_37370047.htm [https://perma.ccVH6R-VC53].
335. Population Projected to Reach 9.6 Billion by 2050, U.N. DEP'T ECON. & SOC. AFF.,
(June 13, 2013), https://www.un.org/development/desalen/news/population/un-report-world-
population-projected-to-reach-9-6-billion-by-2050.html [https://perma.cc/3C4E-32H6].
336. Elliot M. Berry et al., Food Security and Sustainability: Can One Exist Without the
Other?, 18 PUB. HEALTH NUTRITION 2293, 2300 (2015).
337. Id.
338. David Tilman et al., Global Food Demand and the Sustainable Intensification of
Agriculture, 108 PROC. NAT'L ACAD. SCI. U.S. 20260 (2011).
339. See, e.g., Anurag Chaurasia, India Needs Home-Grown GM Food to Stop Starvation,
529 NATURE 439 (2016).
340. The controversy surrounding GMOs-and GM food in particular-is the focus of a
forthcoming publication. See Enriquez, supra note 31. In that article, I examine the underlying
basis for GMO controversies, synthesize the scientific literature concerning the perceived
GMO-related human health and environmental risks, analyze the GMO regulatory framework
654 [Vol. XIX:3:603
2017] GENOME EDITING 655
and critics constantly sparring about the perceived risks and benefits
of GM crops to human health, the environment, and food security.341
However, although a minor potential for adverse events exists, to date,
no overt or deleterious consequences have yet been documented in the
scientific, peer-reviewed literature for the more than two decades that
bioengineered foods have been available to consumers,
34 2 with the
under current law, and prescribe policy recommendations for the future of genome editing in the
GMO realm.
341. See, e.g., Found. on Econ. Trends v. Heckler, 756 F.2d 143, 146 (D.C. Cir. 1985)
(enjoining the University of California from conducting a "deliberate release experiment" to delay
field testing of genetically altered bacteria on select crops); All. for Bio-Integrity v. Shalala, 116
F. Supp. 2d 166, 181 (D.D.C. 2000) (rejecting a challenge, brought by a coalition group of
scientists and religious leaders, to the Food and Drug Administration's policy on genetically
engineered foods). Compare Ming Zhang et al., Long-Term Toxicity Study on Transgenic Rice
with CrylAc and Sck Genes, 63 FOOD & CHEMICAL TOXICOLOGY 76, 82 (2014) (concluding that
insect-resistant GM rice consumption in rodents has no long-term, adverse health effects), with
Gilles-Eric Sbralini et al., Republished Study: Long-Term Toxicity of a Roundup Herbicide and a
Roundup-Tolerant Genetically Modified Maize, 26 ENVTL. SCl. EUR. 14 (2014) (documenting a
series of long-term deleterious effects, including severe hormone-dependent mammary, hepatic,
and kidney disturbances, arising from consumption of GM maize treated with Roundup-the
most widely used herbicide worldwide-in rodents). See also, e.g., E.C., A DECADE OF EU-FUNDED
GMO RESEARCH 2001-2010, at 15-17 (2010) (compiling results from research studies on the
safety of GM organisms funded by the European Union); Allison Kopicki, Strong Support for
Labeling Modified Foods, N.Y. TIMES (July 27, 2013), http://www.nytimes.com/
2013/07/28/science/strong-support-for-labeling-modified-foods.html?_r=1 [https://perma.cc/JE9Z-
NGJL] (citing a New York Times poll that shows 93 percent of American respondents support
labeling GM foods and 75 percent harbor concerns about eating GM foodstuff); Millions March




[https://perma.cclV9XR-HCAU] (reporting on protest rallies organized in the United States and
globally against Monsanto); Lee R. Morisy, Report on the Council for Public Health: Biomedical
Engineering, AM. MED. ASS'N (2012),
https://web.archive.org/web/20120907023039/http://www.ama-assn.org/resources/doc/csaphlal
2 -
csaph2-bioengineeredfoods.pdf [https://perma.cclDM6U-BS2A] (recommending that mandatory
labeling of GM foods is not consistent with the FDA's science-based labeling policies despite
strong consumer interest in labeling); Lynne Peeples, GMO Debate Heats up: Critics Say Biotech
Industry Manipulating Genes, and Science, HUFFINGTON POST (Sept. 21, 2012, 8:30 PM),
http://www.huffingtonpost.com/2012/0
9/2 1/gmo-proposition-37-study-funding-research-n_1904
535.html [https://perma.ccl6UZJ-ZY8P] (commenting on California's 2012 Proposition 37, which
sought to require labeling of GM foods).
342. Although an exposition of the benefits and risks of GMOs, as well as their legal
status and policy recommendations are outside the scope of this Article, a discussion of genome
editing for agricultural purposes at least warrants the inclusion of some background on the
controversy surrounding public perceptions and scientific evidence for or against GMOs. See
supra note 341 and accompanying text.
For an exemplification of the scientific debate surrounding GMOs, see Zhang et al., supra
note 341 (finding no evidence of harmful health effects from GM rice consumption by rodents),
and Morisy, supra note 341, at 2-5 (filing a report with the American Medical Association House
of Delegates that cites literature presenting no evidence of health consequences to humans from
two decades of GM crop consumption). Cf. Gilles-Eric Sdralini et al., RETRACTED: Long Term
Toxicity of a Roundup Herbicide and a Roundup-Tolerant Genetically Modified Maize, 50 FOOD &
VAND. J. ENT. & TECH. L. [Vol. XIX:3:603
exception of one highly contentious study.343 This is not to say that
the lack of current scientific evidence-even decades after introduction
of GM crops-is prima facie evidence of a complete absence of risk.
Conversely, at least some evidence suggests that adoption of GM crops
reduces food insecurity, improves calorie consumption and dietary
quality, and can be a key factor in a broader global food security
strategy.344
Reports of the first GM plants-petunia, tobacco, sunflower,
and carrot-appeared in the literature thirty-three years ago.34 5
Within a decade, Calgene, a California-based firm, introduced FLAVR
SAVR tomato, the first GM crop product to be approved by the US
CHEMICAL TOXICOLOGY 4221 (2012) (retracting a study that concluded consumption of herbicide-
tolerant, GM maize is harmful to rodents). But cf. Gilles-Eric Sbralini et al., supra note 341
(republishing the retracted study, along with all its conclusions, in another journal and refuting
an earlier ninety-day feeding study on rodents by Monsanto scientists that showed organ toxicity
in the animals was not "biologically meaningful").
The Sdralini article published in Food and Chemical Toxicology evaluated lifelong toxic and
pathogenic effects of consumption of an herbicide-resistant, GM maize on rodents and concluded
that significant biochemical disturbances and physiological failures, including tumors, were the
direct result of consumption of popular maize strains sold by Monsanto with or without the use
of herbicide. Id. However, following publication, a flurry of letters to the Journal's editor-in-chief
calling for the article's retraction expressed concerns about the validity of the findings due to
potential improper use of animals and allegations of fraud. See Retraction Notice to "Long Term
Toxicity of a Roundup Herbicide and a Roundup-Tolerant Genetically Modified Maize" [Food
Chem. Toxicol. 50 (2012) 4221-4231], 63 FOOD & CHEMICAL TOXICOLOGY 244 (2014).
Ultimately, after an investigation conducted by the journal, the article was retracted due to
the "inconclusiveness" of its results, although no evidence was found to support allegations of
fraud or intentional misrepresentation of data. Id. In particular, the Journal cited the low
number of animals used in the experiments and a known high incidence of tumors in the rat
strain-Sprague-Dawley-chosen for the study. Id. Sbralini and colleagues responded to the
accusations and the subsequent retraction by, inter alia, pointing to unscientific double
standards in the Journal's peer-review process; the fact that the decision to retract the article
came after the appointment of a former Monsanto employee as the Journal's "editor for
biotechnology," a position the authors claim was created specifically for him; a misconception,
over-generalization, and failure to understand that the study was about chronic toxicity rather
than carcinogenicity; and the result of economic interests. Gilles-Eric Sdralini et al.,
Conclusiveness of Toxicity Data and Double Standards, 93 FOOD & CHEMICAL TOXICOLOGY 357
(2014). As a result of the article's retraction, Sbralini and colleagues resubmitted the manuscript
to Environmental Sciences Europe and republished-without peer review-its contents with
minor modifications, but standing by its results and conclusions. See Sdralini et al., supra note
341. Reaction to the republished study, which is substantially the same as the prior article,
proved to be just as controversial as the original and faced harsh scrutiny from scientists.
Scientists React to Republished Sralini GMO Maize Rat Study, GENETIC LITERACY PROJECT
(June 24, 2014), https://www.geneticliteracyproject.org/2014/06/24/scientists-react-to-
republished-seralini-maize-rat-study/ [https://perma.cc/TD6L-PAAT].
343. See Sbralini et al., supra note 342 and accompanying text.
344. Matin Qaim & Shahzad Kouser, Genetically Modified Crops and Food Security, 8 PLOS
ONE e64879 (2013).
345. Robert T. Fraley et al., Expression ofBacterial Genes in Plant Cells, 80 PROC. NAT'L
ACAD. SCI. U.S. 4803 (1983).
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Food and Drug Administration (FDA) for human consumption and
commercialization.34 6 Today, 190 GM crops ranging from fruits to
grains and vegetables have been approved for human consumption in
the United States and many more countries worldwide.347 In 2014, a
total of 18 million farmers planted GM crops across 448 million acres
of farmland in twenty-eight countries.348 GM crop arable land has
swollen 10,000% since commercialization of GM crops commenced two
decades ago.3 49
Scientists state that the exponential increase in farmlands
devoted to GM crop agriculture is contributing to the global food
crisis.35 0 GM crop supporters point to these statistics to argue that
GM crops and further development of biotechnologies are necessary to
address population growth, climate change, and global demands for
food and feed.351 In contrast, opponents argue that the impact of GM
crops on human health and the environment is not well established
and warrants more research.352 They perceive approval by regulatory
agencies as a precocious exercise that sets dangerous precedents to the
detriment of humankind.353
Regulatory controversies notwithstanding, scientists have
reported proof-of-concept experiments involving genome editing in
many plants, including crops, since CRISPR systems became widely
available to the scientific community a mere three years ago. Among
the CRISPR-Cas9 modified plants are wheat,35 4 rice,355 thale cress,356
346. G. Bruening and J.M. Lyons, The Case of the FLAVR SAVR Tomato, 54 CAL. AGRIC.
6 (2000).
347. GM Crop Events Approved in United States of America, ISAAA,
http://www.isaaa.org/gmapprovaldatabase/approvedeventsin/default.asp?CountrylD=US&Count
ry=United%20States%20of/o20America [https://perma.cc/RD7C-6WG3] (last visited Feb. 13,
2017).
348. ISAAA, 50 BIOTECH BITES 60 (International Service for the Acquisition of Agri-
Biotech Applications ed., 2015), https://www.isaaa.org/resources/publications/50biotechbites
/download/50BiotechBites.pdf [https://perma.cc/4AF7-64FL].
349. Id.
350. Tilman et al., supra note 338.
351. See, e.g., discussion supra notes 336-44and accompanying text.
352. See, e.g., discussion supra notes 341-43 and accompanying text.
353. Id.
354. Qiwei Shan et al., Targeted Genome Modification of Crop Plants Using a CRISPR-
Cas System, 31 NATuRE BIOTECHNOLOGY 686 (2013).
355. Id.; Zhengyan Feng et al., Efficient Genome Editing in Plants Using a CRISPR/Cas
System, 23 CELL RES. 1229 (2013); Jin Miao et al., Targeted Mutagenesis in Rice Using CRISPR-
Cas System, 23 CELL RES. 1233 (2013); Rong-Fang Xu et al., Generation of Inheritable and
"Transgene Clean" Targeted Genome-Modified Rice in Later Generations Using the
CRISPR/Cas9 System, 5 Scl. REP. 11491 (2015).
356. Friedrich Fauser et al., Both CRISPRICas-Based Nucleases and Nickases Can Be
Used Efficiently for Genome Engineering in Arabidopsis thaliana, 79 PLANT J. 348 (2014); Feng
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tobacco,357 sweet orange,358 sorghum,3 59 maize,360 barley,361 wild
cabbage,362 tomato,363 soybean,364 liverwort,365 potato,366 and others.
Two particular studies illustrate well the prototypical uses of
genome editing in crop cultivars. The first involves CRISPR-mediated
endogenous disruption of the tomato RIN gene, which encodes a
transcription factor that regulates fruit ripening.367 RIN-defective
mutations result in peculiar phenotypes in tomatoes including
not turning to red color, maintaining flesh firmness for several
months, and inhibiting other changes associated with fruit ripening.368
RIN-defective tomato cultivars are routinely bred with other tomato
plant varieties to create tomatoes with an extended shelf life.369 These
mutations occur naturally and, thus, mutant tomatoes are not
considered to be transgenic or GMOs.
In the study, the authors used CRISPR-Cas9 to introduce
single or few nucleotide changes in select regions of the RIN locus,
which led to a truncated, nonfunctional RIN protein that mirrored the
et al., supra note 355, at 2; Jian-Feng Li et al., Multiplex and Homologous Recombination-
Mediated Genome Editing in Arabidopsis and Nicotiana benthamiana Using Guide RNA and
Cas9, 31 NATURE BIOTECHNOLOGY 688 (2013).
357. Li et al., supra note 356, at 688-89; Vladimir Nekrasov et al., Targeted Mutagenesis
in the Model Plant Nicotiana benthamiana Using Cas9 RNA-Guided Endonuclease, 31 NATURE
BIOTECHNOLOGY 691 (2013).
358. Hongge Jia & Nian Wang, Targeted Genome Editing of Sweet Orange Using
Cas9/sgRNA, 9 PLOS ONE e93806 (2014).
359. Wenzhi Jiang et al., Demonstration of CRISPR/Cas9/sgRNA-Mediated Targeted
Gene Modification in Arabidopsis, Tobacco, Sorghum and Rice, 41 NUCLEIC ACIDS RES. e188
(2013).
360. Sergei Svitashev et al., Targeted Mutagenesis, Precise Gene Editing, and Site-
Specific Gene Insertion in Maize Using Cas9 and Guide RNA, 169 PLANT PHYSIOLOGY 931 (2015);
Hui-Li Xing et al., A CRISPR/Cas9 Toolkit for Multiplex Genome Editing in Plants, 14 BMC
PLANT BIOLOGY 327 (2014).
361. Tom Lawrenson et al., Induction of Targeted, Heritable Mutations in Barley and
Brassica oleracea Using RNA-Guided Cas9 Nuclease, 16 GENOME BIOLOGY 258 (2015).
362. Id.
363. Christopher Brooks et al., Efficient Gene Editing in Tomato in the First Generation
Using the CRISPR/Cas9 System, 166 PLANT PHYSIOLOGY 1292 (2014).
364. Xianjun Sun et al., Targeted Mutagenesis in Soybean Using the CRISPR-Cas9
System, 5 SCI. REP. 10342 (2015).
365. Shigeo S. Sugano et al., CRISPR/Cas9-Mediated Targeted Mutagenesis in the
Liverwort Marchantia polymorpha L., 55 PLANT & CELL PHYSIOLOGY 475 (2014).
366. Shaohui Wang et al., Efficient Targeted Mutagenesis in Potato by the CRISPR/Cas9
System, 34 PLANT CELL REP. 1473 (2015).
367. Yasuhiro Ito et al., CRISPR/Cas9-Mediated Mutagenesis of the RIN Locus That
Regulates Tomato Fruit Ripening, 467 BIOCHEMICAL & BIOPHYSICAL RES. COMM. 76 (2015).




RIN-defective tomatoes.37 0 They also showed that the mutations could
be passed on to the next generation of plants.371 Hence, this study
shows the feasibility of extending the shelf-life of a tomato fruit via
genome editing without the use of transgenic constructs or selectable
markers. In other words, the mutant tomato lines created in the
experiments are, for all practical purposes, the equivalent of naturally
occurring cultivars.
The second study concerns wheat resistance to the fungus
Blumeria graminis f. sp. tritici, one of the world's most devastating
plant pathogens and the culprit of powdery mildew disease.
372 The
authors showed that small, single or few nucleotide, CRISPR- and
TALEN-induced mutations targeting all six alleles of the ML0
3 7 3 gene
in the hexaploid wheat genome are sufficient to knock out the function
of the MLO protein.374 The mutations led to strong resistance to the
powdery mildew fungal disease in wheat plants.
375 The mutations
conferring broad-spectrum resistance to the disease were also shown
to be heritable, given that the genetic trait was stable in subsequent
generations.376
This remarkable study-the first of its kind-demonstrates the
potential of genome editing technologies to address global problems in
agriculture via biotechnologies. From a genetics standpoint, the MLO
knock-out plants are indistinguishable from mutant plants derived via
conventional mutation breeding. Moreover, the fact that plants could
now acquire disease resistance without the need to introduce DNA
from other species or selectable markers highlight the supersedure of
traditional transgenesis methods with precision genomic targeting.
Fruit ripening and disease resistance are merely the tip of the
iceberg. Academic-industry partnerships will ensure a steady supply
of scientific breakthroughs with commercial applications.
37 7 As more
research unfolds, it may be possible to cultivate crops without the use
of pesticides and herbicides altogether by making plants emit
370. Id. at 79-80.
371. Id. at 80.
372. Yanpeng Wang et al., Simultaneous Editing of Three Homoeoalleles in Hexaploid
Bread Wheat Confers Heritable Resistance to Powdery Mildew, 32 NATURE BIOTECHNOLOGY 947
(2014).
373. Mildew-resistance locus.
374. Wang et al., supra note 372, at 948.
375. Id. at 950.
376. Id. at 948-49.
377. See, e.g., Press Release, Caribou Biosciences, Caribou Biosciences and DuPont
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endogenous, natural compounds that aren't toxic to humans, to protect
themselves against pathogenic organisms.38
Grain seeds needed to feed the world could be engineered to
increase storage tolerance and avoid deterioration and premature
spoiling,379 which may help to ameliorate the ever-increasing need for
arable lands. Production of allergen-free peanuts and other foodstuffs
may now be possible by targeting and disrupting genes that encode
allergens and other toxic cyanogens, which threaten the lives of
millions of people with food sensitivities worldwide.380 Salt-resistant
crop plants could be introduced to permit seawater irrigation.381
Drought-resistant crops could help to allay turmoil in water-poor
regions of the world.382
Emergency biotechnological intervention could also be
established to pioneer crop diversification efforts where needed, and
could even save staple crops from extinction when deadly diseases
threaten their existence. For instance, such intervention could be
used to mitigate the threat to the Cavendish banana, which is
currently in danger of extinction in some parts of the world due to the
Tropical Race 4 fungus.383
Even biofuel production is on the horizon. Oilseeds from the
plant Camelina sativa, and others, have in recent years been
identified as promising sources of renewable biofuels, capable of
reducing C02 emissions by 78.5% compared to petroleum diesel.384 In
378. Cf. Abdul Rashid War et al., Mechanisms of Plant Defense Against Insect Herbivores,
7 PLANT SIGNALING & BEHAV. 1306 (2012).
379. See, e.g., Lei Ma et al., TALEN-Based Mutagenesis of Lipoxygenase LOX3 Enhances
the Storage Tolerance of Rice (Oryza sativa) Seeds, 10 PLoS ONE e0143877 (2015).
380. Cf. Maria Gallo & Richard Sayre, Removing Allergens and Reducing Toxins from
Food Crops, 20 CURRENT OPINION BIOTECHNOLOGY 191 (2009) (suggesting use of earlier
biotechnologies to remove or reduce allergens and toxic cyanogens from food crops); Lena Y.C.
Soo et al., Using Genome-Enabled Technologies to Address Allergens in Seeds of Crop Plants:
Legumes as a Case Study, in SEED DEVELOPMENT: OMICS TECHNOLOGIEs TOWARD
IMPROVEMENT OF SEED QUALITY AND CROP YIELD 503 (2012).
381. See, e.g., Edward P. Glenn et al., Salicornia igelovii Torr.: An Oilseed Halophyte for
Seawater Irrigation, 251 SCIENCE 1065 (1991); Stuart J. Roy et al., Salt Resistant Crop Plants,
26 CURRENT OPINION BIOTECHNOLOGY 115 (2014).
382. See, e.g., Honghong Hu & Lizhong Xiong, Genetic Engineering and Breeding of
Drought-Resistant Crops, 65 ANN. REV. PLANT BIOLOGY 715 (2014).
383. See DAN KOEPPEL, BANANA: THE FATE OF THE FRUIT THAT CHANGED THE WORLD xiv
(2008) (chronicling the alarming destruction of banana plantations around the globe and current
efforts to save the world's most beloved fruit); see also Dan Charles, Our Favorite Banana May
Be Doomed; Can New Varieties Replace It?, NPR (Jan. 11, 2016),
http://www.npr.org/sections/thesalt/2016/01/11/4 6 2 37 5558/our-favorite-banana-may-be-doomed-
can-new-varieties-replace-it [https://perma.cc/H2KE-CRTK].
384. See, e.g., John Sheehan et al., Overview of Biodiesel and Petroleum Diesel Life Cycles
18 (1998), http://www.nrel.gov/docs/1egosti/fy98/24772.pdf [https://perma.cc/8MEG-L2KU]; A.
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fact, the US Navy, US Air Force, and many private entities have
successfully tested Camelina-based fuel and announced plans to
increase the use of biofuels to meet their energy requirements.
3 8 5
Renewable biofuels could not only benefit the domestic economy,' but
also help reduce US dependence of foreign petroleum, greenhouse gas
emissions, and air pollution.386 Genome editing technologies may
finally help to lower current barriers for production of renewable
biofuels including yield requirements and commercial viability.
Unlike transgenic crops created from earlier techniques, all
these new crop varieties derived via modern genome editing
biotechnologies do not require the introduction of any foreign DNA,
are genetically indistinguishable from crops developed by mutation
breeding protocols over the past three millennia, and bear no genetic
manipulation footprints in their progeny. Thus, genome editing
represents a powerful tool to protect and enhance important and
desirable agronomic traits with vast repercussions for crop
agriculture.
2. Animals
To satisfy the predicted food demand by 2050, global food
production must increase by at least 70 percent from current levels,
which translates into an additional-and quite staggering-400 billion
pounds of meat worldwide.387 In the United States alone, red meat
388
production totaled 47.4 billion pounds in 2014.389 More than 140
million livestock were slaughtered, including cattle, hogs, sheep, and
lambs.390 A total of 8.54 billion broiler chickens and nearly 100 billion
Fr6hlich & B. Rice, Evaluation of Camelina sativa Oil as a Feedstock for Biodiesel Production, 21
INDUS. CROPS & PRODUCTS 25 (2005).
385. Bryan R. Moser, Camelina (Camelina sativa L.) Oil as a Biofuels Feedstock: Golden
Opportunity or False Hope?, 22 LIPID TECH. 270, 273 (2010); Mark Matsunaga, Navy Looks to
Biofuels to Sail the Great Green Fleet in 2016, U.S. DEP'T NAVY (July 3, 2014),
http://www.navy.miLLsubmit/display.asp?story-id=820
4 4 [https://perma.cc[LM3R-YAZA]; Terry
Maxon, Southwest Airlines to Use Biofuels Made from 'Forest Residues' Beginning in 2016,
DALLAS MORNING NEWS (Sept. 24, 2014), http://aviationblog.dallasnews.com/2014/09/southwest-
airlines-to-use-biofuels-made-from-forest-residues-beginning-in-2016.html/
[https://perma.cclK3SS-A5ZR].
386. Sheehan et al., supra note 384, at iii-iv.
387. How to Feed the World in 2050, FOOD & AGRIC. ORG. U.N. 8,
http://www.fao.org/fileadmin/templates/wsfs/docs/expert-Paper/How-toFeedtheWorld in205
0.pdf [https://perma.cc/2P82-6FNK] (last visited Feb. 25, 2017).
388. According to the USDA, red meat includes beef, veal, pork, lamb, and mutton. USDA
REP. 0499-0544, National Agricultural Statistics Service, Livestock Slaughter 2014 Summary 6
(2015).
389. Id.
390. Id. at 8.
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eggs were produced in the United States in 2014.391 Global
agricultural activity, and livestock production in particular, is
exerting a colossal impact on the environment and accounts for 22
percent of total greenhouse gas emissions-a greater percentage than
the total contribution from the transportation sector (e.g., cars, trucks,
airplanes).392
Aside from translational and basic research purposes,393 farm
animals constitute an important source of commodities such as food
nutrients,394 natural fiber,395 and labor.39 6 A strategy to mitigate the
current unsustainable rate of meat consumption involves genome
editing in farm animals. One illustration concerns the objective of
increasing the muscle mass of livestock for lean meat production by
interfering with the MSTN gene responsible for muscle growth
inhibition.397
Cases of naturally occurring mutations in the MSTN locus
have been widely reported in animals that exhibit doubling of skeletal
muscle mass.3 9 8 Proof-of-concept MSTN-edited studies aiming to
increase mass yield in farm animals have been successfully
established, inter alia, in pigs, 399 cattle,400 goats,40 1 and sheep.402 More
importantly, these methods of editing MSTN in livestock occur at
native sites of the genome and abrogate the need to insert any foreign
nucleotides that are not already found naturally inside the animals'
391. USDA REP. NO. 1949-1573, National Agricultural Statistics Service,
Poultry-Production and Value 2014 Summary 5 (2015).
392. Anthony J. McMichael et al., Food, Livestock Production, Energy, Climate Change,
and Health, 370 LANCET 1253 (2007).
393. See discussion supra Section IV.C.
394. T.F. Randolph et al., Role of Livestock in Human Nutrition and Health for Poverty
Reduction in Developing Countries, 85 J. ANIMAL SCI. 2788 (2007).
395. Linda L. Lowry, Niche Markets for Natural Fibers: Strategies for Connecting
Farmers Who Raise Fiber Animals with Textile Artists-A New England Perspective, 52 J.
EXTENSION 6FEA6 (2014).
396. See, e.g., LEWIS FALLEY ALLEN, AMERICAN CATTLE: THEIR HISTORY, BREEDING AND
MANAGEMENT 56-58 (1868).
397. See, e.g., Junjie Luo et al., Efficient Generation of Myostatin (MSTN) Biallelic
Mutations in Cattle Using Zinc Finger Nucleases, 9 PLOS ONE e95225 (2014).
398. Ravi Kambadur et al., Mutations in Myostatin (GDF8) in Double-Muscled Belgian
Blue and Piedmontese Cattle, 7 GENOME RES. 910, 910 (1997); Alexandra C. McPherron & Se-Jin
Lee, Double Muscling in Cattle Due to Mutations in the Myostatin Gene, 94 PROC. NAT'L ACAD.
SCI. U.S. 12457 (1997).
399. Wang et al., supra note 301, at 1.
400. Luo et al., supra note 397, at 1.
401. Wei Ni et al., Efficient Gene Knockout in Goats Using CRISPR/Cas9 System, 9 PLOS
ONE e106718 (2014).
402. M. Crispo et al., Efficient Generation of Myostatin Knock-Out Sheep Using
CRISPR/Cas9 Technology and Microinjection into Zygotes, 10 PLOS ONE e0136690 (2015).
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genomes. This type of genome editing without the use of transgenes
stands in contrast to the recent approval of transgenic salmon-
genetically modified to grow at accelerated rates-by the FDA,
403
which, despite being labeled as safe for human consumption, has
engendered controversy from anti-GMO groups.
404
Another priority in animal agriculture is the development of
methods to improve disease resistance to pathogens that threaten
animal and human health. Substantial progress toward this goal has
been documented by two recent studies. One demonstrated that
minimal changes to the CD163405 gene confer immunity in pigs
against Porcine Reproductive and Respiratory Syndrome Virus, the
most economically significant swine disease in North America,
Europe, and Asia.406 The other targeted the RELA gene, which has
been associated with the African Swine Fever Virus that triggers a
deadly immune reaction in pigs. 4 0 7 Although the latter team has not
yet exposed edited pigs to the virus, the study showed modern genome
editing biotechnologies can adequately deliver live pigs without the
use of older, often cumbersome, cloning technologies like Somatic Cell
Nuclear Transfer.40
8
These scientific advances open the door for new strategies to
combat other pathogenic organisms that affect important animals in
agriculture. For example, the SAL1 gene in chickens has been linked
to resistance against certain Salmonella strains responsible for food-
borne gastroenteritis in humans.409 Genome editing now provides an
opportunity to exploit this naturally occurring resistance to immunize
chickens and avert serious economic losses stemming from human
transmission events.4 10
403. Bernadette M. Dunham, AquAdvantage Salmon Approval Letter and Appendix,
FDA (Nov. 19, 2015), http://www.fda.gov/AnimalVeterinary/DevelopmentApprovalProcess
/GeneticEngineering/GeneticallyEngineeredAnimals/ucm
466 2 14.htm [https://perma.cclQ5ZS
-QTGV].
404. See Andrew Pollack, Genetically Engineered Salmon Approved for Consumption,
N.Y. TIMES, Nov. 20, 2015, at Al.
405. Cluster of differentiation 163.
406. Kristin M. Whitworth et al., Gene Edited Pigs Are Protected from Porcine
Reproductive and Respiratory Syndrome Virus, 34 NATURE BIOTECHNOLOGY 20 (2016).
407. Simon G. Lillico et al., Live Pigs Produced from Genome Edited Zygotes, 3 Scl. REP.
2847 (2013).
408. Id.
409. Paul Wigley et al., In Vivo and in Vitro Studies of Genetic Resistance to Systemic
Salmonellosis in the Chicken Encoded by the SAL1 Locus, 4 MICROBES & INFECTION 1111 (2002).
410. C.f, e.g., Elizabeth Weise, Salmonella Outbreaks Lead to Food-Safety Changes, USA
TODAY (Apr. 2, 2009), http://usatoday30.usatoday.com/news/healthl2009-04-01-nuts-salmonella-
food-safetyN.htm [https://perma.cclWQ75-N32G] (reporting on food-related salmonella
outbreaks that caused millions of dollars in economic losses).
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Lastly, other potential uses of genome editing for animal
agriculture range from the production of textiles-e.g., by triggering
modifications in the Shannbei cashmere goat FGF5411 gene that
controls hair length412-to the development of safer dairy products-
e.g., by generating animals that secrete milk with natural
antibacterial propertieS413-and animal welfare-e.g., by creating
hornless cattle breeds with naturally occurring mutations in the
POLLED gene to avoid painful, costly, and inhumane dehorning of
animals.414 Like every other field mentioned above, genome editing
technologies are poised to revolutionize the optimization of livestock
production to meet future demands for food and animal products that
could affect human health, the environment, intellectual property,4 1 5
the economy, and animal welfare.
E. Human Germline Editing
In 2015, a group of researchers launched humanity into
uncharted territory. For the first time in the history of planet Earth
and civilization, the human germline-gamete cells (sperm or eggs),
zygotes, and embryos-underwent endogenous genetic manipulation
by the macromolecular CRISPR-Cas9 system.4 1 6  Genome editing in
human germ cells was largely predictable in light of the successes of
germline editing in a plethora of animal and plant species over the
last four years.4 1 7  Yet, predictability did not allay the global
shockwaves created by the research.
In principle, manipulation of the human germline is not much
different than germline manipulation in other species. Although
411. Fibroblast growth factor 5.
412. Xiaolong Wang et al., Generation of Gene-Modified Goats Targeting MSTN and
FGF5 via Zygote Injection of CRISPR/Cas9 System, 5 SCI. REP. 13878 (2015).
413. See, e.g., Xu Liu et al., Generation of Mastitis Resistance in Cows by Targeting
Human Lysozyme Gene to ,8-Casein Locus Using Zinc-Finger Nucleases, 81 PROC. ROYAL SOC. B
20133368 (2014); Xu Liu et al., Zinc-Finger Nickase-Mediated Insertion of the Lysostaphin Gene
into the Beta-Casein Locus in Cloned Cows, 4 NATURE COMM. 2565 (2013) (generating gene-
edited cows-though via a transgene-with the ability to secrete milk that kills Staphylococcus
aureus bacteria).
414. Wenfang Tan et al., Efficient Nonmeiotic Allele Introgression in Livestock Using
Custom Endonucleases, 110 PROC. NAT'L ACAD. SCI. U.S. 16526 (2013).
415. A parade of patent applications has followed many of the scientific findings
discussed throughout this paper. See, e.g., Hornless Livestock, U.S. Patent Application No.
14/154,906 (filed Jan. 14, 2014); Control of Sexual Maturation in Animals, U.S. Patent
Application No. 13/067,502 (filed Oct. 30, 2013); Genetically Edited Animal, U.S. Patent
Application No. 14/427,776 (filed Mar. 1, 2013).
416. Puping Liang et al., CRISPR/Cas9-Mediated Gene Editing in Human Tripronuclear
Zygotes, 6 PROTEIN & CELL 363 (2015).
417. See supra discussion Section TV.A-D.
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humans are biologically more complex than other organisms, the
process of CRISPR-mediated genome editing is virtually the same:
concoct a lab recipe that combines specific types of all three major
bioorganic polymers-a target DNA, a sgRNA designed to hybridize
with the DNA, and the Cas9 protein to trigger cuts in the DNA; allow
the mix to form a complex inside the germ cells; and let science run its
course. A group of Chinese researchers followed that precise formula
and used the CRISPR system to interrogate the feasibility and
efficiency of genome editing coupled to DNA repair mechanisms in the
human germline."18
To establish proof-of-concept for human germline
manipulation, the group chose to target the human P-globin (HBB)
gene, the mutated form of which is linked to P-thalassemia,
a debilitating and sometimes fatal blood disorder.
419  A total of
eighty-six non-viable human zygotes-the first cell formed upon a
fertilization event-were injected with the CRISPR-Cas9 complex.
420
Seventy-one of those zygotes survived the microinjection process and
fifty-four were tested to confirm correct editing.42
1
Results revealed that only twenty-eight zygotes had their
genome cleaved by the Cas9 enzyme, and a meager four zygotes (14%)
had been successfully edited at the HBB locus using the template
supplied by the scientists.422 From the outset, the team preemptively
clarified that the zygotes used were triponuclear, that is, zygotes that
carry an extra set of chromosomes due to fertilization of a single egg
by two sperm.423 This property renders subsequent embryos non-
viable, as the zygotes progress through the first stages of cell divisions
in vitro, but become arrested in development and cannot result in a
live birth.424
Three significant findings were identified in the experiment: (1)
the editing and repair efficiency was dismally low (only 14% of
embryos were successfully edited); (2) off-target mutations formed by
cut-and-repair events in unintended DNA sites were detected, which
resembled off-target events that typically occur in human cancer cells;
and (3) the edited embryos were mosaic-i.e., some of the embryo cells
418. Liang et al., supra note 416, at 363.
419. Id. at 364.
420. Id. at 366-67.
421. Id.
422. Id.
423. The process of In Vitro Fertilization (IVF) typically leads to formation of
approximately 5% triponuclear zygotes from the total zygote pool. Id. at 364. Because they
cannot become viable embryos, the zygotes are usually discarded in IVF clinics, although they
could be used to study human development where it is lawful. Id.
424. Id.
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had the desired mutations while others did not.4 2 5 The landmark
study showed that CRISPR-Cas9 can mediate DSB and DNA repair
via HR in human embryos, but is replete with failures in terms of
efficiency, specificity, and fidelity of the CRISPR-Cas9 system.4 26
More importantly, the data presented automatically preclude clinical
use of CRISPR-Cas9 in the reported form 4 2 7 and demonstrate that
human germline editing is not yet ready for primetime.
To be clear, the paper represents a somewhat outdated
snapshot of the state of the art at the time of its publication. Other
published research around the time had already shown some
improvements on efficiency and specificity, and the Chinese team's
results were consistent with already months-to-years-old CRISPR
technology.428  Scientists at the forefront of genome editing
technology were unimpressed with the results of the Protein & Cell
paper-primarily because the research did not use the latest version
of CRISPR-Cas9 technology-and called the attempt to edit human
germ cells premature.429 Furthermore, it appears that some of the
lackluster results could be attributable to inexperience with using
CRISPR protocols.430  Palpably, the first try at human germline
editing has gotten off to a rocky start. But tweaks and improvements
in the field are occurring at an astounding speed.431
. From a scientific standpoint, the report did not contribute any
novel understanding of the CRISPR system. Indeed, the authors
pointed out that similar efficiencies had been reported in other
organisms, including mice.4 32 In effect, the paper was merely a clone
425. Id. at 368.
426. See id. at 364.
427. Id. at 368.
428. Compare, e.g., Benjamin P. Kleinstiver et al., Engineered CRISPR-Cas9 Nucleases
with Altered PAM Specificities, 523 NATURE 481 (2015) (improving DNA target specificity by a
variant Cas9 that reduces off-target effects), with Yanfang Fu et al., High-Frequency Off-Target
Mutagenesis Induced by CRISPR-Cas Nucleases in Human Cells, 31 NATURE BIOTECHNOLOGY
822 (2013) (reporting high frequency of off-target mutations using an older version of the
CRISPR system).
429. Jocelyn Kaiser & Dennis Normile, Embryo Engineering Study Splits Scientific
Community, 348 SCIENCE 486, 487 (2015).
430. Id. Not a single study coming out of Junjiu Huang's laboratory in Sun Yat-sen
University, Guangzhou, China describes the use of CRISPR-Cas9 predating the triponuclear
zygote study published in Protein & Cell, suggesting the investigation marked the first time the
laboratory had worked with CRISPR-Cas9. See Junjiu Huang, PUBMED.GOV,
http://www.ncbi.nlm.nih.gov/pubmed/?term=junjiu+huang[author] [https://perma.cc/5HNF-
3MFE] (last visited Feb. 13, 2017).
431. See, e.g., Jean-Baptiste Renaud et al., Improved Genome Editing Efficiency and
Flexibility Using Modified Oligonucleotides with TALEN and CRISPR-Cas9 Nucleases, 14 CELL
REP. 1 (2016).
432. Liang et al., supra note 416, at 364-66.
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of the same studies performed on other organisms. However, this
time, the experiments were notable because they were conducted in
human germ cells. The paper had first been submitted to Nature and
Science, but was rejected by both journals in part because of ethical
concerns.43  Notwithstanding the article's scientific shortcomings, the
true nuances of this momentous report lie in the ethical implications
of the research and the subsequent consternation it spawned.
Rumors that Chinese scientists had performed experiments to
edit the human germline, purportedly circulated by reviewers or
parties privy to the manuscript's content at one or both of the journals
to which it was initially submitted, reverberated with a loud echo
among scientific circles.434  Alarmed scientists rushed to publish
commentaries in response to the leak in both Nature
435 and Science436
to criticize the experiments and preemptively call for either a ban or
an outright moratorium on facets of human germline editing research.
The situation was reminiscent of some bygone controversies.
Not since the days of In Vitro Fertilization (IVF)4 3
7 and the birth of
Dolly the sheep, the first animal cloned from an adult cell,
438 had
clamor been so thunderous concerning an emerging technology.
439 A
stentorian tone began to permeate news and media outlets within
days of the published commentaries with several groups, including the
Center for Genetics and Society in Berkeley, California,
440 the Society
for Developmental Biology in Bethesda, Maryland,
441 and the
International Society for Stem Cell Research442 echoing calls to halt
433. Kaiser & Normile, supra note 429, at 486. Neither Nature nor Science confirmed the
review or rejection of the manuscript. Id. at 487.
434. See id.
435. Lanphier et al., supra note 28.
436. David Baltimore et al., A Prudent Path Forward for Genomic Engineering and
Germline Gene Modification, 348 SCIENCE 36 (2015).
437. See generally RUTH DEECH & ANNA SMAJDOR, FROM IVF TO IMMORTALITY:
CONTROVERSY IN THE ERA OF REPRODUCTIVE TECHNOLOGY (2007).
438. K.H.S. Campbell et al., Sheep Cloned by Nuclear Transfer from a Cultured Cell Line,
380 NATURE 64 (1996).
439. See, e.g., Sophie Hutchinson, Controversy and the Cloning Race, BBC NEWS (Jan. 17,
2004), http://news.bbc.co.uk/2/hiluk-news/3406027.stm [https://perma.cc/2X93-WHF9]; Michael
Cook, A Decade of Debate over Dolly, MERCATORNET (Feb. 27, 2007),
http://www.mercatornet.com/articles/view/a-decadeofdebateoverdolly/1479
[https://perma.cc/7628-ZDLR].
440. Public Interest Group Calls for Strengthening Global Policies Against Human
Germline Modification, CTR. GENETICS & SOC'Y (Apr. 22, 2015),
http://www.geneticsandsociety.org/article.php?id=85
28 [https://perma.cc/QM3N-DD54].
441. Kaiser & Normile, supra note 429, at 486.
442. Nicholas Wade, Scientists Seek Ban on Method of Editing the Human Genome, N.Y.
TIMES, Mar. 20, 2015, at Al.
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human germline editing research.443 Declarations of an urgent need
to organize meetings about the appropriateness of using CRISPR-like
biotechnologies for human germline research have led to meetings
such as the International Summit on Human Gene Editing, which
took place in December 2015 in Washington, D.C.4 44
Just months earlier in September 2015, British scientists had
promptly applied to the UK Human Fertilization and Embryology
Authority (HFEA) for a license to edit genes in human embryos.445
The license was granted in February 2016. It allows biologists at the
Francis Crick Institute in London to commence research on healthy
human embryos younger than seven days, pending approval by a local
research ethics board.446
The HFEA approval marks the first time a national regulatory
agency condones investigations based on research involving human
germline editing.447 It is also an important step toward elucidating
more knowledge regarding CRISPR systems and their roles in genome
editing within a more rigorous and developed framework than that of
the research performed by the Chinese scientists, which involved non-
viable human embryos and outdated versions of the CRISPR system.
Findings derived from this forthcoming and unprecedented UK
research will not only have an immediate impact on current
reproductive technologies and human development, but may provide
clues that will be useful for future clinical applications of genome
editing.448
Genome editing technologies involving the human germline
have far greater prospects for human health and welfare than somatic
or stem cell gene editing therapies. In addition to tackling acquired
diseases, as well as monogenic and polygenic-dominant or
recessive-congenital disorders in a particular individual,449 correcting
gene errors or conferring prophylactic protection to diseases in the
germline means the changes can be inherited in a firm and self-
perpetuating configuration to subsequent generations. In essence,
human germline editing is truly the holy grail of modern-day
medicine.
443. Id.
444. Nicholas Wade, Scientists Seek Moratorium on Edits to Human Genome That Could
Be Inherited, N.Y. TIMES, Dec. 3, 2015, at Al.




449. See discussion supra Sections IV.A and IV.C.
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The potential benefits are infinite. Further maturation and
tweaking of genome editing biotechnologies in combination with other
foundational biotechnologies like genome sequencing and induced
pluripotent stem cell (iPSC) biology may, sooner rather than later,
enable us to ablate, mitigate, counteract, or safeguard against an
extensive array of complex human ailments discussed earlier,
including neurodegenerative disorders, congenital diseases, cognitive
and behavioral anomalies, HIV and other viruses, obesity,
cardiovascular disease, cancers, and more.
Contemplate, for a moment, the well-publicized dilemma of
actress and director Angelina Jolie. In back-to-back op-eds in The
New York Times, she shared with the world her decision to endure a
preventive double mastectomy to remove her breasts
4 50 and a
laparoscopic bilateral salpingo-oophorectomy to remove her ovaries
and fallopian tubes.451 Her decisions to undergo the procedures came
following genetic testing via a blood test, which revealed she carried
common mutations in the BRCA1 gene that placed her at an 87% risk
of developing breast cancer and a 50% risk of ovarian cancer.
452 Jolie
lost her grandmother, aunt, and mother to cancer,453 making her
family history a cautionary tale that could likely have foreshadowed
her own destiny. In the span of two years, she took a surgical plunge
any woman would dread. Her journey rendered her a menopausal
woman well before her natural time. However, she also stands strong
by her life-altering decision because she feels her children will no
longer have to face losing their mother prematurely, as she did.
4 5 4
Jolie's remarkable story mirrors those of millions of women
worldwide facing the deadly threat of cancer.455 The same can be said
of men choosing to part ways with their prostateS456 or testes,
457 and
millions of men and women all over the world facing tough decisions
450. See Angelina Jolie, My Medical Choice, N.Y. TIMES, May 14, 2013, at A25.
451. See Angelina Jolie Pitt, Diary of a Surgery, N.Y. TIMES, Mar. 24, 2015, at A23.
452. Id.
453. Id.
454. See Jolie, supra note 450, at A25.
455. Id. The World Health Organization estimates that breast cancer alone kills nearly
458,000 people each year, mainly in low- and middle-income countries. Id.
456. Prostate cancer was the third most common type of cancer in the United States in
2016, causing an estimated 26,120 deaths last year. SEER Stat Fact Sheets: Prostate Cancer,
NAT'L CANCER INST., http://seer.cancer.gov/statfactsfhtml/prost.html [https://perma.cclLN6M-
QNLB] (last visited Feb. 14, 2017).
457. An estimated 8,720 new cases of testicular cancer were reported in 2016. SEER Stat
Fact Sheets: Testis Cancer, NAT'L CANCER INST., http://seer.cancer.gov/statfactsfhtml/testis.html
[https://perma.ccNKW2-VZEJ] (last visited Feb. 14, 2017).
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because of various forms of pervasive cancer diseases.4 58 But what if
such drastic choices could be avoided? In Jolie's case, the cancer risk
was accentuated based on a familial history of cancer and mutations
in the BRCA1 gene. Had genome editing been safe and readily
available to her, her decision to extirpate her breasts and ovaries
would not even have been considered.
In the future, humans may be able to identify quantitative-
trait loci linked to a genetic basis or predisposition to disease and
proactively correct deleterious mutations that could pose grave threats
to human life. Genome editing finally brings into the realm of reality
clinical applications that had been unreachable for decades. It is quite
likely that the next generation of children and grandchildren may
grow up in a CRISPR world, where they will no longer have to make
Jolie-type choices due to cancers and numerous other human diseases.
Even more remarkable is the notion that by correcting those mistakes
in the germline DNA, new generations of would-be disease-prone
mutation carriers may never have to witness the death of mothers,
aunts, and grandmothers at the hands of the same killer.
Despite the vast potential for good by the use of genome
editing biotechnologies, to some the notion of human germline
modification-no matter what the purpose-conjures up the insidious
spirit of eugenics and other potential societal harms.459 Frivolous
enhancement of human traits, rising inequality, and a multitude of
"designer babies" are commonly cited as major threats stemming from
the use of genome editing biotechnologies.460 Others have chosen to
either favorably cherry-pick or denounce certain applications of
genome editing, as they worry that widespread opposition to the
technology may curtail uses from which they stand to profit.461 This
458. Cancers are among the leading causes of morbidity and mortality worldwide. Cancer:
Fact Sheet No. 297, WORLD HEALTH ORG. (Feb. 2015), http://www.who.int
/mediacentre/factsheets/fs297/en/ [https://perma.cc/A6J3-KLQD]. In 2012, approximately 14
million new cases of cancer and 8.2 million cancer-related deaths were reported worldwide. Id.
New cancer cases are expected to increase by 70% in the next twenty years. Id.
459. See, e.g., Cook, supra note 439 (commenting on the media's perception that cloning
research might give rise to "armies of Adolf Hitlers"); Robert Pollack, Eugenics Lurk in the
Shadow of CRISPR, 348 SCIENCE 871 (2015) (analogizing the introduction of germline
modification with a return to an agenda of eugenics that aims to select "good" traits and weed
out "bad" ones).
460. See, e.g., Antonio Regalado, Engineering the Perfect Baby, MIT TECH. REV. (Mar. 5,
2015), https://www.technologyreview.com/s/535661/engineering-the-perfect-baby/ [https://perma
.cc/G46W-BQ3N].
461. See, e.g., Lanphier et al, supra note 28, at 410 (providing a pulpit to Sangamo
BioSciences executives from which to argue that germline, but not somatic, genome editing
should be banned). Sangamo BioSciences holds key patents in ZFN technology directed at
somatic cell editing. Newer CRISPR-based technologies could negatively impact Sangamo's
business strategies. Id.
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Article sets the stage to explore some of these themes arising from
human germline editing in forthcoming genome editing-related
scholarship.
The applications of genome editing biotechnologies described
above constitute the first comprehensive-yet non-exhaustive-
representation of the potential uses of this budding biotechnology to
appear in legal literature. It is important to note that other uses of
genome editing and CRISPR-based biotechnologies currently exist,
including development of new antibiotics and antimicrobials,
4 6 2 drug
target discovery,463 systematic identification of gene and drug
combinations,464 targeted epigenome editing,465 live imaging to study
conformational and cellular dynamics,466 cell lineage tracing,4
67 whole
genome screening and labeling,468 and others.
469 However, it would be
462. See, e.g., David Bikard et al., Exploiting CRISPR-Cas Nucleases to Produce
Sequence-Specific Antimicrobials, 32 NATURE BIOTECHNOLOGY 1146 (2014); Robert J. Citorik et
al., Sequence-Specific Antimicrobials Using Efficiently Delivered RNA-Guided Nucleases, 32
NATURE BIOTECHNOLOGY 1141 (2014); Ido Yosef et al., Temperate and Lytic Bacteriophages
Programmed to Sensitize and Kill Antibiotic-Resistant Bacteria, 112 PROC. NAT'LACAD. Sol. U.S.
7267 (2015). Some concerns of biosecurity and bioterrorism have been associated with
applications of CRISPR-based biotechnologies such as gene drives. See, e.g., Kozminski, supra
note 249, at 3896-97; Rhodi Lee, Government Experts Concerned About Possible Bioterrorism
Using GM Organisms, TECH TIMES (Aug. 5, 2015), http://www.techtimes.com
/articles/74 121/20 150805/government-experts-concerned-about-possible-bioterrorism-using-gm-
organisms.htm [bttps://perma.ccPY3Y-WN3B]; Webber et al., supra note 249, at 10565-67.
Similar concerns may be raised in the future regarding the ability to manipulate deadly bacteria
and viruses. See Catherine Jefferson et al., Synthetic Biology and Biosecurity: How Scared
Should We Be?, KING'S COLLEGE LONDON 1, 9 (2014), http://www.kcl.ac.uk
/newsevents/news/newsrecords/docs/Jefferson-et-al-20 14-Synthetic-Biology-and-Biosecurity.pdf
[https://perma.cc/5WHA-YTXX] (recounting how anthrax was used as a bioweapon during the
attacks of September 11, 2001).
463. See, e.g., Junwei Shi et al., Discovery of Cancer Drug Targets by CRISPR-Cas9
Screening of Protein Domains, 33 NATURE BIOTECHNOLOGY 661 (2015).
464. See, e.g., Alan S.L. Wong et al., Multiplexed Barcoded CRISPR-Cas9 Screening
Enabled by CombiGEM, 113 PROC. NAT'LACAD. SCl. U.S. 2544 (2016).
465. Paul Enriquez, CRISPR-Mediated Epigenome Editing, 89 YALE J. BIOLOGY & MED.
471 (2016).
466. See, e.g., Baohui Chen et al., Dynamic Imaging of Genomic Loci in Living Human
Cells by an Optimized CRISPRICas System, 155 CELL 1479 (2013).
467. Aaron McKenna et al., Whole Organism Lineage Tracing by Combinatorial and
Cumulative Genome Editing, 353 SCIENCE aaf7907 (2016).
468. Andrew B. Lane et al., Enzymatically Generated CRISPR Libraries for Genome
Labeling and Screening, 34 DEVELOPMENTAL CELL 373 (2015).
469. See, e.g., Lukas E. Dow et al., Inducible in Vivo Genome Editing with CRISPR-Cas9,
33 NATURE BIOTECHNOLOGY 390 (2015) (describing a tool for inducible genome editing); Luke A.
Gilbert et al., CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in
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impractical to list them all within the context of a law journal article,
particularly given the astounding rate at which new applications
continue to emerge.
Next, this Article weaves the genome editing scientific
empiricism articulated above with jurisprudence to advocate for a
normative approach that will lay a foundation for future examinations
of the synergistic roles that law, science, and public policy will play in
the development of this truly exceptional and transformative incipient
biotechnology.
V. SCIENTIFIC EMPIRICISM AS A BEDROCK FOR GENOME EDITING
JURISPRUDENCE
The pervasive reach of genome editing harbingers that the
technology will continue to be a source of controversy in legal and
policy arenas. Already, signs of impending controversy are coming
into focus. 4 70 However, the current legal landscape lacks a structural
framework to systematically address questions of science in law. This
Article proposes a normative framework to consolidate scientific
empiricism and jurisprudence and argues that Myriad marks a
turning point that facilitates the path to link these disciplines. The
interdisciplinary approach set forth in this Article can be avidly
applied to combat seeds of deceptive simplicity-namely, preposterous,
impractical, or sensationalist claims that so often take root in
dialogues concerning issues raised by technological advances.
This Article identifies the specter of "designer babies" as one of
many quintessential examples of deceptive simplicity that law and
policy makers should beware of as they deliberate on the future of
genome editing. The doctrinal approach advocated here demonstrates
Eukaryotes, 154 CELL 442 (2013) (introducing a platform to regulate transcriptional activation or
repression in cells); Andrew A. Horwitz et al., Efficient Multiplexed Integration of Synergistic
Alleles and Metabolic Pathways in Yeasts via CRISPR-Cas, 1 CELL SYS. 88 (2015) (explaining a
technique to promote identification of biosynthetic pathways); Silvana Konermann et al., Optical
Control of Mammalian Endogenous Transcription and Epigenetic States, 500 NATURE 472 (2013)
(establishing a method for the optogenetic control of epigenetic chromatin modifications); Morgan
L. Maeder et al., Targeted DNA Demethylation and Activation of Endogenous Genes Using
Programmable TALE-TET1 Fusion Proteins, 31 NATURE BIOTECHNOLOGY 1137 (2013) (exploring
targeted demethylation and its functional significance in cells); Lei S. Qi et al., Repurposing
CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression, 152 CELL
1173 (2013) (introducing a platform to regulate transcriptional activation or repression in cells);
Owen W. Ryan et al., Selection of Chromosomal DNA Libraries Using a Multiplex CRISPR
System, 3 ELIFE 03703 (2014) (developing a CRISPR-based approach to facilitate directed
evolution of biomolecules); Yuexin Zhou et al., High-Throughput Screening of a CRISPR/Cas9
Library for Functional Genomics in Human Cells, 509 NATURE 487 (2014) (unveiling a large-
scale genetic library screen for functional genomics).
470. See, e.g., discussion supra notes 435-44 and accompanying text.
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the efficacy of adopting a jurisprudence of scientific empiricism as a
proverbial herbicide against rapidly spreading deceptive simplicity
weeds. In addition, the Article reconsiders the illegitimacy of Buck v.
Bell to argue that, contrary to the current prevailing wisdom, Buck
relied not on false science, but on rampant deceptive simplicity
instead.
A. The Exorcism of Designer Baby's Specter
Nearly a quarter-century ago, advances in assisted
reproductive technology pioneered the emergence of an unusual set of
human pregnancies.47 1  Scientists had figured out an innovative
approach to couple IVF and a novel way of screening fertilized
embryos derived from couples at risk of transmitting genetic diseases
to their offspring.472 The revolutionary method, called pre-
implantation genetic diagnosis (PGD), involved screening for the
presence of the Y chromosome in cells biopsied from fertilized
embryos.473 Embryos carrying the Y chromosome are male4 7
4 and,
thus, susceptible to inheriting recessive X-linked diseases such as
X-linked mental retardation, Lesch-Nyhan syndrome, and DMD.
4 75
PGD proved scientists could successfully screen embryos from these
X-linked disease-carrier parents on the basis of gender and,
consequently, it was presented as an alternative to abortion for
couples whose only path to becoming parents to a healthy child had
been to get pregnant, wait to find out the sex of the fetus-or do
prenatal testing-and then decide to terminate the pregnancy if the
fetus turned out to be genetically "defective" or male.
4 76
It was not long before a debate on the social and ethical
implications of PGD commenced. Some immediate concerns regarding
PGD technologies initially focused on eliminating certain genetic
471. The first human pregnancies derived from this approach were reported in 1990. See
A.H. Handyside et al., Pregnancies from Biopsied Human Preimplantation Embryos Sexed by
Y-Specific DNA Amplification, 344 NATURE 768, 768 (1990).
472. See id.
473. Id. at 769.
474. Id.; Whitney Akchurin & Ryan Kartzke, The Ethics of Gender Selection, in THE
ETHICAL IMPERATIVE IN THE CONTEXT OF EVOLVING TECHNOLOGIEs 33 (Dan McIntosh et al. eds.,
1996), http://www.ethicapublishing.com/3CH2.htm [https://perma.cc/Z4U3-6NNM] (wildtype
human embryos are diploid and inherit one sex-determining chromosome from each parent;
embryos carrying X and Y chromosomes are male, while those carrying two sets of X
chromosomes are female).
475. Handyside et al., supra note 471, at 768.
476. Id.
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diseases, family balancing,477  and the prospect of gender
discrimination arising from embryonic sex selection,478 all of which
were actual considerations raised by the technology at the time.
However, other more dubious concerns-such as commercialization
of children, dehumanization of childbirth, and "playing
god"-piggybacked on the discussion.479
Unfounded claims predicted the inevitable use of PGD to
essentially make people "smarter" or increase brain capacity,
"eventually lead[ing] to the entire human race becoming increasingly
intelligent."4 80 Allegations that PGD was the first step in the creation
of a "designer baby" as a way to "use money and technology to fulfill
superficial desires" began to circulate.481 Alluring declarations that
parents could choose to endow their children with beautiful features
and athletic prowess became normalized.482  Soon thereafter, PGD
became associated with a radical expansion of the old eugenics
movement in which parents would be able to select offspring based on
non-pathological characteristics in a free-market form of eugenics.483
These sensational perceptions of technological uses to create
designer babies who are genetically enhanced to be, inter alia, "more
intelligent, athletic, musically talented, and the like" 4 84 has become an
emblem of misinformation in areas of reproductive technology, and
now genome editing.485  Regardless of why some perpetuate the
477. Family balancing is a term for the use of PGD in families with one or more children
of one gender seeking to "balance" the offspring gender ratio by ensuring the next child is of the
opposite gender. See Akchurin & Kartzke, supra note 474, at 33.
478. See, e.g., Blake Rodgers & Brandon Peterson, The Ethics of Stem Cell Research and
Prenatal Genetic Alteration, in THE ETHICAL IMPERATIVE IN THE CONTEXT OF EVOLVING
TECHNOLOGIES 47 (Dan McIntosh et al. eds., 1996), http://www.ethicapublishing.com/3CH3.htm
[https://perma.cc/D5ZU-XBJF]; Akchurin & Kartzke, supra note 474, at 32-33.
479. See, e.g., Rodgers & Peterson, supra note 478, at 46-48.
480. Id. at 48.
481. See, e.g., Akchurin & Kartzke, supra note 474, at 35.
482. Rodgers & Peterson, supra note 478, at 47.
483. See, e.g., David S. King, Preimplantation Genetic Diagnosis and the 'New' Eugenics,
25 J. MED. ETHICS 176, 176, 179-80 (1999).
484. Marcy Darnovskyfeb, Genetically Modified Babies, N.Y. TIMES, Feb. 25, 2014, at
A25.
485. See, e.g., Michael D. Lemonick, Designer Babies, TIME MAG., Jan. 11, 1999, at 64
(arguing-back in 1999-that "[w]ithin a decade or two, it may be possible to screen kids ... for
an enormous range of attributes, such as" height, body type, hair and eye color, intelligence,
personality type, etc.). Accord James Gallagher, Is It Time to Make Designer Babies?, BBC NEWS
(Sept. 10, 2015), http://www.bbc.com/news/health-34207470 [https://perma.cc/R8GC-Y96V];
Antonio Michele Grygotis, Higher Level of Embryo Testing Raises Questions About Possibility of
Creating "Designer Babies", TRANSPLANT NEWS, June 30, 2001, at 12; Rubanath Karuthedath,
Biotech Nightmare: Science Fiction Dystopian Visions of Human Genetic Engineering and
Cloning with Special Reference to the Boys from Brazil and Beggars in Spain, 2 RES. J. ENG.
LANGUAGE & LITERATURE 1 (2014), http://www.rjelal.com/2.4.14/RUBANATH
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designer baby canard-whether due to misinformation, intent to
deceive, or a desire to sensationalize-the inherent inaccuracies they
are promulgating have taken root in the culture and severely interfere
with the ability to have a reasoned debate on true issues.
Consider a STAT-Harvard poll on public opinion of genetic
editing, testing, and therapy published in early 2016.486 Results
revealed that 83% of Americans believe modifying "unborn babies" to
improve their "intelligence or physical characteristics" should be
illegal.4 8 7  Likewise, 65% believe genetic modifications should be
illegal even to reduce the risk of developing serious diseases.
488
Polling, of course, is not quite a science and certainly is not an
exact one. In fact, it is highly vulnerable to the use of specific
terminology and ambiguity in framing the questions asked. For
instance, there is likelihood of bias in the STAT-Harvard poll's
reference to "changing genes of unborn babies"489 as opposed to the
more technically accurate terms "embryo," "zygote," or "germ cells
(sperm and eggs)," particularly given the respondents' probable lack of
knowledge that genome editing in a fetus or near full-term baby is not
likely to be a viable option. Other polls over the years reflect similar
views regarding genetic enhancement o boost intelligence or athletic
ability of "designer babies,"490 but conflict with the STAT-Harvard poll
%20KARUTHEDATH%201-6.pdf [https://perma.cc/5SSU-YQ2Y]; Gautam Naik, A Genetic Code
for Genius?, WALL ST. J. (Feb. 15, 2013), https://www.wsj.com/articles
/SB10001424127887324162304578303992108696034 [https://perma.cc/FA4L-KRUV]; Regalado,
supra note 460; Antonio Regalado, Scientists Call for a Summit on Gene-Edited Babies, MIT
TECH. REV. (Mar. 19, 2015), https://www.technologyreview.com/s/536021/scientists-call-for-a-
summit-on-gene-edited-babies/ [https://perma.cc/4D53-3AX9]; "Designer Babies" on the Way? In
China, Scientists Attempt to Unravel Human Intelligence, CBS NEWS (Mar. 5, 2014),
http://www.cbsnews.com/news/designer-babies-on-the-way-in-china-scientists-attempt-to-
unravel-human-intelligence/ [https://perma.cclW3GE-3Z6B].
486. The Public and Genetic Editing, Testing, and Therapy, STAT & HARV. T.H.
CHAN SCH. PUB. HEALTH 1 (Jan. 2016), https://cdnl.sph.harvard.edulwp
-content/uploads/sites/94/2016/01/STAT-Harvard-Poll-Jan-2016-Genetic-Technology.pdf
[https://perma.cclGK6F-MVGN].
487. Id. at 13.
488. Id.
489. Id. (emphasis added).
490. See, e.g., United Kingdom: Reproductive and Research Cloning, Genetic Modification
and Selection, Sex Selection, YouGov 6 (Aug. 19, 2005) [hereinafter U.K. Poll],
http://iis.yougov.co.uklextranetslygarchives/content/pdf/TEL050101042-1.pdf
[https://perma.cclZBD6-2ARY] (reporting that only 4% of total respondents approve of using
genetic modification to improve a child's academic or sporting abilities); VCU Life Sciences
Survey: Public Values Science but Concerned About Biotechnology, VCU CTR. PUB. POL'Y 4, 10
(2003), http://lifesciences.vcu.edulmediallife-sciences/docs/survey200
3 .pdf [https://perma.cc
/MB2A-LJJ2] (94% of respondents opined that "changing a baby's characteristics for cosmetic
purposes such as eye or hair color ... is taking medical advances too far").
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in regard to the legality of using genetic modifications to prevent or
reduce the risk of serious diseases in offspring or embryos.491
Yet, nothing in these observations detracts from the surprising
revelation that, according to this poll, a majority of Americans
apparently believe that genome modifications can actually be used
for altering inherently polygenic-determined by more than one
gene-traits such as intelligence, eye color, athletic ability, and
beauty-many of which are intrinsically subjective.
Indeed, even discounting the bias in the premise of the poll
questions, namely, that the potential for improving intelligence,
athletic ability, or appearance is true, the data suggest that the public
is largely unaware of what is technologically feasible or not. More
importantly, the poll results suggest that the general population
cannot recognize, and is highly susceptible to, technological deceptive
simplicity.
Contemplate the claim that genetic modifications can be used
to create a superhuman race of geniuses. This claim was precisely the
subject matter of an article with a cheeky headline492 featured in a
popular magazine4 9 3  pseudo-reporting on BGI, 4 9 4  a Chinese
491. Biotechnology Australia, Increasing Public Support for Stem Cell Research 1-2 (July
7, 2003), http://www.geneticsandsociety.org/downloads/20030707 Biotechnology Australia.pdf
[https://perma.cclHZ65-96UX] (reporting 61% support for genetic testing of unborn children and
79% support for gene therapy to correct any genetic disorders that may be diagnosed); Antonio
Regalado, Patients Favor Changing the Genes of the Next Generation with CRISPR, MIT TECH.
REV. (Dec. 2, 2015), https://www.technologyreview.com/s/544141/patients-favor-changing-the-
genes-of-the-next-generation-with-crispr/ [https://perma.cclU7LB-FQ3Y]; U.K. Poll, supra note
490, at 6 (noting that 57% and 43% of respondents approve using genetic modifications to
"prevent children from suffering serious genetic diseases" or to reduce the risk of developing
diseases such as cancer, Alzheimer's disease, and heart disease, respectively); see also id.
(reporting that 51% of respondents believe that it should be legal for parents and doctors to
"carry out genetic tests on embryos created during IVF treatment in order to select those with
the lowest chances of developing [serious] diseases . . . later in life," while only 30% believe that
such testing should be illegal).
492. The article appears in Vice Magazine. It features a picture of school-age Chinese
children lined up in a formation that stretches as far as the camera lens can capture and gives
the appearance that China is trying to build an army of homogeneous, little human robots. Aleks
Eror, China Is Engineering Genius Babies, VICE MAG. (Mar. 15, 2013),
http://www.vice.com/read/chinas-taking-over-the-world-with-a-massive-genetic-engineering-
program [https://perma.cc/4BSB-5Z7S].
493. Vice is a print magazine and website focused on popular culture, news, and
entertainment. See Vice (Magazine), WIKIPEDIA, https://en.wikipedia.org/wikilVice_(magazine)
[https://perma.cc/HGH5-GF6C] (last visited Feb. 25, 2017). The magazine expanded into Vice
Media LLC, a company that now operates the magazine and a multimedia network including
several digital channels, Vice News, a record label, a film production studio, and book publishing
division. Vice Media, WIKIPEDIA, https://en.wikipedia.org/wiki/ViceMedia
[https://perma.cc/S36E-JF3U] (last visited Feb. 25, 2017). Vice is the media company that funded
Dennis Rodman's-the former NBA player-2013 trip to meet North Korea's dictator. Lindsay
Silberman, Rodman's Revelations, DUJOUR, http://dujour.com/culture/dennis-rodman-north-
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biotechnology firm partly funded by the Chinese government, and its
Cognitive Genomics Research (CGR) project.495 According to BGI, the
goal of the CGR branch is to study human cognition and use next-
generation DNA sequencing technologies to interrogate the
relationships between genes, the environment, and cognitive ability in
the human brain.496
Although BGI's Gene-Trait Association Study of Intelligence
may arguably suffer from cohort methodological flaws related to
recruitment of "cognitively gifted" volunteer subjectS
4 9 7 who meet
peculiar-to say the least-qualifying criteria,
498 BGI's approach to
human cognition research appears to have nothing in common with
the bombastic claims made against it. Furthermore, over the past
fifteen years, some BGI-sponsored research has been featured in many
of the most prominent scientific journals.499  There is simply no
evidence to suggest that the Chinese government is trying, or even
would be able, to create an army of geniuses born out of basic research
into human cognition. But that has not prevented the dissemination
of misinformation, which is eagerly picked up by diverse media and
spreads like wildfire in a dry deciduous forest.
5 00
korea-kim-jong-un-interview/ [https://perma.cc/35XY-Q6EV] (last visited Feb. 25, 2017). In
recent years, Vice Media has been valued at more than $2.5 billion following investments from
Technology Crossover Ventures ($250 million), A&E Networks ($250 million), and Rupert
Murdock's Twenty-First Century Fox ($70 million). Emily Steel, Vice Gets 2nd Investment, to Aid
Expansion, N.Y. TIMES, Sept. 4, 2014, at BI.
494. For more information on BGI, see BGI, http://bgi-international.com/us/about-
us/introduction/ [https://perma.cc/8KE5-U5EA] (last visited Feb. 25, 2017).
495. For more information on BGI's Cognitive Genomics Research group, see BGI,
https://www.cog-genomics.org/ [https://perma.cc/2N2V-DVBL] (last visited Feb. 13, 2017).
496. Christopher C. Change et al., BGI Cognitive Genomics Lab: Proposal for Gene-Trait
Association Study of g, BGI 2, https://www.cog-genomics.org/static/pdflbgi-gproposal.pdf
[https://perma.cc/VZJ2-BU5H] (last visited Feb. 25, 2017).
497. Id.
498. Automatic qualifying criteria include obtaining high scores in select standardized
tests (SAT/ACT/GRE), having "performed well" in academic competitions (e.g., the Math,
Physics, or Informatics Olympiads, the William Lowell Putnam Mathematical Competition, and
TopCoder), and earning a Ph.D. from a "top" US program in physics, math, electrical
engineering, or theoretical computer science. See id. A volunteer may also qualify by making a
case for herself via specification of "exceptional academic credentials or technical
accomplishments." See How to Qualify, BGI, https://www.cog-genomics.org/volunteer
[https://perma.cc/787Y-L8HK] (last visited Feb. 13, 2017).
499. See Our Publications, BGI, http://bgi-international.com/us/about-us/our-publications/
[https://perma.cc/7MTV-8G39] (last visited Feb. 25, 2017) (providing a list of scientific articles
published in various high-quality, peer-reviewed journals).
500. See, e.g., Eror, supra note 492; republished in Chinese Company Attempts to
Engineer Genius Babies, GENETIC LITERACY PROJECT (Mar. 22, 2013),
https://www.geneticliteracyproject.org/
2013/03/22/chinese-company-attempts-to-engneer-genius-
babies/ [https://perma.cc/5ZZW-TSLF]; also republished in How China Is Trying to Engineer
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Even more disheartening is the fact that this kind of deceptive
simplicity surrounding designer babies has permeated scholarly
fields,501 including legal scholarship.502 Much ink has been spilled
entertaining hypotheticals of "made-to-order boutique babies"503 to
genetically modify traits such as eye, hair, and skin color,504 or even
more subjective ones like sexual orientation,505 beauty, charm, and
intelligence.5 06 Such world of "designer genes" would purportedly give
parents a menu of choices "from any genes imaginable, human or
not."507 It is time to adhere to higher standards in this regard.
Genius Babies, REAL CLEAR POLITICs (Mar. 17, 2003),
http://www.realclearpolitics.com/2013/03/17/how-china-istrying to engineer genius babies_30
4097.html [https://perma.cc/GZ9A-MPLW]; referred to in, e.g., George Dvorsky, Is China
Selectively Breeding a New Generation of Genius Babies?, 109 (Mar. 18, 2013),
http://io9.gizmodo.com/is-china-selectively-breeding-a-new-generation-of-geniu-455634018
[https://perma.cc/72WA-A5RK]; Roy Klabin, Chinese Labs Are Engineering Genius Babies,
Should the U.S. Follow Suit?, POLICY.MIC (Mar. 18, 2013), http://mic.com/articles/30111/chinese-
labs-are-engineering-genius-babies-should-the-u-s-follow-suit#.Q5X5YENgb
[https://perma.ccXM3W-3E4R]; China to Begin Producing 'Designer Babies' in Horrific Scheme,
CATHOLIC ONLINE (Jan. 16, 2014), http://www.catholic.org/news/technology/story.php?id=53890
[https://perma.cc/B9A9-K7K5].
501. See, e.g., supra notes 479-83 and accompanying text.
502. See discussion infra notes 503-07.
503. Peter H. Huang, Herd Behavior in Designer Genes, 34 WAKE FOREST L. REV. 639,
659 (1999).
504. See, e.g., id. at 642 (arguing that in the near future, genetic selection of hair color,
skin color, intellectual ability, or behavior pre-dispositions may be feasible); Mahoney, supra note
47, at 313 (proposing that new technology may presumably allow parents to decide eye color and
sexual orientation of designed babies).
505. Mahoney, supra note 47, at 313.
506. See, e.g., Jason T. Corsover, The Logical Next Step? An International Perspective on
the Issues of Human Cloning and Genetic Technology, 4 ILSA J. INT'L & COMP. L. 697, 744 (1998)
("One can imagine menus offering a price list of particularly desirable traits. . . . For the right
price, one may have the option to purchase the DNA of a world class athlete, award winning
actor, or a beautiful supermodel."); Sarah M. Markwood, Comment, Creating a Perfect Human Is
Not So Perfect: The Case for Restricting Genetic Enhancement Research, 110 PENN. ST. L. REV.
473, 473-74 (2005) (proposing a scenario where genetic enhancement will lead to producing
"athletically gifted," "physically attractive" children, or "a theatrical prodigy, a strong wrestling
champion, or a mathematical genius"); Maxwell J. Mehlman, The Law of Above Averages:
Leveling the New Genetic Enhancement Playing Field, 85 IOWA L. REV. 517, 528-29 (2000)
(entertaining the possibility that new technologies may allow genetic manipulation of traits such
as beauty, strength, stamina, charm, cheerfulness, confidence, memory, intelligence, and
creativity); Daniel L. Tobey, What's Really Wrong with Genetic Enhancement: A Second Look at
Our Posthuman Future, 6 YALE J.L. & TECH. 54, 56 n.1 (2003) (asserting that "[g]enetic
enhancement will, in the short run, be more concerned with improving present traits such as
intelligence, personality, and strength"); Lindsey A. Vacco, Comment, Preimplantation Genetic
Diagnosis: From Preventing Genetic Disease to Customizing Children. Can the Technology Be
Regulated Based on the Parents' Intent?, 49 ST. LOuiS U. L.J. 1181, 1183 (2005) (stating a
scenario where PGD will be used "to select for traits such as intelligence, athletic ability, or
musical inclination").
507. Huang, supra note 503, at 658 (emphasis added).
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B. Dispelling the Myth of IQ Heritability-A Case Study
The source of human intelligence and cognition has been the
subject of study for well over a century.
508  Francis Galton first
proposed in the 1860s that genius and mental ability are as heritable
as physical traits.509  Evidence to support his thesis consisted of
"showing how large is the number of instances in which men who are
more or less illustrious have eminent kinsfolk."
510 The "laws" of
heredity with respect to genius were thus initially laid out by
surveying men of high reputation-judges of England, statesmen,
literary men, men of science, poets, musicians, etc.-within
hierarchies.511
From the start, this field was destined for controversy and
prone to racial animus masquerading as science. The founding father
of the field sponsored racial hierarchies, affirmed the superiority of
the ancient Greek race, and professed "the average intellectual
standard of the negro race is some two grades below [his] own."
512
Galton's vitriol had few limits. He even expressed that he often felt
ashamed of being human when flagrantly pondering about the "idiocy
among the negroes."513 Galton's ideology cemented racial contempt
into the foundation of the pseudoscience surrounding hereditable
human intelligence and mental cognitive ability.
General cognitive ability (GCA), also known as general
intelligence, or g, was first formally introduced in 1904.514 Research
on familial515 and twin516 studies in the early twentieth century
508. See generally FRANCIS GALTON, HEREDITARY GENIUS: AN INQUIRY INTO ITS LAWS AND
CONSEQUENCES (1st ed. 1869) [hereinafter GALTON 1st ed.], http://galton.org/books/hereditary-
genius/galton-1869-HereditaryGenius.pdf [https://perma.cc/82YP-SRMF]. For the second edition
published in 1892, see FRANCIS GALTON, HEREDITARY GENIUS: AN INQUIRY INTO ITS LAWS AND
CONSEQUENCES (2d ed. 1892), http://galton.org/books/hereditary-genius/text/pdf/galton-1
8 6 9 -
genius-v3.pdf [https://perma.cclLM6D-WNMU}.
509. GALTON 1st ed., supra note 508, at 1.
510. Id. at 6.
511. See id. at 2.
512. Id. at 338, 340.
513. Id. at 339.
[T]he number among the negroes of those whom we should call half-witted men, is
very large. . . . The mistakes the negroes made in their own matters, were so childish,
stupid, and simpleton-like, as frequently to make me ashamed of my own species. ... I
have no information as to actual idiocy among the negroes-I mean, of course, of that
class of idiocy which is not due to disease.
Id.
514. See C. Spearman, "General Intelligence", Objectively Determined and Measured, 15
AM. J. PSYCHOL. 201, 268-72 (1904).
515. See, e.g., HENRY HERBERT GODDARD, FEEBLE-MINDEDNESS: ITS CAUSES AND
CONSEQUENCEs vii (1914); HENRY HERBERT GODDARD, THE KALLIKAK FAMILY: A STUDY IN THE
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cemented the notion of the heritability of intelligence. Adoption
studies contributed a layer of complexity by concluding that the
environment has some considerable effect on a child's intelligence
quotient (IQ).517 Current estimates of g heritability attributed to
genetic factors ranges from 0.5 to 0.7,518 and to as high as 0.8.519
Studies over decades have consistently shown that g is a highly
heritable trait.520 Although the extent of the range of g heritability
estimates has been contested,521 the bulk of literature demonstrates
that g is at least reasonably heritable.522
Empirical evidence for g heritability provided by quantitative
genetics highlights the issue of whether there are specific genes and
Single Nucleotide Polymorphisms (SNPs)-variations in single
nucleotides at specific positions in the genome-responsible for
intelligence and GCA. Thanks to the advent of DNA sequencing
technology in the twenty-first century, attempts to identify the
"intelligence" gene(s) at the molecular level are underway.523 The
search, however, has proved the gene(s) to be incredibly elusive.
To date, several Genome-Wide Association Studies (GWAS)
have interrogated potential connections between various SNPs and g.
For instance, a GWAS of intelligence in middle to older adulthood
probing nearly 600,000 SNPs in approximately 3,500 individuals
found no specific genetic variants robustly associated with human
HEREDITY OF FEEBLE-MINDEDNESS viii (1912); Daniel Starch, The Similarity of Brothers and
Sisters in Mental Traits, 24 PSYCHOL. REV. 235, 237 (1917) (concluding that mental traits
resemblance among siblings is as great as that of physical traits).
516. See, e.g., Curtis Merriman, The Intellectual Resemblance of Twins, 33 PSYCHOL.
MONOGRAPHS 1, 16-18 (1924) (studying the intellectual level of a population of twin
children ages 5-14).
517. See, e.g., Frank N. Freeman et al., The Influence of Environment on the Intelligence,
School Achievement, and Conduct of Foster Children, in THE TWENTY-SEVENTH YEARBOOK OF
THE NATIONAL SOCIETY FOR THE STUDY OF EDUCATION 103, 106 (Guy Montrose Whipple ed.,
1928) (using foster children as a cohort to test whether residence in a foster home environment
can influence intellectual capacity).
518. Thomas J. Bouchard & Matthew McGue, Familial Studies of Intelligence: A Review,
212 SCIENCE 1055, 1056 (1981).
519. Thomas J. Bouchard, Jr., Genetic Influence on Human Intelligence (Spearman's g):
How Much?, 36 ANNALS HUM. BIOLOGY 527, 533 (2009).
520. See, e.g., Beben Benyamin et al., Large, Consistent Estimates of the Heritability of
Cognitive Ability in Two Entire Populations of 11-Year-Old Twins from Scottish Mental Surveys
of 1932 and 1947, 35 BEHAV. GENETICS 525 (2005).
521. See, e.g., B. Devlin et al., The Heritability of IQ, 388 NATURE 468, 470 (1997)
(arguing that, in addition to genes and environments, the heritability of IQ also depends on
maternal effects).
522. Contra Mae-Wan Ho, No Genes for Intelligence in the Fluid Genome, 45 ADVANCES
CHILD DEV. & BEHAV. 67, 70 (2013) (pointing out that some scientists and popular media tend to
mistakenly assume that highly heritable traits are predominantly genetically determined).
523. See supra and infra notes 518-58 and accompanying text.
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intelligence.5 24  Although a prior published gene-based test for
association had found one genome-wide significant association with
the gene FNBP1L, 525 which is highly expressed in neurons in
developing brains, the GWAS failed to replicate that result using an
independent sample.526
Members of the same team followed up with another GWAS,
this time focusing on childhood intelligence from nearly 18,000
individuals (ages six to eighteen) in six discovery and three replication
samples.527  Again, the study failed to identify individual SNPs
associated with childhood intelligence. 528 Gene-based analysis
revealed that SNP rs236330, located in FNBP1L, was strongly
associated with childhood intelligence.5 2 9 Yet, not even this SNP could
explain more than 0.24% of the total phenotypic variation,
530
suggesting that the largest effects of such SNPs are so minuscule that
other smaller-effect SNPs are virtually undetectable. Both studies
concluded that intelligence is highly heritable and polygenic, yet
GWAS results are consistent with a model of intelligence under which,
many genetic variants have very small additive effects.
53 1
A little over one year ago, an independent group attempted to
replicate the findings related to general cognitive ability and FNBP1L
via a more robust method (GWAS Plus) using nearly 2.6 million
SNPs.53 2 Results could not corroborate the aforementioned findings
and no gene reached statistical genome-wide significance using the
same methodology of the prior report.
533 Polygenic scores from all
SNPs considered could not even account for 1% of the total variance
(0.7%).534
524. G. Davies et al., Genome-Wide Association Studies Establish That Human
Intelligence Is Highly Heritable and Polygenic, 16 MOLECULAR PSYCHIATRY 996, 1001 (2011).
525. Id. at 999 (citing Jimmy Z. Liu et al., A Versatile Gene-Based Test for Genome-Wide
Association Studies, 87 AM. J. HUM. GENETICS 139 (2010)).
526. Id.
527. B. Benyamin et al., Childhood Intelligence Is Heritable, Highly Polygenic and
Associated with FNBP1L, 19 MOLECULAR PSYCHIATRY 253 (2014).
528. Id. at 257.
529. See id. at supp. fig. 6, https://genepi.qimr.edu.au/contents/p/stafflBENYAMIN
FNBPIL_MOLPSYCH_OSI.pdf [https://perma.cclQF6H-DYPZ].
530. Id. at 255.
531. Id.
532. Robert M. Kirkpatrick et al., Results of a "G WAS Plus": General Cognitive Ability Is
Substantially Heritable and Massively Polygenic, 9 PLOS ONE 4 (Nov. 10, 2014),
http://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0112390&type=printable
[https://perma.cc/TP2S-KKY6].
533. Id. at 10.
534. Id.
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A recent GWAS meta-analysis of more than 125,000
individuals identified ten SNPs associated with increased educational
attainment, three of which had genome-wide significant
associations.53 5 However, the contribution of each genetic locus was
incredibly small and the largest estimated effect was 0.02% of the
variance.53 6  The findings hint that the genetic basis of complex
behavioral phenotypes-e.g., intelligence-is far more diffuse than
that of complex physical traits.537 Three additional SNPs spanning
genomic regions across the KNCMA1, NRXN1, POU2F3, and SCRT
genes-all predicted to be involved in the glutamate
neurotransmission pathway and synaptic plasticity-were identified
in a subsequent publication using an alternate method.538 These
SNPs were statistically associated with cognitive performance in the
cohort, but like other preceding reports, the estimated effect for each
SNP was negligible (0.02%).539
The heritability of fluid general cognitive function in middle
and older age was studied in a large meta-analysis GWAS of nearly
2.5 million SNPs in approximately 54,000 individuals.540 Genome-
wide significant SNP associations were identified in three genomic
regions comprising thirteen SNP variants, associated with, inter alia,
MIR2113, AKAP6, NPAS3, TOMM40, and APOE.5 4 1 Gene-based tests
of association yielded one genome-wide significant result for HMGN1,
a gene that has been linked to some neurodevelopmental disorders.542
Together, all SNPs identified barely accounted for 1% of the total
variance, corroborating the conclusion that general cognitive function
is heritable and highly polygenic as others have shown before.543
Conflicting research and the manifest failure to reproduce
GWAS results connecting specific genes with human cognition have
prompted some scientists to call into question the validity of nearly a
decade's worth of research. For instance, a study published in 2012
535. Cornelius A. Rietveld et al., GWAS of 126,559 Individuals Identifies Genetic Variants
Associated with Educational Attainment, 340 SCIENCE 1467, 1468 (2013).
536. Id. at 1469.
537. Id.
538. Cornelius A. Rietveld et al., Common Genetic Variants Associated with Cognitive
Performance Identified Using the Proxy-Phenotype Method, 111 PROC. NAT'L ACAD. Sol. U.S.
13790, 13793 (2014).
539. Id. at 13792.
540. G. Davies et al., Genetic Contributions to Variation in General Cognitive Function: A
Meta-Analysis of Genome- Wide Association Studies in the CHARGE Consortium (N=53 949), 20
MOLECULAR PSYCHIATRY 183, 185 (2015).
541. Id. at 186-87.
542. Id. at 189.
543. Id. at 187.
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sought to replicate findings related to a dozen other genes reported to
be associated with g.5 44  Using data sets from three large,
independent, and well-characterized longitudinal studies, the group
found only one SNP associated with g that was nominally significant,
despite expectations of finding ten to fifteen significant associations.
545
The failure to identify unequivocal correlations prompted the group to
conclude that most reported genetic associations with GCA are likely
false positives.546
Given the existing body of literature in quantitative and
molecular genetics concerning g, it is not surprising that, to date, "[n]o
single SNP has yet been replicably associated with human intelligence
at genome-wide significance levels."
54 7 Although there is consensus
regarding the heritability of g, the hunt for the "intelligence gene(s)"
has largely proved to be an exercise in futility.
The molecular underpinnings of intelligence may ultimately be
a question that science will wrestle with for some time. The genetics-
based view that mere SNPs account for highly complex and polygenic
traits such as intelligence may very well be a gross underestimation of
the unknown truth. The missing heritability of intelligence may be
due to uncommon polymorphisms our current technologies cannot
detect or Copy Number Variations (CNVs)-deletions or duplications
of large sections of DNA. 548 In other words, entire sections of DNA, as
opposed to SNPs, could be responsible for a large proportion of human
genetic variation.549 On this point, several CNV regions have been
shown to carry genes related to development and cognitive ability.
5 50
. Alternatively, the basis for intelligence may rest in epigenetic
mechanisms. In contrast to genetics, which focus on the four
nucleotides (A, C, G, T) of the DNA alphabet, epigenetics is far more
complex in nature.551 Epigenetic mechanisms are capable of altering
gene expression without ever changing DNA sequences and comprise
post-translational modifications of histones and other proteins,
552
544. Christopher F. Chabris et al., Most Reported Genetic Associations with General
Intelligence Are Probably False Positives, 23 PSYCHOL. SCI. 1314 (2012).
545. Id. at 1319.
546. Id. at 1314.
547. Kirkpatrick et al., supra note 532, at 10.
548. Id. at 11.
549. See Andrew T.M. Bagshaw et al., No Effect of Genome- Wide Copy Number Variation
on Measures of Intelligence in a New Zealand Birth Cohort, 8 PLOS ONE e55208 (2013).
550. Id. (citations omitted).
551. See Enriquez, supra note 465, at 471, 483.
552. See, e.g., Andre Fischer et al., Recovery of Learning and Memory Is Associated with
Chromatin Remodelling, 447 NATURE 178 (2007) (studying the role of histone acetylation and
chromatin remodeling on learning and memory access).
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DNA modifications-e.g., methylation553-and regulatory RNA
molecules.554 Collectively, these epigenetic processes add an incredible
degree of complexity to gene regulation that takes into consideration
dietary, nutritional, social, cultural, pharmacological, and
environmental exposures.555
Yet another basis for g heritability could rest on principles of
pleiotropy-one gene affects many traits-and epistasis-one gene
affects expression of one or more genes. An article published recently
performed a systems-level analysis of genome-wide expression data to
reveal the existence of conserved gene-regulatory networks enriched
with genetic variants linked to human cognitive abilities.556 One such
network comprises up to 150 genes with tight coexpression
relationships.5 57 It may be the case that hundreds or thousands of
genes clustered into networks contribute to genetic associations and
heritability of g. It has been proposed that human intelligence is not
unitary, but rather rises from multiple cognitive components
organized into functionally specialized brain networks.558
As detailed in this Section, the potential complexity for highly
polygenic traits such as intelligence is remarkable. The take-home
message is that deceptively simplistic notions of "gene X is responsible
for trait Y' breed mass misperceptions about the role genetic
associations play in trait formation and development. In the case of
genome editing, one common "concern" advanced by some is that
genome editing technologies are inherently insidious because they will
eventually lead to creation of "designer babies" with a panoply of
artificial traits; high intelligence is purportedly one of them.55 9
However, as documented in this Section, anyone who claims that
technology is at the verge of enabling the creation of genius designer
babies has simply fallen prey to, or wishes to distract others with,
deceptive simplicity.
This Section used intelligence as a model for confronting
deceptive simplicity. However, the same principles apply to other
553. See, e.g., Swati Gupta et al., Histone Methylation Regulates Memory Formation, 30 J.
NEUROSCIENCE 3589 (2010) (investigating the role of the H3K4me3 epigenetic mark in memory
formation).
554. See Enriquez, supra note 465, at 471.
555. See id.
556. Michael R. Johnson et al., Systems Genetics Identifies a Convergent Gene Network for
Cognition and Neurodevelopmental Disease, 19 NATURE NEUROSCIENCE 223 (2016).
557. Id.
558. Adam Hampshire et al., Fractionating Human Intelligence, 76 NEURON 1225, 1233
(2012).
559. See, e.g., discussion supra note 506 and accompanying text.
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designer baby polygenic traits, such as height.
560 Simply put, human
knowledge is vastly incomplete concerning the genetics of these
complex polygenic traits. And the lack of knowledge does not justify
entertaining far-fetched hypotheticals in legal scholarship. It is
imperative that future scholars inform themselves about the scientific
matters on which they choose to comment. Scholarly standards ought
to be higher. Deceptive simplicity may appear benign at first glance,
but, as the next Section demonstrates, misinterpreting science and
spreading misinformation can lead to catastrophic societal
consequences.
C. Buck v. Bell-The Prototypical Fruit of Deceptive Simplicity
Buck v. Bell 5 6 1 is among the most horrid illustrations of
deceptive simplicity in the exercise of American jurisprudence. In a
surreal series of events, government-sanctioned sterilization arrived
at the most powerful court in the world: the US Supreme Court. It
made its case before learned judges and came out victorious without a
single word in opposition. A near unanimous Court upheld-eight to
one562-the constitutionality of a Virginia statute that legalized the
involuntary sterilization of individuals deemed "mental defectives" in
state institutions, provided it was in "the best interest of the patients
and of society."563
Writing for the Court, Oliver Wendell Holmes, Jr. infamously
memorialized what is arguably among the most incendiary and
ignorant language ever published in the United States Reports. "It is
better for all the world, if instead of waiting to execute degenerate
offspring for crime, or to let them starve for their imbecility, society
can prevent those who are manifestly unfit from continuing their
kind. . . . Three generations of imbeciles are enough."
564
The question presented in Buck was whether a statute
authorizing compulsory sterilization of the "feeble-minded" violated
the Due Process and Equal Protection clauses of the Fourteenth
560. At least 180 genetic variants have been reported to influence height in humans.
Hana Lango Allen et al., Hundreds of Variants Clustered in Genomic Loci and Biological
Pathways Affect Human Height, 467 NATURE 832 (2010). Thus, it is preposterous to claim that,
at this time or any time in the near future, genome editing technologies will allow humans to
engineer a world-class basketball player in a petri dish. See, e.g., Corsover, supra note 506, at
744.
561. Buck v. Bell, 274 U.S. 200 (1927).
562. Justice Pierce Butler dissented from the Court's decision, but filed no opinion of his
own. Id. at 200, 208.
563. Id. at 205-06.
564. Id. at 207 (emphasis added) (internal citation omitted).
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Amendment.565 The Court belabored-in one-third of its nearly three-
page decision-the argument that Carrie Buck had sufficient
procedural Due Process at law.5 66 Yet, the Court virtually ignored the
Equal Protection challenge, ridiculing it as a desperate "last resort"
argument for defending individual rights.5 6 7
The entirety of the opinion cited no constitutional authorities,
save for Jacobson v. Massachusetts,568 an inapposite case that
sanctioned the exercise of State police powers to authorize compulsory
vaccination statutes. At the same time, the Court ignored a series of
State cases dealing squarely with the Equal Protection question.5 69
Applying a primitive form of modern rational basis review, the Court
determined the State had a legitimate legal and policy justification to
sterilize Buck and promote the welfare of society by severing her
fallopian tubes.570 Notably, the decision did not examine any scientific
evidence to support its assertion that mental deficiencies are
congenital.
Appellant Carrie Elizabeth Buck, a teenager who had been
raped571 and institutionalized was characterized by the Court as "a
feeble-minded white woman . . . daughter of a feeble-minded mother
and the mother of an illegitimate feeble-minded child." 5 72
Reporters and scholars who met Buck before her death in 1983 all
agreed that she was not "feeble-minded" as the Court had stated, but
appeared to be a woman of normal intelligence.57 3 Furthermore,
research revealed that Vivian, Buck's daughter who lived until the age
of eight, had been an average student in school and was not mentally
disabled.574 Some have argued that the case itself was fraudulently
pursued.5 75 In any event, one can hardly disagree with the view that
what was done to Carrie Buck was gravely unjust and remains a stark
blemish on American law.
565. Id. at 205.
566. Id. at 206-07.
567. Id. at 208.
568. Id. at 207 (citing Jacobson v. Massachusetts, 197 U.S. 11 (1905)).
569. See id. at 200; see also Haynes v. Lapeer, 166 N.W. 938, 939, 941 (Mich. 1918)
(declaring Michigan's sterilization law unconstitutional); Smith v. Bd. of Exam'rs of Feeble-
Minded, 88 A. 963, 964, 967 (N.J. 1913) (striking, on Equal Protection grounds, New Jersey's
sterilization law); Davis v. Berry, 216 F. 414, 418 (S.D. Ia. 1914) (prohibiting the enforcement of
vasectomies for criminals twice convicted of a felony in Iowa).
570. Buck, 274 U.S. at 205.
571. PAUL A. LOMBARDO, THREE GENERATIONS, No IMBECILES: EUGENICS, THE SUPREME
COURT, AND BUCK V. BELL 140 (2008).
572. Buck, 274 U.S. at 207.
573. See Gould, supra note 50, at 331, 336.
574. Id. at 337-38.
575. LOMBARDO, supra note 571, at 154-55.
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Many have chronicled the history and legal implications of
Buck in bookS5 76 and legal scholarship.5 77 Consequently, this Article
will not belabor and rehash what has already been said about the
case.57 8 The conventional view is that Buck's holding is illegitimate
because it rests on false science5 79 and incorrect moral and ethical
principles.5 80 This Article rejects that conventional view and instead
contends that Buck is not the result of false science, but instead of
deceptive simplicity. In fact, as this Article argues below, Buck's
ruling is grounded more on deceptive simplicity than on the "science"
of the time, which was greatly void of empiricism, reproducibility,
adequate statistical methodology, and did not even come close to
establishing the heredity and genetic contributions of intelligence.
To support this proposition, consider first and foremost the
substantively porous decision published by the Court. Holmes cited
not a single scientific source for the Court's lending of credence to the
precarious notion that "heredity plays an important part in the
transmission of insanity, imbecility, etc."
581 In fact, the Court was
blatantly clear that its decision relied on "general declarations of the
Legislature"5 8 2 and "experience"583 showing the heritability of traits
related to cognitive deficiencies. The "experience" Holmes referred to
was quite probably the direct derivation of Galton's showing numerous
instances in which illustrious men engender illustrious kindred.
584 In
other words, the Court did not even bother to consider the existing
576. For a good, detailed historical account of the events leading up to the Supreme Court
litigation and the decision's aftermath, see id. at 149-55.
577. See, e.g., Robert J. Cynkar, Buck v. Bell: 'Felt Necessities' v. Fundamental Values?, 81
COLUM. L. REV. 1418 (1981); James C. Dugan, Note, Conflict Between 'Disabling' and 'Enabling'
Paradigms in Law: Sterilization, the Developmentally Disabled, and the Americans with
Disabilities Act of 1990, 78 CORNELL L. REV. 507 (1993); Paul A. Lombardo, Disability, Eugenics,
and the Culture Wars, 2 ST. LOUIs J. HEALTH L. & POL'Y 57 (2008).
578. For example, some scholars have discussed Buck's dismissal of the Equal Protection
Clause as the "last resort of constitutional arguments," Buck v. Bell, 274 U.S. 200, 208 (1927).
See, e.g., Nourse, supra note 50, at 115. Others contend that Equal Protection in state and lower
federal courts preceding Buck actually afforded strong constitutional claims against involuntary
sterilization. See Stephen A. Siegel, Justice Holmes, Buck v. Bell, and the History of Equal
Protection, 90 MINN. L. REV. 106, 108 (2005).
579. See, e.g., Lombardo, supra note 577, at 69 n.84, 69 n.85, 70-71 n.90 (citing Res. 247,
149th Gen. Assem., Reg. Sess. (Ga. 2007), which referred to the "so-called science of eugenics" as
a "pseudo-scientific movement"); Nourse, supra note 50, at 107 (arguing Buck is not part of
constitutional law curricula partly because it "is seen as a case about a false science").
580. See, e.g., Gould, supra note 50, at 336, 338-39.
581. Buck, 274 U.S. at 206.
582. Id. at 207.
583. Id. at 206.
584. See GALTON 1st ed., supra note 508, at 6.
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science. Instead, it wholly deferred to the Legislature and treated the
heredity of insanity and imbecility as a foregone conclusion.
Consequently, the notion that Buck's holding was based on
false science rests on an analytically precarious foundation. Simply
put, Buck relied on no science at all.
The case epitomizes an instance where the Supreme Court
allowed a State's erroneous scientific assertions to go unchallenged
and ruled on the basis of those faulty assertions. Although the Court
is not required to cross-examine every statement made by a legislative
branch before properly ruling on a given issue, it ought to consider, at
the very least, whether "general declarations" and "anecdotal
experience" constitute unequivocal evidence that withstands
constitutional scrutiny. Such analysis is imperative, more so in cases
where fundamental rights may be curtailed. In light of its blank
endorsement of compulsory sexual sterilization for mentally defective
and undesirable individuals-all justified by public welfare
pretenses-the Buck Court might as well have been acting as a lifeless
extension of a State's legislative branch.
Had the Court bothered to critically examine and analyze the
state of the science, it would have discovered that, contrary to popular
belief at the time, heredity's role in cognition and other traits was
highly inconclusive, contentious, and likely supported by flawed
methods. On this point, perhaps one of the most prominent examples
was the discovery of inheritance-independent genetic mutations by
Thomas H. Morgan, the late Nobel Laureate, in 1910.585 Morgan
observed that one white-eyed fruit fly had inexplicably appeared from
a contained stock of wildtype586 red-eyed flies in his laboratory.58 7 The
implications of this realization were that certain traits are not merely
inherited, but rather appear spontaneously as a result of
mechanisms-e.g., mutations-other than Mendelian genetics.
Morgan's observation and subsequent experiments using the
white-eyed mutant fly provided the foundations for the establishment
of the modern theory of the gene, which expanded and challenged the
simple model of Mendelian inheritance588 established at the turn of
the twentieth century.589
585. T.H. Morgan, Sex Limited Inheritance in Drosophila, 32 SCIENCE 120 (1910).
56 "Vildtype" refers to the most common phenotype for an organism in a natural breeding
population. Wildtype, BIOLOGY ONLINE http://www.biology-online.org/dictionary/Wildtype
[https://perma.cc/2QPV-S5VU] (last modified June 10, 2009).
587. Morgan, supra note 585, at 120.
588. Mendel's theory of inheritance was derived from his experiments of pea plants that
displayed only one physical trait-e.g., seed color (green or yellow), plant height (tall or short),
etc. Mendel challenged the existing view that all offspring were a combination of parental traits
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Morgan, who initially supported but later renounced the
eugenics movement590 after uncovering empirical scientific truth
through his research, eloquently presented the problem of the modern
interpretation of Mendelian inheritance when he stated:
[F]acts are being transformed into factors at a rapid rate.... The superior
jugglery sometimes necessary to account for the result, may blind us, if taken too
naively, to the common-place that the results are often so excellently "explained"
because the explanation was invented to explain them. We work backwards from
the facts to the factors, and then, presto! explain the facts by the very factors that
we invented to account for them . .. yet I cannot but fear that we are rapidly
developing a sort of Mendelian ritual by which to explain the extraordinary facts of
alternative inheritance. . . . [I]t is only fair to state that those who are doing the
actual work of progress along Mendelian lines are aware of the hypothetical nature
of the factor-assumption. But those who know the results at second hand and hear
the explanations given, almost invariably in terms of factors, are likely to exaggerate
the importance of the interpretations and to minimize the importance of the facts.
59 1
In time, others too began to publicly oppose eugenics,592 along
with its racist and classist undertones,593 as a pseudoscience.
594
However, despite the shouts of a few dissenting voices, eugenics
became deeply rooted in American culture, garnering support from
elites, scholars, and several institutions, including the Supreme
Court.595 Between 1907, when the first sterilization statute passed in
Indiana, and 1930, a total of twenty-three states had enacted
blended together. Among his scientific contributions are the laws of allele segregation and
independent assortment. See generally Mendel, supra note 58, at 1-2, 4.
589. See generally THOMAS H. MORGAN ET AL., THE MECHANISM OF MENDELIAN HEREDITY
1-2 (1915).
590. See Garland E. Allen, The Eugenics Record Office at Cold Spring Harbor, 1910-1940:
An Essay in Institutional History, 2 OSIRIS 225, 250 (1986).
591. T.H. Morgan, What Are 'Factors' in Mendelian Explanations?, 5 J. HEREDITY 365,
365 (1909).
592. Francis Galton was Charles Darwin's half-cousin and is considered to be the father
of eugenics. See LOMBARDO, supra note 571, at 7. He defined eugenics as "the science of
improving stock ... which, especially in the case of man, takes cognisance of all influences that
tend . . . to give to the more suitable races or strains of blood a better chance of prevailing
speedily over the less suitable." FRANCIS GALTON, INQUIRY INTO HUMAN FACULTY AND ITS
DEVELOPMENT 17 n.1 (1883) (internal citation omitted).
593. See PAUL POPENOE, APPLIED EUGENICS 15-16 (1918) ("The distinguished father is
likely to have a distinguished son, while the son of two 'nobodies' has a very small chance of
becoming distinguished. . . . [T]he son of a distinguished judge ha[s] about one chance in four of
becoming himself distinguished, while the son of a man picked out at random from the
population ha[s] about one chance in 4,000.").
594. See, e.g., LOMBARDO, supra note 571, at 155-56 (describing views from a Harvey
Wickham book, critical of outdated Mendelian inheritance, that was published just before the
announcement of the Buck decision).
595. Paul A. Lombardo, Taking Eugenics Seriously: Three Generations of ??? Are
Enough?, 30 FLA. ST. U. L. REV. 191, 203-07 (2003).
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eugenical sterilization laws.5 96  By 1933, four years after Buck,
twenty-two states introduced new sterilization laws.5 9 7 During the
span of seven decades (1907-1979), a total of more than 65,000
sterilizations in thirty-two states took place in the United States.598
Morgan's conceptualization of second-hand explanations that
lead to exaggeration, oversimplification, and a poor understanding of
scientific progress is precisely the deleterious essence of deceptive
simplicity, which is broader and more damaging than mere
pseudoscience.
The distinction is crucial. Whereas false, or pseudo, science
refers to a system of theories and rules configured to give the
appearance of being grounded in scientific methodology,599 deceptive
simplicity dangles from vague intuition derived from reductive
explanations that strip logic beyond a bare minimum.
Accordingly, Galton's elaborate, hyperbolic, cognitive
hereditability theses and explanations, which worked backwards
"from the facts to the factors," were so "excellently explained"60 0
because he created a counterfeit theoretical basis to support his
unscrupulous racist ideology. It was false science. In contrast,
Holmes' opinion in Buck did not even attempt to embellish its
reasoning with false science. Buck institutionalized compulsory
sterilization using vague intuition born out of second-, third-, and
fourth-hand reductive explanations that diminished heredity to a
deceptively simple catchphrase popularized by false science: imbecility
is a heritable disease. Consequently, Buck embodies a conclusory
ruling bereft of legal or scientific reasoning. It was deceptive
simplicity, bred to be more dangerous than false science. Indeed, the
Nazi party relied on Buck and its deceptive simplicity to legitimize its
eugenic agenda.601
Pseudo-intellectual hogwash became the deceptive simplicity
that propelled, maintained, and expanded the eugenics agenda. The
596. HARRY H. LAUGHLIN, THE LEGAL STATUS OF EUGENICAL STERILIZATION 7, 57 (1930).
597. Nourse, supra note 50, at 103 n.18 (quoting VICTORIA F. NOURSE, IN RECKLESS
HANDS: SKINNER V. OKLAHOMA AND THE NEAR TRIUMPH OF AMERICAN EUGENICS 24 (2008)).
598. LOMBARDO, supra note 571, at xiii, 294 app. C.
599. Pseudoscience is defined as "a system of theories, assumptions, and methods
erroneously regarded as scientific." Pseudoscience, MERRIAM-WEBSTER ONLINE DICTIONARY,
http://www.merriam-webster.com/dictionary/pseudoscience [https://perma.cclRAT7-SH36] (last
visited Feb. 15, 2017).
600. Morgan, supra note 591, at 365.
601. See, e.g., TRIALS OF WAR CRIMINALS BEFORE THE NUREMBERG MILITARY TRIBUNALS
VOL. IV 1158-59 (1950) (publishing an extract from a document entered on behalf of Otto
Hofmann, a high ranking SS officer and key contributor to Nazi Germany's eugenics laws, citing
Buck v. Bell, 274 U.S. 200 (1927) to establish that Nazi eugenic practices during World War II
were derived from race protection laws in other European countries and the United States).
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historical account is crystal clear: Buck did not rely on false science; it
was the product of pervasive deceptive simplicity concerning a
rationale for the heritability of human cognitive abilities and mental
deficiencies. No legitimate scientific debate existed regarding the
simplistic pre-twentieth century view of Mendelian inheritance
adopted by the Court in 1927.
At the time Buck made its way into the Supreme Court,
eugenics was not a real scientific movement,
602 but rather a reductive
political and social fad that fed off of outdated scientific theories,
misinformation, and gossip. The propaganda had been de facto
codified into popular culture by deceptive merchants with ulterior
motives and dangerous agendas. And Justices of the US Supreme
Court, despite all their education and intellect, proved to be highly
susceptible to it.
Given the fact that Buck lacked any constitutional
603 or
scientific support for its holding and came thickly veiled with
deceptive simplicity, the decision amounts to no more than
institutionalized legal quackery built upon social and scientific
quackery.
D. Forging a Path Forward
This Article's genome editing primer coupled with the proposed
normative legal framework makes the case that a jurisprudence of
scientific empiricism is the best available weapon against the
deleterious harms of deceptive simplicity. Judicial review is in dire
need of structure when addressing questions of science in law.
One promising sign that the Supreme Court is open to adopting
a jurisprudence of scientific empiricism is the 2013 decision in
Myriad.604 The case contemplated whether isolated DNA
605 segments
602. For instance, during the 1920s, only approximately 10 percent of members of the
Advisory Council of the American Eugenics Society were trained geneticists. Cynkar, supra note
577, at 1426.
603. See discussion supra notes 565-70 and accompanying text.
604. Ass'n for Molecular Pathology v. Myriad Genetics, Inc., 133 S. Ct. 2107, 2110 (2013).
605. In Myriad, the Supreme Court considered the patentability of two types of DNA
molecules: DNA fragments isolated from naturally occurring genomic DNA and complementary
DNA (cDNA). The Court held that genic sequences isolated from genomic DNA were not patent
eligible under section 101 because they are products of nature. Id. at 2120. In contrast, the Court
held that cDNA was patent eligible under section 101 because it is "not naturally occurring." Id.
at 2119. The decision to distinguish between these types of DNA molecules raises some
uncertainty about the patent eligibility of other types of DNA molecules under section 101, many
of which are used in biotechnological research. See id. at 2120 (withholding judgment on the
applicability of section 101 to DNA in which the order of the naturally occurring nucleotides has
been altered because it "presents a different inquiry").
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from naturally occurring genes are patent eligible under 35 U.S.C. §
101.606 Justice Thomas prefaced the Court's unanimous opinion with
a foundation of genetic concepts relevant to the question presented.6 07
Despite some inaccuracies related to protein synthesis,608 RNA
processing,609 and DNA non-coding regions,6 10 the Court more or less
accurately described the science-certainly enough to competently
rule on the merits. The Court's efforts to ground its decision in
scientific facts should be commended.611  However, other recent
Similarly, although the Court determined cDNA was patent eligible under section 101, it
expressed no opinion regarding cDNA's ability to withstand the test of other statutory
requirements under patent law. See id. at 2119 n.9. While cDNA has cleared section 101 hurdles,
potential future sections 102, 103, and 112 challenges could ultimately render it unpatentable.
Lastly, it bears noting that Myriad is important in ways we do not yet fully understand.
Future application of Myriad's holding is likely to have significant implications not only for
section 101 litigation, but other areas of patent law.
606. Id. at 2111.
607. Id. at 2111-12.
608. "Sequences of DNA nucleotides contain the information necessary to create strings of
amino acids, which in turn are used in the body to build proteins." Id. at 2111. This statement is
incorrect because amino acid "strings" are not used in the body to build proteins. Amino acid
"strings" are the proteins themselves in an unfolded state. As ribosomes synthesize polypeptide
chains ("strings"), a series of intermolecular forces-ionic interactions, hydrophobic effect,
hydrogen bonding, and others-begin the process of protein folding. Thus, the strings of amino
acids fold into proteins. Proteins can come together to form ("build") complexes. Protein Structure
Jmols: Primary Structure, CTR. BIOMOLECULAR MODELING, http://cbm.msoe.edulincludes
/modules/j molProteinStructure/primarystructure.html [https://perma.cclB6U5-K62V] (last
visited Feb. 15, 2017). Alternatively, the Court could have been referring to messenger RNA
(mRNA) molecules, which are used by the ribosomes as templates to create ("build") the strings of
amino acids. CHRIS R. CALLADINE ET AL., UNDERSTANDING DNA: THE MOLECULE AND How IT
WORKS 14 (3rd ed. 2004).
609. "Transcription results in a single strand RNA molecule, known as pre-RNA."
Myriad, 133 S. Ct. at 2111. This statement refers to the transcription of DNA into primary
transcripts-a single stranded RNA molecule that has not been processed. Suzanne Clancy, DNA
Transcription, 1 NATURE EDUC. 41 (2008). A primary transcript is later processed to yield
various forms of RNA molecules-e.g., mRNAs, piRNAs, miRNAs, tRNAs, IncRNAs, rRNAs, etc.
Anita Quintal Gomes et al., Non-Coding RNAs: Multi-Tasking Molecules in the Cell, 14 INT'L J.
MOLECULAR SCI. 16010 (2013). The Court may have been referring to mRNA processing, in
which a pre-mRNA (not pre-RNA) molecule undergoes processing to become a mature mRNA.
Introducing mRNA Processing, VIRTUAL CELL ANIMATION COLLECTION,
http://vcell.ndsu.edulanimations/mrnaprocessing/index.htm [https://perma.cc/7FGX-T9GW] (last
visited Feb. 15, 2017).
610. "Nucleotides that do not code for amino acids ... are known as 'introns."' Myriad,
133 S. Ct. at 2111. This statement is factually inaccurate because many non-coding nucleotides
exist in promoter, enhancer, silencer, and other regulatory regions of the genome that are not
introns. The Court may have been referring to non-coding nucleotides within a gene's open
reading frame (ORF) that are spliced out during processing. Lucy W. Barrett et al., Regulation of
Eukaryotic Gene Expression by the Untranslated Gene Regions and Other Non-Coding Elements,
69 CELLULAR & MOLECULAR LIFE SCI. 3613 (2012).
611. So should US District Judge Sweet, who published a substantive section on the
relevant scientific concepts in his lower court ruling. See Ass'n for Molecular Pathology v.
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decisionS612 suggest that Myriad may have been an outlier case as it
dealt with patent law, which is fundamentally scientific and highly
technical.
Both the legal and scientific communities should strive to
eradicate the influence of deceptive simplicity. Such a task is not
monistic and will require interdisciplinary cooperation. For example,
the Buck-era eugenics movement was successful partly because
scientists with the most relevant knowledge were largely confined to a
life of research and failed to effectively communicate with the public to
correct scientific misperceptions. At the same time, the legal
community's disengagement from science was partly responsible for
the failure to overcome scientific deceptive simplicity in the judiciary.
Building a system structured in a manner that encourages lawyers to
weld scientific empiricism and jurisprudence would greatly benefit
society.
Many questions will be raised and answered regarding
numerous aspects of genome editing biotechnologies in the near
future. Lawyers and scientists must be careful to properly frame
those questions rationally and fairly. An example of a legitimate issue
regarding genome editing is whether the technology will be safe for
clinical use in the near future.613 However, constructing arguments
based on impracticalities when supporting or opposing technological
advances should have no place in jurisprudential calculus. Seeking to
ban a genome editing technology because of a perceived threat of the
possibility of introducing designer babies, when no evidence exists to
suggest that the technology is capable of delivering such outcomes,
makes as much sense as seeking to ban space travel because we might
encounter an extraterrestrial race that will want to annihilate
USPTO, 702 F. Supp. 2d 181, 192-99 (S.D.N.Y. 2010), aff'd in part, rev'd in part in Myriad, 133
S. Ct. 2107.
612. See, e.g., Burwell v. Hobby Lobby Stores, Inc., 134 S. Ct. 2751, 2759 (2014) (holding
closely held corporations may be exempt from the contraceptive mandate in the Patient
Protection and Affordable Care Act of 2010 based on the sincerely held religious beliefs of
owners). In Hobby Lobby, Justice Alito, writing for the Court, erroneously stated that all four
methods at issue in Hobby Lobby may operate after an egg's fertilization, which contradicts the
scientific empirical evidence available both at the time the case was decided and today. Id. at
2777; see also, U.S. Food & Drug Admin., Birth Control: Medicines to Help You, FDA,
https://www.fda.gov/forconsumers/byaudience/forwomen/freepublications/ucm
3 13215.htm
[https://perma.cclX8RT-ZGPW] (last updated Sept. 8, 2016) (providing some information on FDA-
approved and cleared methods for birth control).
613. Jesse Gelsinger, an eighteen-year-old man suffering from an X-linked genetic disease
characterized by an inability to metabolize ammonia in the liver, died on September 17, 1999,
after receiving a dose of gene therapy under a clinical trial run by the University of
Pennsylvania. See Rick Weiss & Deborah Nelson, Teen Dies Undergoing Experimental Gene
Therapy, WASH. POST, Sept. 29, 1999, at A01. He was the first person reported to have died from
an experimental gene therapy treatment. Id.
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humankind. At this moment in time, designer babies are as
hypothetical as extraterrestrial monsters.
Rather than advocating haphazard bans on genome editing
technologies as some have proposed,614 this Article advocates for a
system that lays a doctrinal foundation to proliferate rejection of
deceptive simplicity. 6 15 This concept is more sensible because, unlike
outright banning technologies that the public is unfamiliar with, it
promotes broad debate of the issues and does not dictate unilaterally
what should or should not be permissible in society.
In sum, the normative framework advocated here seeks to
cultivate and expand Myriad's roots of scientific empiricism. This
approach is broadly applicable to other fields of law in which scientific
inquiry may play important or dispositive roles.
VI. CONCLUSION
CRISPR systems and their future progeny hold the power to
change the world. This nascent biotechnology has incredible potential,
but its future is filled with uncertainty regarding how the law will
treat it going forward. The scientific community has made efforts to
begin a dialogue about genome editing technologies and their
implications for the future of humankind. However, the legal
community has yet to fully address the significant challenges that
genome editing will pose for law and policy making. The void in legal
scholarship is quickly growing to the detriment of society. This Article
marks a first step toward closing the gap between science and law
regarding this momentous scientific breakthrough.
Cooperation between lawyers and scientists will be pivotal as
genome editing technologies continue to develop and mature in an
increasingly globalized and interconnected world.616 Thus, a uniform
doctrinal structure is sorely needed to address future questions that
will be raised by the ensuing applications of CRISPR-based
technologies. To that end, this Article presents a robust and
comprehensive primer on genome editing as a resource and proposes a
jurisprudence of scientific empiricism as a normative legal framework
to broadly address questions of science in law. This paradigm seeks to
promote a system in which lawyers are able to fuse scientific
614. See Lanphier et al., supra note 28 and accompanying text.
615. If there is anything this Article would support banning, it would be the use of the
term "designer babies"-alongside its derivations-in future discussions concerning genome
editing technologies. See discussion supra Part V.A. This Article's position is that it makes no
sense to pollute debate of scientific advances with the use of such misleading terminology.
616. See Enriquez, supra note 24, at 1289-91, 1336.
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empiricism and jurisprudence to combat scientific illiteracy, as well as
the oversimplification and misinterpretation of scientific advances,
which are all common substantive impediments to constructive
debate. It is time to adhere to higher standards in this regard.
Taken together, a compilation of the genome editing research
performed globally over the last three years begins to paint a very
specific portrait: genome editing biotechnologies, and CRISPR systems
in particular, represent not only tools for basic research, but gateways
to significant medical and scientific breakthroughs to come. This
Article provides a foundation for a series of forthcoming articles
617 that
will analyze many of the prospective benefits and risks associated
with the use of genome editing biotechnologies from statutory,
constitutional, international, ethical, regulatory, egalitarian, and
policy standpoints. The goal is to jumpstart a scholarly dialogue,
highlight the crucial roles that law, science, and public policy will play
in the development of this emerging technology, and encourage debate
grounded in reason rather than baseless conjecture.
We owe it to ourselves and future generations to treat this
remarkable new technology with the gravitas it deserves.
617. See, e.g., Enriquez, supra note 31. Collectively, these works seek to build a
foundation for what may be considered "genome editing law" in general, and "CRISPR law" in
particular.
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